Home Blog Page 4

Bioidentical Hormones: Key Facts in a Clinical Approach

By
Dr Alexander D Jimenez DC, APRN, FNP-BC, CFMP, IFMCP
-

Understand how bioidentical hormones are used in a clinical approach for personalized treatments and improved hormonal balance.

Abstract

In this educational post, I share how I identify and treat hormonal insufficiency in women and men using modern, evidence-based protocols, while integrating chiropractic care to improve neuromuscular function and autonomic balance. I explain what declining estradiol and testosterone feel like, why symptoms can be misattributed to mood disorders, and how I use pellets, split-dose injections, transdermal patches, and strategically applied nutraceuticals to restore physiologic signaling. I detail formulation advances, such as ethylcellulose and triamcinolone in pellets; fertility-preserving options, like clomiphene; and decision rules guided by FSH, free testosterone, and symptom scales. Throughout, I present the latest findings from leading researchers, describe how I safely titrate therapy, and show how integrative chiropractic care supports endocrine outcomes by aligning biomechanics, autonomic function, and recovery. My goal is to help you feel like yourself again, consistently, by uniting precise physiology with compassionate clinical care.

Understanding Hormone Insufficiency: What Patients Feel and Why It Matters

Every week in clinic, I hear versions of the same story: “I feel irritable, foggy, and exhausted,” “my drive is gone,” or “I can’t sleep.” These are hallmark signs of hormone insufficiency, most often involving estradiol and testosterone, with downstream effects across dopamine, serotonin, and GABA systems that modulate mood, motivation, and sleep (Gordon & Girdler, 2021).

  • Common symptom clusters:
    • Women: hot flashes, night sweats, sleep disturbance, low libido, mood instability, fibromyalgia-like pain
    • Men: low stamina, reduced libido, weight gain, daytime fatigue, mood changes
    • Both: anxiety, restlessness, poor stress tolerance, nonrestorative sleep

Physiologically, estradiol modulates synaptic plasticity in the prefrontal cortex and hippocampus, stabilizing sleep architecture and emotional regulation (Gordon & Girdler, 2021). Testosterone supports mitochondrial function, muscle integrity, and nitric oxide signaling; when low, energy drops and musculoskeletal resilience declines (Basualto-Alarcón et al., 2017). Far beyond “sex hormones,” these are systemic regulators of brain, muscle, vascular, and immune physiology.

Moving Beyond Symptom-Only Care: Why Replacement Is Often the Root Solution

Historically, patients with mood or sleep symptoms were rapidly placed on SSRIs or anxiolytics. While these tools can be helpful, they may leave the underlying endocrine deficit unaddressed. Evidence shows that bioidentical estradiol and carefully titrated testosterone can reduce vasomotor symptoms, improve sleep, and restore libido and mood when physiologically appropriate (Manson & Kaunitz, 2020; Rosenthal & Gleason, 2019).

  • Why I consider hormone replacement:
    • Corrects root-level signaling instead of masking symptoms
    • Stabilizes circadian cues and autonomic tone
    • Supports musculoskeletal repair and improves pain thresholds
    • Reduces vasomotor instability and sleep fragmentation

My stepwise approach:

  • Validate symptoms and map them to likely endocrine pathways
  • Test estradiol, FSH, LH, SHBG, total/free testosterone, and metabolic safety labs
  • Build an individualized plan using pellets, patches, or targeted transdermals, plus nutraceuticals, sleep care, and integrative chiropractic to optimize neuromuscular function and autonomic balance.

Testosterone and Estradiol: Choosing Delivery Methods That Fit Physiology

Bioidentical Pellets: Continuous, Convenient, and Stable

Pellets deliver steady-state micro-doses over months, avoiding peaks and troughs typical of daily or weekly routes. In women, visits are often 3–4 times per year. When executed with sterile technique and proper aftercare, complications are rare, and side effects are usually dose-dependent and reversible (Rosenthal & Gleason, 2019).

  • Benefits:
    • Smooth pharmacokinetics minimize bolus-related side effects.
    • Convenience and improved adherence
    • Reversible dosing with careful management
  • Risks:
    • Uncommon cellulitis or local reactions; typically managed medically without pellet removal
    • Mild androgenic effects (chin hair, acne) in some women; adjust dose to resolve

Formulation Innovations: Ethylcellulose and Triamcinolone

Since 2017, I have favored pellets utilizing ethylcellulose to create a sustained-release profile, which lowers rapid peaks that can trigger acne and excess aromatization in men. A small amount of triamcinolone reduces local inflammatory reactions and scarring, improving tissue tolerance. Together, these choices:

  • Smooth peak-trough curves
  • Reduce transient estradiol spikes in men
  • Improve procedure-site tolerance

This aligns with the principle of hormone mimicry—delivering levels that resemble physiologic production (Rosenthal & Gleason, 2019).

Pellet Mechanics: Horizontal vs. Vertical Pressing

Pellet manufacturing matters. Horizontal pressing distributes integrity evenly, promoting consistent dissolution and steadier serum levels. Vertical pressing can produce softer cores late in the dissolution process, leading to abrupt changes in symptoms. I prefer horizontally pressed pellets to avoid “roller-coaster” experiences.

Transdermal Creams and Patches: Targeted Use

Transdermal estradiol patches offer cardiometabolic neutrality compared with oral routes, avoiding first-pass hepatic effects that may elevate thrombotic risk (Manson & Kaunitz, 2020). In women, labial testosterone or DHEA can provide predictable local uptake for vulvovaginal symptoms due to high vascularity and receptor density, though creams are unreliable for consistent systemic androgen levels.

  • When I use creams:
    • Localized vulvovaginal issues (dryness, vestibulodynia)
    • Adjunct to systemic therapy for libido and tissue integrity
  • Patches:
    • Postmenopausal: start mid-range and titrate
    • Older patients: low-dose to gently “wake up” receptors

Injections: Why Split-Dose Strategies Improve Stability

Injectable testosterone cypionate works well in men when dosed and monitored appropriately. To reduce peak-related aromatization, erythrocytosis, and mood lability, I typically split the weekly dose (e.g., 200 mg/week → 100 mg twice weekly). Smaller, more frequent doses improve peak-trough stability, reduce estradiol spikes, and lower hematologic risk (Bhasin et al., 2018; Grossmann, 2018; Finkelstein et al., 2013).

  • Practical dosing:
    • Younger men may transiently require higher totals under close monitoring
    • Older men often do best with low doses (e.g., 25 mg/week)
    • Subcutaneous microdosing in daily aliquots can further smooth absorption and mood (Snyder et al., 2016)

Fertility-Preserving Option in Younger Men: Clomiphene Citrate

For younger men prioritizing fertility, clomiphene citrate can stimulate endogenous testosterone by increasing LH and FSH via selective estrogen receptor modulation (Taylor et al., 2013). I commonly start at 25 mg daily, watch symptom response, and titrate cautiously.

  • Rationale:
    • Maintains intratesticular testosterone and spermatogenesis
    • Avoids testicular atrophy seen with exogenous testosterone
  • Caveats:
    • Less effective with advancing age, as LH signaling weakens
    • Best used short-term while addressing sleep, nutrition, and training

Modulating Women’s Hormones-Video

Modulating Women Hormones Part 1 of 3 l El Paso, Tx (2021)

How Hormones Shape Weight, Pain, and Sleep

Estradiol enhances brown adipose tissue activation and leptin sensitivity, supporting thermogenesis and appetite regulation as estradiol declines, visceral adiposity, inflammation, and glycemic drift rise (Santoro et al., 2022). Testosterone drives muscle protein synthesis and mitochondrial biogenesis, improving resting metabolic rate and load resilience (Basualto-Alarcón et al., 2017). Both modulate nociception and central pain amplification, explaining fibromyalgia-like presentations in deficiency.

  • Clinical reports:
    • Difficulty losing weight despite conscientious nutrition
    • Higher pain sensitivity and slow recovery from strain
    • Nonrestorative sleep that amplifies fatigue and brain fog

Correcting hormones, paired with sleep optimization, anti-inflammatory nutrition, and chiropractic neuromechanical care, improves vagal tone, reduces sympathetic overdrive, and normalizes pain thresholds.

Integrative Chiropractic Care: Aligning Structure, Autonomics, and Endocrine Signaling

In my model, chiropractic care is synergistic with hormone therapy. Mechanical dysfunction alters afferent signaling to the CNS, shifting autonomic balance and hypothalamic regulation. Restoring joint mechanics and soft-tissue health reduces nociceptive input, dampens sympathetic load, and supports HPA/HPG axis stability.

Clinical observations shared through the Sciatica & Chiropractic Clinic and my professional updates consistently show:

  • Correcting lumbo-pelvic and thoracic biomechanics improves sleep depth and reduces pain rumination
  • Targeted myofascial release and nerve mobilization to lower neurogenic inflammation and enhance circulation
  • Breathing retraining and postural stabilization increase vagal tone, improving hormone feedback loops and resilience

Practical integration:

  • Use hormone therapy to restore systemic reserves
  • Apply chiropractic adjustments and soft-tissue work to reduce allostatic load
  • Prescribe mobility and strength progressions to reinforce neuromuscular signaling
  • Monitor heart rate variability and sleep metrics to track autonomic change

Explore more of my clinical observations:

Progesterone in Perimenopause and Postmenopause: Calming the System and Protecting the Endometrium

By the early 40s, many women experience progesterone decline, presenting as heavy, clotty periods, PMS, anxiety, and sleep disruption. I commonly use micronized progesterone:

  • Perimenopause:
    • 100 mg nightly to stabilize cycles, reduce anxiety, and improve sleep
    • Flex the dose during symptomatic phases to match luteal volatility
    • Sublingual use can provide rapid GABAergic calming within ~25 minutes (Friess et al., 1997)
  • Postmenopause with estrogen therapy:
    • 200 mg nightly is typical for endometrial protection and sleep support
    • Adjust timing or split doses if morning grogginess occurs
    • In very elderly patients, lower doses and lower estradiol reflect reduced receptor sensitivity

Progesterone transforms the endometrium into a secretory state, counteracting estrogen’s proliferative effects and reducing the risk of hyperplasia (Stute et al., 2016; Santoro et al., 2023).

Practical Testosterone in Women: Low, Thoughtful, and Monitored

Women benefit from low-dose testosterone to support libido, energy, lean mass, and cognitive clarity. I often start at 10–12 mg/day, either topically or sublingually, titrating based on symptoms and tolerability. In select cases, microdosed subcutaneous injections (e.g., 25–50 mg/week, divided daily) may be considered, with careful monitoring of hair, skin, and lipids. If androgenic signs appear (e.g., alopecia), I reduce or stop high-density regimens, check ferritin, thyroid, DHEA, SHBG, and support scalp health (Trueb, 2010).

Key point: In women, symptom clusters often outweigh single serum values because tissue-level metabolism, SHBG, and receptor sensitivity vary widely. I respect labs but treat patients, confirming benefit through improved sleep, libido, mood, energy, and body composition (Davis & Braunstein, 2012; Parish et al., 2019).

Monitoring and Safety: Symptom Scales, Labs, and Data-Driven Follow-Up

I integrate standardized symptom scales and careful lab timing to steer care:

  • Scales:
    • Menopause Rating Scale (MRS) at baseline and ~3 weeks to quantify change (Heinemann et al., 2004)
    • Aging Male Symptoms (AMS) Scale similarly anchors outcomes in men (Da Silva et al., 2014)
  • Lab strategy:
    • For injections: draw through labs just before the next dose, after 4–5 cycles
    • Track total/free testosterone, estradiol, SHBG, CBC (hematocrit), CMP, lipids, A1c/insulin, TSH/free T4/T3, vitamin D, ferritin
    • In women on estrogen, investigate bleeding with appropriate imaging and endometrial assessment (Santoro et al., 2023)

I also use FSH as a compass for postmenopausal estrogen status: high FSH indicates low estradiol; replacement lowers FSH, mirroring TSH suppression in thyroid care. Early reductions of about 50 percent in elevated FSH correlate with rapid improvements in vasomotor symptoms, sleep, mood, and joint pain; I often aim for FSH around 20 IU/L over several insertions, noting consistent improvements in energy and body composition (Rope, 2022).

Perimenopause Strategy: Why Low-Dose Estradiol Stabilizes Symptoms and Migraines

Perimenopause is defined by volatility—ovaries still produce estrogen, but the swings trigger vasomotor symptoms, sleep disruption, mood lability, and menstrual migraine. A low-dose estradiol pellet (~6 mg) sets a basal floor that prevents deep dips. High postmenopausal doses can overwhelm endogenous patterns and provoke mastalgia, fluid retention, and breakthrough bleeding. Low-dose baseline smooths variability while respecting residual ovarian output and has been highly effective in aborting cyclical migraines linked to estrogen withdrawal (Santoro et al., 2016; MacGregor, 2018).

Transition Rules and Sequencing: Smoother Pharmacokinetics, Better Adherence

To avoid withdrawal and overlap effects:

  • Women on an estradiol patch who receive pellets can typically stop the patch within 3–5 days
  • Men and women moving from injections or gels to pellets often continue the prior modality for ~2 weeks as a bridge while pellets reach peak integration over 6–8 weeks.

I also sequence add-ons like DHEA, thyroid therapy, or GLP-1 agents after initial stabilization (often reassessing around 6 weeks). This prevents misattribution of side effects to pellets and improves adherence (Manson & Kaunitz, 2020).

Aromatase Management in Men: Split Dosing First, AIs Rarely

In “shot world,” men sometimes reach for aromatase inhibitors (AIs) preemptively. My evidence-based approach is first to adjust the dose and frequency, then optimize sleep, body composition, insulin sensitivity, and alcohol intake—each of which can shift aromatase activity. Over-suppressing estradiol can impair libido, vascular function, lipid levels, and bone health, so if an AI is truly needed, I use the lowest effective dose for a brief period and reassess (Finkelstein et al., 2013; Coviello et al., 2005).

Nutraceutical and Lifestyle Supports: Enhancing Signaling and Resilience

Hormone therapy works best on a foundation of anti-inflammatory and regenerative supports:

  • Evidence-informed nutraceuticals:
    • Omega-3 fatty acids for neuroinflammation and membrane health (Bazinet & Layé, 2014)
    • Vitamin D and magnesium as cofactors for steroidogenesis and muscle function (Deng et al., 2017)
    • Creatine for ATP buffering in muscle and brain, synergistic with androgens (Dolan et al., 2017)
    • Adaptogens (ashwagandha, rhodiola) to modulate stress responses and support HPA resilience (Panossian & Brendler, 2020)
  • Lifestyle pillars:
    • Sleep: 7.5–8.5 hours with consistent circadian timing
    • Resistance training to enhance insulin sensitivity and endogenous androgen signaling
    • Mediterranean-style nutrition to reduce inflammatory load
    • Breathwork, mindfulness, and HRV biofeedback to strengthen autonomic balance

These pillars reduce the dose burden required for symptom control and accelerate recovery.

Clinical Pearls from Practice: What Consistently Improves Outcomes

  • Steady-state wins: Pellets with ethylcellulose reduce acne and mood volatility compared with large bolus shots in my practice (Rosenthal & Gleason, 2019).
  • Local-first for vulvovaginal issues: Labial DHEA/testosterone improves tissue health and libido without chasing systemic lab targets.
  • Fertility matters: In younger men, clomiphene is a smart bridge—start low, monitor, and acknowledge diminishing LH responsiveness with age (Taylor et al., 2013).
  • Structural support for signaling: Chiropractic interventions that reduce nociception and improve alignment deepen sleep and make hormone therapy feel more effective.
  • Safety is practical: Most side effects are reversible. Medical management of rare infections is typical; pellet removal is seldom necessary.

For ongoing insights and case reflections:

References

SEO tags: hormone optimization, bioidentical hormone pellets, ethylcellulose sustained release, triamcinolone pellets, estradiol patch safety, testosterone split dosing, aromatase management, erythrocytosis risk, micronized progesterone perimenopause, endometrial protection, clomiphene fertility preservation, integrative chiropractic care, autonomic balance HRV, neuromuscular function, menopause migraines estradiol, FSH guidance postmenopause, free testosterone SHBG, labial DHEA testosterone, sleep optimization, anti-inflammatory nutrition

Hormone Optimization and Health for Everyone

By
Dr Alexander D Jimenez DC, APRN, FNP-BC, CFMP, IFMCP
-
Hormone Optimization and Health for Everyone
Hormone Optimization and Health for Everyone

Integrative Hormone Optimization and Health: An Evidence-Based, Chiropractic-Informed Guide

Abstract

In this educational post, I walk you through a practical, research-informed approach to optimizing hormones in all individuals, addressing iron deficiency, cyclic progesterone for heavy bleeding, PCOS considerations, post–gastric bypass care, and the physiology of testosterone therapy. I also discuss contraception choices around age 40–45, SHBG-driven symptoms, and the nuanced use of progesterone versus progestins. Throughout, I highlight how integrative chiropractic care and functional medicine principles support endocrine regulation, inflammatory control, vascular safety, and musculoskeletal resilience. Clinical observations from my practice inform the protocols presented, and I link them to the latest evidence from leading researchers using modern, high-quality methods.

Hormone Optimization and Health for Everyone

Iron Deficiency, Heavy Bleeding, and Cyclic Progesterone: Getting the Fundamentals Right

When I meet a woman with fatigue, heavy periods, or cognitive fog, I first consider iron metabolism and menstrual blood loss. Many women present with iron deficiency, even when hemoglobin appears acceptable, because ferritin and transferrin saturation better reflect true iron status. Chronic heavy bleeding depletes iron stores and precipitates anemia, impairs thyroid hormone utilization, and worsens fatigue and mood symptoms.

  • Key points:
    • Assess ferritin, transferrin saturation, CBC, and reticulocyte count.
    • Replete iron with gentle protocols (e.g., oral ferrous bisglycinate or sucrosomial iron) to maximize absorption and minimize GI upset.
    • Coordinate thyroid evaluation: TSH, free T4, free T3, reverse T3, and thyroid antibodies for a complete picture.

Why cyclic progesterone? In women with heavy bleeding and luteal phase insufficiency, cyclic micronized progesterone can reduce endometrial proliferation, stabilize the lining, and decrease blood loss. The physiology is straightforward: progesterone opposes estrogen-driven endometrial growth, improves spiral artery regulation, and shortens the duration of bleeding. I often initiate cyclic micronized progesterone in the luteal phase while correcting iron and supporting thyroid function; the combination reduces bleeding and restores energy by addressing both input (blood loss) and systemic utilization (thyroid-driven metabolic rate) (Barbieri, 2020; ACOG, 2021).

  • Practical approach:
    • Begin cyclic micronized progesterone in the luteal phase (e.g., days 14–28) and adjust based on cycle length and bleeding.
    • Pair with iron repletion and a thyroid-appropriate protocol to improve cellular oxygen delivery and metabolic efficiency.
    • Monitor ferritin target 50–100 ng/mL for symptom resolution while avoiding iron overload.

Section Title: PCOS, SHBG, and Progesterone Nuances: Tailoring to the Individual

Polycystic ovary syndrome (PCOS) involves hyperandrogenism, ovulatory dysfunction, and metabolic dysregulation. Elevated insulin increases variability in hepatic production of sex hormone–binding globulin (SHBG) and alters free androgen and estrogen availability. Women on combined oral contraceptives often show very high SHBG values; this binds circulating testosterone with little increase in free T, leaving them symptomatic despite normal or high total values (Escobar-Morreale, 2018; ACOG, 2019).

  • Clinical reasoning:
    • If a 45-year-old patient has very high SHBG (e.g., 115 nmol/L) and significant symptoms, her free testosterone may remain low until total values are quite high; many clinicians hesitate to titrate to effective total levels.
    • Consider contraception alternatives that reduce SHBG impact, such as a levonorgestrel intrauterine device (IUD), thereby improving free hormone availability and symptom response.
    • Treat PCOS with insulin-sensitizing strategies (nutrition, physical activity, inositol, metformin, if appropriate) alongside cyclic progesterone to support regularity and reduce the risk of endometrial hyperplasia.

Why this matters: By shifting contraception to an option that does not drive SHBG upward, we reduce binding of bioactive hormones and restore physiologic signaling. Cyclic progesterone addresses heavy bleeding and PMS symptoms without the thrombotic risks associated with estrogen-containing pills in older age groups (Legro et al., 2013; ACOG, 2019).

Post–Gastric Bypass Care: Absorption, Microbiome, and Targeted Supplementation

Bariatric procedures alter gastric acidity, transit time, and absorptive surface area. Patients are at greater risk of deficiencies in iron, B12, folate, fat-soluble vitamins, and trace minerals. Because nutrient absorption shifts distally, we must rethink dosing forms and microbiome support (ASMBS, 2020).

  • Practical steps:
    • Use more bioavailable nutrient forms (e.g., methylcobalamin sublingual, transdermal Vitamin D3/K2 when needed, chelated minerals).
    • Employ probiotics and prebiotics to support lower bowel reconditioning and SCFA production; consider multi-strain formulations with Lactobacillus and Bifidobacterium species.
    • Monitor iron, ferritin, B12, folate, Vitamin D, zinc, copper, and thiamine regularly.

Physiology: Lower gastric acidity decreases iron and B12 liberation from food, while altered transit reduces contact with absorptive sites. Microbiome shifts can modulate estrogen recycling via the estrobolome, affecting hormone balance and systemic inflammation. Supporting the gut improves nutrient uptake and endocrine homeostasis (Wilson et al., 2020).

Testosterone Therapy Physiology: Absorption, Distribution, and Renal Excretion

Understanding testosterone kinetics guides safer dosing and better outcomes. Transdermal or pellet-based testosterone follows an intuitive pharmacokinetic path:

  • Absorption: Dependent on skin surface area, capillary perfusion, and cardiac output. Increased physical activity improves perfusion, enhancing absorption from pellets or creams.
  • Distribution: Influenced by body mass and composition. After significant weight loss, there is less tissue volume to distribute the dose, often resulting in a stronger clinical response to the same dose. Conversely, higher BMI dilutes concentration across larger compartments.
  • Excretion: Primarily renal. Older adults with reduced renal clearance maintain higher levels for longer; hence, lower doses can last for months.

In my practice, older men may maintain therapeutic pellet levels for 6–9 months due to slower excretion. In younger, active patients, pellets are metabolized more quickly, necessitating standard durations of 3–4 months. Thinking in terms of absorption, distribution, and excretion allows us to set expectations and adjust dose and interval appropriately (Bhasin et al., 2018).

  • Managing estrogenic symptoms:
    • Early therapy sometimes triggers transient breast tenderness due to rapid shifts in aromatization and receptor sensitivity. This typically resolves once steady state is achieved.
    • In men with persistent symptoms, lifestyle measures (weight loss, reduced alcohol, sleep optimization) lower aromatase activity. Selective use of nutraceuticals such as diindolylmethane (DIM) may aid estrogen metabolism, but I reserve anti-estrogen drugs for specific, documented indications, ensuring we do not blunt anabolic benefits without cause (Eisenberg et al., 2017).

DVT Risk, Contraception After Age 40, and Safer Symptom Control

Deep vein thrombosis risk rises with estrogen-containing contraceptives, especially as age and vascular risk factors accumulate. For a woman around age 45 who no longer needs pregnancy prevention (IUD or tubal ligation already in place), continuing combined pills for period control is rarely a favorable risk–benefit decision. Instead, I address heavy bleeding and PMS with non-estrogen options: cyclic micronized progesterone, levonorgestrel IUD, or targeted endometrial therapy depending on the case (ACOG, 2019; Lidegaard et al., 2012).

  • Strategy:
    • Clarify the purpose of contraception: pregnancy prevention vs symptom management.
    • If pregnancy prevention is covered, discontinue estrogen pills and transition to a progestin IUD or cyclic progesterone for bleeding/PMS.
    • Evaluate SHBG, free and total testosterone, thyroid, and replete iron when bleeding has been heavy.
    • This reduces thrombotic risk while effectively addressing symptoms.

Progesterone vs Progestins: Different Molecules, Different Outcomes

It is essential to differentiate natural micronized progesterone from synthetic progestins (e.g., medroxyprogesterone acetate, norethindrone). Micronized progesterone binds progesterone receptors with physiologic signaling, supports sleep and mood through GABAergic effects, and has a more favorable metabolic and vascular profile. Progestins are designed for contraception; they can activate androgenic, glucocorticoid, and mineralocorticoid pathways to varying degrees, with different effects on lipids, insulin sensitivity, and breast tissue (Stute et al., 2016; Santen et al., 2020).

  • Clinical implications:
    • In perimenopause and menopause, micronized progesterone is often preferred for symptom control, sleep quality, and endometrial protection alongside transdermal estradiol when indicated.
    • In premenopausal contraception, progestins are used for pregnancy prevention; they are not interchangeable with progesterone when the main goal is symptom relief.
    • For heavy bleeding without contraception needs, micronized progesterone cyclic regimens can be safer and more effective.

Environmental Factors, SHBG Modulation, and Realistic Expectations

Patients frequently ask about environmental exposures and supplements that claim to lower SHBG. While certain nutrients and lifestyle strategies can shift SHBG by 10–15%, this modest change often does not translate into clinically meaningful differences in free hormone levels for symptomatic patients. I focus on targeted endocrine drivers: insulin resistance, thyroid status, iron deficiency, hepatic health, and inflammation. A realistic conversation prevents frustration and directs effort to interventions with measurable impact (Dunn et al., 2015).

Integrative Chiropractic Care: Bridging Neuroendocrine, Vascular, and Musculoskeletal Health

Integrative chiropractic care complements hormone optimization by improving autonomic balance, reducing mechanical pain generators, and enhancing circulation and lymphatic flow. The neurophysiological rationale includes:

  • Autonomic regulation: High sympathetic tone exacerbates vasoconstriction, sleep disruption, and cortisol dysregulation. Gentle spinal manipulation, myofascial release, and breathing techniques reduce sympathetic dominance and improve vagal tone, supporting uniformity of hormonal rhythms and menstrual regularity.
  • Pain and inflammation: Mechanical pain amplifies systemic cytokine levels (IL-6, TNF-α), which can interfere with gonadal hormone signaling and thyroid hormone conversion. Addressing sacroiliac dysfunction, thoracolumbar junction restrictions, and cervical proprioception reduces inflammatory load, improving endocrine responsiveness.
  • Circulation and lymphatics: Mobilization and targeted exercise prescriptions increase the efficacy of the muscular pump, aiding venous return and mitigating edema—particularly relevant when managing heavy bleeding, fatigue, or estrogen-related fluid changes.

In my clinical observations at the Sciatica & Chiropractic Clinic and across my patient cohort, combining endocrine protocols with chiropractic-informed movement retraining yields better sleep, fewer PMS symptoms, and a more stable mood. I also employ functional nutrition and gut-focused care to support the estrobolome and metabolic flexibility, particularly in patients with PCOS and post–gastric bypass.

  • Integrative plan components:
    • Spine and pelvis alignment to reduce nociceptive input and autonomic stress.
    • Prescribed walking intervals and resistance training to lower aromatase activity and improve insulin sensitivity.
    • Diaphragmatic breathing, HRV biofeedback, and sleep hygiene to stabilize cortisol and melatonin rhythms.
    • Gut-directed therapies (probiotics, fiber diversity, polyphenols) to balance estrogen metabolism.

Practical Dosing Nuances, Safety, and Patient Expectations

Patients sometimes request extra testosterone doses due to anecdotes from peers. I counsel that supraphysiologic dosing can lead to paradoxical outcomes: erectile softness due to receptor downregulation or increased aromatization, fluid shifts, and mood volatility. Evidence-based dosing respects physiological windows while monitoring hematocrit, lipids, liver enzymes, and PSA in men. For women, I titrate carefully to avoid virilizing effects and balance symptom relief with safety (Bhasin et al., 2018).

  • Safeguards:
    • Check hematocrit/hemoglobin thresholds and avoid unnecessary elevations; manage with dose adjustment and lifestyle before considering phlebotomy.
    • Track SHBG, free testosterone (calculated or measured via equilibrium dialysis), estradiol, and progesterone.
    • In older adults, adjust for slower renal excretion to prevent prolonged supra-therapeutic levels.

Case-Inflected Insights: Weight Loss, Testosterone, and Dose Response

Significant weight loss reduces distribution volume, often increasing effective testosterone exposure per unit dose. I have observed that patients who drop 20% of body fat achieve target symptom resolution with lower or less frequent dosing, while those with persistent central adiposity may need more aggressive lifestyle intervention to reach the same endpoints. In women, I am cautious with testosterone; we use the lowest dose necessary for sexual function, energy, or musculoskeletal support, and we reassess frequently to maintain a favorable safety profile (Eisenberg et al., 2017).

Clinical Workflow: Building the Right Team and Sequence

Complex endocrine cases benefit from a coordinated care team: primary care, endocrinology or women’s health, nutrition, and integrative chiropractic. My workflow emphasizes:

  • Initial labs: CBC, ferritin, transferrin saturation, TSH, free T4/T3, insulin, fasting glucose, HOMA-IR, SHBG, total and free testosterone, estradiol, progesterone, hs-CRP, and Vitamin D.
  • Prioritize bleeding control and iron repletion before escalating hormone therapies.
  • Choose a contraception aligned with vascular safety and symptom goals.
  • Integrate movement and stress modulation early to improve absorption and clearance dynamics.

This sequence reduces risk, clarifies clinical signals, and preserves patient trust through predictable milestones.

Key Takeaways and Next Steps

  • Correct iron deficiency and stabilize thyroid function before refining hormone dosing; both are foundational to energy and mood.
  • Use cyclic micronized progesterone to reduce heavy bleeding; reserve estrogen-containing pills in older patients only when pregnancy prevention is necessary, and risks are acceptable.
  • In PCOS, prioritize insulin sensitization, weight management, and low-SHBG-impact contraception to enhance free hormone bioavailability.
  • Understand testosterone kinetics (absorption, distribution, and excretion) to set dosing intervals; older adults often require lower doses with longer durations due to reduced clearance.
  • Leverage integrative chiropractic care to modulate autonomic tone, reduce inflammation, and support musculoskeletal resilience; improved physiology amplifies endocrine therapy effectiveness.
*How do we evaluate patients? * Dr. Alex Jimenez | El Paso, Tx (2021)

References

DHEA: Understanding Its Importance in Hormonal Health

By
Dr Alexander D Jimenez DC, APRN, FNP-BC, CFMP, IFMCP
-

Discover ways to optimize your hormonal health and DHEA levels for improved energy, mood, and overall well-being.

Abstract

In this educational post, I walk you through a practical, evidence-based approach to optimizing hormones from a systems perspective. We explore why high or low sex hormone-binding globulin (SHBG) signals important metabolic phenotypes; how gut dysbiosis drives polycystic ovary syndrome (PCOS) and why insulin resistance must be corrected to restore ovulation; how to use percent-free PSA, velocity of change, and prostate MRI to manage testosterone therapy in men safely; and why dehydroepiandrosterone (DHEA) is a powerful neurosteroid and immunomodulator that often unlocks clinical progress when patients still “don’t feel it” despite good serum levels. I also describe how integrative chiropractic care—targeted musculoskeletal stabilization, autonomic regulation, graded movement, and lifestyle coaching—fits into the plan, and I share clinical observations from my practice. The goal is to equip you with modern, research-backed methods and clear reasoning so you can confidently apply these protocols.

About the author

I’m Dr. Alexander Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST. I bring together chiropractic, functional medicine, and advanced nursing to deliver integrative care grounded in physiology, clinical outcomes, and the latest research. You can explore more of my work and case insights at sciatica. clinic and on my LinkedIn profile.

Foundational Concepts: Building a Metabolic Map That Makes Hormones Work

Over the years, I realized the most successful outcomes come from understanding the terrain surrounding hormones—not just placing pellets or writing a prescription. Early in my career, I learned basic dosing rules and lab timing. But the real training happened over years of managing patients with “good labs” and poor outcomes. That gap is where physiology meets lived experience.

Key lessons I internalized:

  • Hormones operate within a metabolic ecosystem.
  • Thyroid status, vitamin D, oxygenation, cardiorespiratory fitness, inflammation, glycemic control, and gut integrity determine receptor sensitivity and downstream signaling.
  • SHBG is not just a lab nuisance; it’s an adaptive signal with real metabolic meaning.
  • DHEA isn’t merely a precursor—it’s a neurosteroid with distinct receptors and immunological actions.
  • In women, syndromes like PCOS are rarely “ovary-first” disorders—they are often gut-immune-metabolic disorders that secondarily disrupt ovarian function.

Clinical observation: I have patients who come in convinced “these hormones aren’t working.” They have normal-to-high serum levels, yet symptoms persist—fatigue, low mood, low libido, poor skin, irregular cycles. When we optimize vitamin D, correct thyroid, address insulin resistance, and repair the gut, receptors start responding, and the same hormone doses begin to “work.”

Why this matters: Hormone therapy without a metabolic context yields inconsistent results. This is why integrative chiropractic care—autonomic regulation through manual therapies, graded movement, sleep, and stress coaching—becomes essential. By stabilizing the neuro-musculoskeletal system and autonomic tone, we decrease inflammatory signaling, improve circulation and oxygen delivery, and normalize vagal inputs that modulate endocrine and immune axes.

Sex Hormone-Binding Globulin: A Metabolic Signal, Not a Foe

SHBG binds sex steroids (testosterone, estradiol), modulating bioavailability. Clinicians often try to”lower SHBG” to get more free testosterone. That’s a mistake. SHBG tracks with cardiometabolic health.

  • Low SHBG commonly associates with insulin resistance, metabolic syndrome, hepatic steatosis, and higher cardiometabolic risk (Ding et al., 2009; Pascual-Leone et al., 2020).
  • Higher SHBG levels are often associated with improved insulin sensitivity and reduced risk of type 2 diabetes, particularly in women (Travison et al., 2017; Maggio et al., 2013).

Physiology: When insulin is high, hepatic SHBG production falls, increasing free androgens. This can exacerbate acne, hirsutism, and ovarian dysfunction in women and can distort androgen signaling in men by saturating tissues with labile free androgen peaks, yet poor receptor coherence.

Clinical implications: Don’t “chase SHBG down.” Instead, correct insulin resistance, improve liver health, and optimize thyroid and vitamin D to improve receptor function.

  • If SHBG is high and the patient on testosterone has symptoms, consider:
  • Incrementally titrating total testosterone to saturate enough binding capacity while monitoring free levels.
  • Using nutraceuticals that improve androgen metabolism and hepatic function (e.g., diindolylmethane, shilajit compounds with supportive data for mitochondrial and endocrine effects) while addressing diet, fiber, and circadian rhythms.
  • Prioritizing lifestyle interventions—sleep regularity, resistance training, aerobic conditioning—to normalize insulin and hepatic SHBG production.

Integrative chiropractic fit:

  • Thoracic and rib mechanics influence ventilation and oxygenation; adjusting them can improve O2 delivery and aerobic capacity, thereby indirectly supporting endocrine signaling.
  • Vagal afferent stimulation through manual therapy may reduce sympathetic overdrive, which worsens insulin resistance and inflammatory tone.

PCOS As a Gut–Immune–Metabolic Disorder: Correct the Root, Calm the Ovaries

PCOS is the most common endocrine disorder in women of reproductive age. Many are not obese; not all have cysts. The phenotype is diverse. The thread connecting these phenotypes is often gut dysbiosis, systemic inflammation, and hyperinsulinemia, driving hyperandrogenism.

  • Diagnostic frame (Rotterdam criteria): At least two of the following—oligo/anovulation, hyperandrogenism (clinical or biochemical), polycystic ovaries (ESHRE/ASRM, 2004; Teede et al., 2018).
  • Insulin resistance precedes and amplifies ovarian hyperandrogenism via reduced SHBG and increased LH pulsatility (Lundsberg et al., 2021).

Physiology:

  • Dysbiosis increases gut permeability, allowing lipopolysaccharide (LPS) and other microbial products to provoke immune activation and insulin resistance.
  • Hyperinsulinemia lowers SHBG, raises ovarian androgen production, and disrupts folliculogenesis.
  • Chronic low-grade inflammation blunts progesterone signaling and increases miscarriage risk.
  • PCOS patients often have progesterone deficiency, elevating miscarriage risk even when conception occurs.

Clinical approach I use:

  • Keep it simple and consistent:
    • Ensure daily bowel movements; normalize fiber, hydration, and magnesium when needed.
    • Add a high-quality probiotic with clinically studied strains to support metabolic and GI health.
    • Coach sustainable dietary changes—high-fiber, low-ultra-processed choices; prioritize protein; reduce refined sugars; consider intermittent fasting if appropriate.
    • Correct insulin resistance:
  • Metformin titrated slowly to 2,000 mg/day to minimize GI side effects (start 500 mg nightly, layer doses every few weeks).
  • Consider GLP-1 receptor agonists (semaglutide, tirzepatide), which can lower insulin and weight, thereby allowing SHBG to rise and bind excess free androgens (Wilding et al., 2021; Jastreboff et al., 2022).
    • Optimize thyroid parameters and vitamin D, both critical for receptor function and ovulatory signaling.
    • Correct progesterone deficiency:
  • In women aiming to conceive or with recurrent luteal phase defects, I aim for luteal progesterone levels >20 ng/mL (often 200 mg nightly of micronized progesterone, with an additional 100 mg in the daytime if indicated), while monitoring cycles and symptoms.
  • Symptom relief for hirsutism/acne:
  • Spironolactone can help; in PCOS, I may use 100 mg/day because of androgen receptor sensitivity, while in non-PCOS hair issues, I seldom exceed 50 mg/day to avoid excessive androgen blockade. Topicals can be added for acne.
  • Pelleting testosterone in PCOS phenotypes:
  • Start low and go slow. PCOS-spectrum patients exhibit heightened hair follicle sensitivity and often have lower SHBG levels. Aggressive dosing can trigger cystic acne and hirsutism.
  • I start around 87.5 mg and titrate based on free testosterone, symptoms, and side effects, rather than chasing total numbers.

Integrative chiropractic fit:

  • For PCOS-related abdominal bloating and pelvic discomfort, gentle stabilization of the abdominal wall, pelvis, and lumbar spine, combined with diaphragmatic breathing, reduces intra-abdominal pressure and improves motility and vagal tone.
  • Stress-regulation protocols—graded breathing work, cervical and suboccipital release—may reduce sympathetic dominance, which worsens insulin resistance and menstrual irregularity.

Clinical outcome example:

A patient with PCOS took three years to restore regular ovulation. She optimized thyroid function, adhered to metformin titration, improved sleep and stress management, and corrected progesterone deficiency. Without a drastic dietary overhaul, her consistency in these fundamentals led to spontaneous conception and a healthy pregnancy. Progress can be gradual—patience and fidelity to protocol matter.

PSA, Percent-Free PSA, and MRI: Safely Managing Testosterone in Men

When men seek testosterone optimization, prostate risk management must be precise and updated to modern standards.

Key points:

  • PSA velocity: A jump from 0.9 to 2.9 ng/mL year-over-year implies a markedly increased risk, even if the absolute PSA seems” not high enough.”
  • Percent-free PSA enhances sensitivity. Lower percent-free PSA suggests a higher likelihood of clinically significant cancer (Catalona et al., 1998; Murtola et al., 2017).
  • Activities like ejaculation or prostate massage can elevate total PSA, but do not alter percent-free PSA—helpful in interpretation.
  • 5-alpha-reductase inhibitors, e.g., (finasteride), reduce total PSA by about 50%; double the measured value to approximate true PSA when interpreting results (Thompson et al., 2003).
  • Newer guidance supports resuming TRT once PSA normalizes after appropriate urologic management, rather than waiting years, with shared decision-making and close monitoring (Mulhall et al., 2018).

Clinical pathway I use:

  • If total PSA is elevated, I automatically reflex to percent-free PSA.
  • If percent-free PSA is <10%, cancer likelihood is high; I refer to urology and often order a prostate MRI, which is now considered the gold standard for detection and localization, reducing unnecessary biopsies (Futterer et al., 2015; Kasivisvanathan et al., 2018).
  • MRI frequently distinguishes prostatitis or BPH from suspicious lesions, providing clarity and sparing invasive procedures when possible.
  • For percent-free PSA in intermediate ranges, I treat symptomatic prostatitis and recheck.
  • I educate patients on abstaining from ejaculation for 48 hours before a blood draw to reduce spurious total PSA elevations.

Integrative chiropractic fit:

  • Pelvic floor and lumbosacral mechanics affect prostatic venous/lymphatic drainage. Gentle pelvic floor coordination and sacral mobilization can lower pelvic congestion, potentially easing prostatitis symptoms when combined with medical therapy.
  • Anti-inflammatory lifestyle coaching—sleep, movement, nutrient density—supports lower CRP and cytokine burden that can aggravate prostatic symptoms.

DHEA: The Overlooked Neurosteroid That Often Closes the Symptom Gap

Clinicians and patients frequently treat DHEA as a mere precursor to testosterone. Modern evidence shows that DHEA is a potent steroid with its own receptors in the brain and nervous system, as well as immunomodulatory and endothelial effects. Levels decline with age, mirroring and amplifying the decline in testosterone and thyroid conversion efficiency.

Physiology and actions:

  • DHEA modulates natural killer cells, cytokine balance, and endothelial function, supporting vascular health and mood (Weiss et al., 2009; Maninger et al., 2009).
  • It influences the HPA axis; high cortisol suppresses DHEA. Restoring DHEA helps counter catabolic, stress-related physiology and may improve mood and resilience.
  • Neurosteroid actions support cognitive function, mood, and libido—especially via conversion to DHT, the primary libido metabolite in many patients.

Clinical pattern I see:

  • Women with optimized thyroid and estrogen/testosterone still complain of fatigue, low mood, and low libido. When we measure DHEA-S and find it low to midrange, careful titration of DHEA often improves subjective vitality, libido, and mood.
  • DHEA levels are typically much higher in magnitude than testosterone levels; moving patients into the upper-normal range is often associated with better clinical outcomes, similar to vitamin D and T3 optimization strategies.

Dosing approach:

  • I prefer compounded DHEA for precision (e.g., 10–20 mg nightly in sensitive patients; titrate based on symptoms and labs).
  • For over-the-counter forms, I start cautiously because conversion to DHT can cause acne or hair changes; PCOS-spectrum patients often do not tolerate DHEA well due to androgen sensitivity.
  • Targeting upper-normal DHEA-S levels (sex-specific) is often associated with improved well-being and lower inflammatory markers (Vasan et al., 2016).

Integrative chiropractic fit:

  • Stress physiology matters. Manual therapy that reduces nociception and improves autonomic balance can lower cortisol and help DHEA “take hold.”
  • Structured movement programs increase neurotrophins and vascular health; paired with DHEA, patients often report synergistic improvements in mood, energy, and sexual health.

Vitamin D: Receptor Biology and Why Patients “Suddenly Feel It”

One of my long-term patients was prepared to quit hormone therapy because she felt nothing. We discovered she was inconsistent with her vitamin D intake. I asked her to take it daily for three months—no other changes. She returned transformed: better energy, mood, and libido, and she refused to stop vitamin D again.

Reasoning:

  • Vitamin D binds nuclear receptors (VDR) that cross-talk with steroid hormone receptors, modulating gene transcription, immune balance, and tissue responsiveness (Carlberg, 2019). Optimizing vitamin D enhances receptor sensitivity, often turning “good labs” into “good outcomes.”

Integrative chiropractic fit:

  • Outdoor movement for circadian entrainment and safe sun exposure, combined with strength training and myofascial work, improves bone, muscle, and endocrine signaling. Vitamin D sufficiency supports calcium handling and neuromuscular function—patients feel stronger and more resilient.

Putting It All Together: Protocol Logic and Clinical Sequencing

My approach is stepwise:

  1. Assess the metabolic terrain
  • Thyroid, vitamin D, glucose/insulin status (fasting insulin, A1c), lipids, CRP, liver panel, SHBG, free testosterone, DHEA-S.
  • In women with cycle issues, evaluate progesterone and consider AMH where fertility is relevant.
  • Correct the foundation
  • Normalize sleep, movement, fiber, and hydration.
  • Add appropriate probiotic and anti-inflammatory nutrition.
  • Titrate metformin to 2,000 mg/day if insulin resistance; add GLP-1 RA if indicated.
  • Supplement vitamin D to sufficiency; optimize thyroid.
  • Tailor hormone therapy intelligently.
  • Respect SHBG as a health signal; adjust dosing based on free levels and symptoms, not only totals.
  • In PCOS phenotypes, start testosterone low, titrate slowly, and use spironolactone for symptom relief when needed, while addressing root insulin resistance and gut dysbiosis.
  • In men, always pair PSA with percent-free PSA and consider MRI when indicated. Account for 5-ARI effects and PSA velocity.
  • Add DHEA when appropriate
  • If symptoms persist despite reasonable labs, test DHEA-S and consider careful supplementation, especially in women without PCOS-spectrum androgen sensitivity.
  • Monitor for DHT-related side effects and adjust as needed.
  • Integrative chiropractic care is the glue
  • Use targeted manual therapy to reduce pain and sympathetic tone.
  • Employ diaphragmatic breathing and pelvic-lumbar stabilization to improve GI motility and pelvic circulation.
  • Prescribe graded movement to enhance insulin sensitivity and oxygen delivery.
  • Provide lifestyle coaching to sustain these gains.

Clinical observations from my practice

  • Patients with consistent sleep, movement, and GI care respond faster to hormone adjustments and need fewer dose escalations.
  • In PCOS, ovulatory restoration is often an 18–36 month journey; honest timelines avoid discouragement.
  • In men, percent-free PSA and MRI save many from unnecessary biopsies while safely continuing TRT under thoughtful surveillance.
  • In women, optimized DHEA-S plus vitamin D often unlocks libido and mood when other levers have stalled.

Conclusion: Evidence-Based, Physiology-Driven, Integrative Care Works

Hormone therapy succeeds when we respect physiology. SHBG tells a metabolic story; PCOS arises from gut–immune–insulin interactions; PSA requires nuanced interpretation to keep men safe on testosterone; and DHEA’s neurosteroid actions are routinely underappreciated. Pairing these insights with integrative chiropractic care creates a practical, human-centered pathway. The result is not only improved labs but meaningful, lived improvements in energy, mood, pain, fertility, and sexual health.

Key Takeaways

  • Treat SHBG as a health marker; correct insulin resistance rather than suppress SHBG.
  • PCOS care begins in the gut and with insulin; progesterone support is essential for pregnancy maintenance.
  • Combine PSA with percent-free PSA and consider MRI to refine risk and reduce unnecessary biopsies.
  • DHEA is a neurosteroid and immunomodulator; optimize DHEA-S to the upper-normal range when appropriate.
  • Integrative chiropractic modalities enhance autonomic regulation, reduce inflammation, and improve endocrine responsiveness.

References

In-text citation examples (APA-7):

  • SHBG and metabolic syndrome relationships (Travison et al., 2017; Maggio et al., 2013)
  • PCOS insulin resistance mechanisms (Lundsberg et al., 2021; Teede et al., 2018)
  • MRI as gold standard for prostate evaluation (Futterer et al., 2015; Kasivisvanathan et al., 2018)
  • DHEA neurosteroid actions (Maninger et al., 2009; Vasan et al., 2016)

SEO tags: SHBG and testosterone, PCOS gut dysbiosis, percent-free PSA MRI, DHEA neurosteroid libido, integrative chiropractic hormone therapy, metformin titration GLP-1 PCOS, progesterone miscarriage prevention, vitamin D hormone receptor sensitivity, testosterone therapy safety, functional medicine endocrine optimization

Unlocking Hormonal Balance and Personalized Treatment

By
Dr Alexander D Jimenez DC, APRN, FNP-BC, CFMP, IFMCP
-
Unlocking Hormonal Balance and Personalized Treatment
Unlocking Hormonal Balance and Personalized Treatment

Unlocking Hormonal Balance: A Patient-Centered Guide to Hormone Replacement Therapy

Abstract

Hello, I’m Dr. Alexander Jimenez. This educational post examines the complex signs of hormonal decline in all individuals and delves into the various evidence-based hormone replacement therapy (HRT) methods available today. As a practitioner holding titles including DC, APRN, FNP-BC, and CFMP, I will guide you through the clinical signs of low testosterone and estrogen, including mood changes, sleep disturbances, metabolic shifts, and chronic pain. We will then compare and contrast different treatment modalities such as pellets, injections, creams, and oral/sublingual options, evaluating their efficacy, benefits, and potential drawbacks. Special attention will be given to the physiological mechanisms behind each method, dosing considerations for different patient populations, and the importance of individualized, layered treatment plans. The discussion will cover the crucial roles of progesterone and FSH in symptom management and therapy guidance, concluding with foundational principles of hormone optimization. We will also touch on how integrative chiropractic care complements these hormonal strategies by addressing the body’s structural and neurological integrity, which is often compromised by the systemic effects of hormonal imbalances.

Unlocking Hormonal Balance and Personalized Treatment

The Human Experience of Hormonal Decline

Hello, I’m Dr. Alexander Jimenez. In my years of clinical practice at my sciatica and wellness clinic, I’ve had countless patients describe their emotional and physical state with a single, powerful image—one of a person barely holding on, overwhelmed and frayed at the edges. This picture perfectly encapsulates the mood of someone experiencing the often-disorienting effects of hormonal decline, particularly during andropause (in men) and perimenopause/menopause (in women).

Patients don’t just feel “off”; they describe feeling depressed, anxious, and irritable. They struggle with sleep, find it impossible to focus, and sometimes confess, “I feel like I’m going out of my mind” or “I want to kill everybody, but I don’t have a good reason to.” This isn’t a sign of mental instability; it’s a profound physiological shift that impacts every aspect of their being. Women’s bodies, in particular, are incredibly responsive systems. We tend to feel every subtle shift, which means a cautious, observant approach to therapy is paramount.

Key Symptoms of Hormonal Imbalance

From my clinical observations, I’ve seen how these symptoms manifest in daily life. Here are some of the most common complaints I hear:

  • Sleep Disruption: A hallmark sign is difficulty staying asleep, with many patients reporting they consistently wake up between 2:00 AM and 4:00 AM, a classic indicator of an anxious mind driven by hormonal flux.
  • Energy Crashes: Hitting a wall in the mid-afternoon is common. While one might dismiss it as a typical slump, for those with hormonal deficiencies, it’s a debilitating wave of fatigue that a cup of coffee can’t fix.
  • Loss of ‘Get-Up-and-Go’: Men often tell me, “My get-up-and-go got up and went.” They lose the desire to engage in activities they once loved. This loss of enjoyment, or anhedonia, is a significant red flag.
  • Sexual Health Changes: While low libido is often stereotyped as a female symptom, it’s a primary complaint for men with low testosterone. This is frequently accompanied by erectile dysfunction and, most tellingly, the loss of morning erections, a cornerstone symptom of testosterone insufficiency.
  • Metabolic Resistance: Patients find it nearly impossible to lose weight, despite their best efforts with diet and exercise. They may also experience night sweats, which can be a symptom of both low testosterone and low estrogen.
  • Chronic Pain: Conditions like fibromyalgia and other chronic pain syndromes are frequently linked to hormonal decline. The anti-inflammatory and neuroprotective properties of hormones such as testosterone and estrogen are lost, leading to heightened pain perception.

The Art of Layering: A Foundational Approach to Hormone Therapy

The key to successful hormone therapy is to implement a layered approach. Instead of an aggressive, all-in-one strategy, we introduce treatments sequentially. This allows us to carefully observe the body’s response to each intervention, making precise adjustments as needed. For many women, especially those years past menopause, starting with testosterone alone can be a gentle way to “wake up” the hormone receptors. This approach provides a subtle conversion to estrogen via the aromatase enzyme, priming the system before the direct introduction of estradiol.

After a few months on testosterone, I might then layer in a low dose of estradiol, followed by progesterone. This methodical process ensures we don’t overwhelm an already imbalanced system and provides a clearer path to restoring equilibrium. A structured, algorithmic approach ensures that we are not just treating numbers in a lab report but holistically addressing the patient’s overall well-being.

Essential Tools for Diagnosis and Assessment

A cornerstone of my practice is the use of validated tools and comprehensive lab work to create a data-driven treatment plan from the very first visit.

Symptom Assessment Tools

Before initiating any therapy, we use specific questionnaires to capture the patient’s subjective experience.

  • Menopausal Rating Scale (MRS): A critical tool for assessing the severity of menopausal symptoms before and after therapy. By comparing baseline and follow-up scores, we can objectively measure treatment efficacy in the patient’s own words. It often becomes a powerful conversation starter, revealing hormonal deficiencies that might otherwise go unaddressed.
  • AIMS Scale (Abnormal Involuntary Movement Scale): Other scales, such as AIMS, are used as needed to provide a comprehensive clinical picture.

Interpreting Lab Work: A Guide for Patients and Practitioners

Lab work is indispensable, but it’s crucial to know what to look for and how to interpret it. I always take a comprehensive, integrative approach.

  • Foundational Labs for Women: This includes a hormone panel (Total and Free Testosterone, Estradiol, FSH), a full thyroid panel, general health markers (CBC, CMP), and integrative markers like Vitamin D, Hemoglobin A1c, Fasting Insulin, C-Reactive Protein (CRP), DHEA-Sulfate, and Ferritin.
  • Foundational Labs for Men: The panel is similar, with the addition of the Prostate-Specific Antigen (PSA). I don’t routinely test estrogen in men unless there are specific concerns like gynecomastia, as the body often finds its own equilibrium.

Evidence-Based Hormone Replacement Therapies: A Modern Overview

The goal of integrative medicine is to use the most appropriate tools for the individual. Let’s explore the primary HRT modalities.

Subcutaneous Hormone Pellets: The Steady State Solution

Pellets represent a continuous form of hormone replacement.

  • How They Work: Hormone pellets, made from compressed bioidentical estradiol or testosterone, are inserted into the subcutaneous fatty tissue. They dissolve slowly, releasing a steady, consistent dose of hormones over three to five months.
  • The Patient Experience: Levels rise gradually and then stabilize, avoiding the “roller coaster” of peaks and troughs associated with other methods. This leads to a stable mood and consistent symptom relief.
  • Benefits: Continuous release and convenience. Patients don’t have to remember to apply daily creams or receive weekly shots.
  • Considerations: Once inserted, pellets cannot be easily removed. However, in my extensive experience, I have never had to remove a pellet. Any side effects are typically nuisance-level (like unwanted hair growth) and fade as the pellet dissolves. It is also crucial to understand that not all pellets are created equal; their manufacturing process dramatically affects their release rate and efficacy.

Hormone Injections: The Traditional Approach

Injectable testosterone is common and effective, particularly for men.

  • How They Work: Testosterone cypionate is typically injected intramuscularly (IM), providing a time-release effect.
  • Dosing for Men: A standard starting dose for a 50-year-old male is approximately 200 mg once weekly, though this is highly individualized.
  • Use in Women: I generally do not recommend testosterone injections for women due to the high risk of permanent virilizing side effects from the rapid peak in hormone levels.
  • Transitioning from Creams: When transitioning a male patient from topical gels to injections, I advise them to continue their topical application for about two to three weeks after starting shots. This bridges the gap, ensuring stable testosterone levels while the long-acting injectable form takes full effect.

Topical Creams and Gels: The Absorption Challenge

Creams are an option, but they come with significant challenges.

  • The Problem with Absorption: The primary issue is unpredictable absorption. The hormone must penetrate the skin barrier to reach the bloodstream, and this process is highly variable.
  • Optimizing Absorption: Application to thin, highly vascular skin—such as the scrotum in men or the labia in women—yields the best results.
  • Monitoring Difficulties: Lab testing for patients on creams is notoriously unreliable due to the risk of contamination from residual cream on the skin. For this reason, we typically monitor symptoms rather than labs.

Oral and Sublingual Hormones: Bypassing the Liver

Oral and sublingual routes offer another way to deliver hormones.

  • The First-Pass Effect: When you swallow a hormone like testosterone, it is heavily metabolized by the liver in a process called “first-pass metabolism.” This not only reduces the amount of active hormone but can also create potentially harmful estrogen metabolites (García-Cruz et al., 2012).
  • Sublingual and RDTs: To bypass the liver, rapidly dissolving tablets (RDTs) are placed under the tongue for direct absorption into the bloodstream. We’ve seen excellent results with RDT testosterone in women (typically 4-10 mg), but the required dose for men can be prohibitively expensive.

Navigating Estrogen and Progesterone: The Core of Women’s Health

The Critical Role of Progesterone

Progesterone is the great balancer to estrogen and is essential for mood, sleep, and uterine health.

  • Perimenopause: In their 40s, women experience a steep decline in progesterone while estrogen levels fluctuate wildly. This imbalance drives the anxiety, irritability, and insomnia of perimenopause. Supplementing with exogenous progesterone (typically 100 mg at night) can provide profound relief.
  • Postmenopause: For a postmenopausal woman with a uterus who is on estrogen therapy, progesterone is not optional—it is the standard of care. Estrogen alone can cause the uterine lining to build up, increasing the risk of endometrial cancer.
  • The Correct Form and Dose: The standard of care is 200 mg of oral micronized bioidentical progesterone taken at bedtime. Progesterone cream is not an acceptable substitute, as it does not achieve systemic levels sufficient to protect the endometrium (The NAMS 2022 Hormone Therapy Position Statement Advisory Panel, 2022).

Navigating Estrogen Dosing: From Perimenopause to Menopause

Estrogen management is a delicate dance. A common challenge is determining the right starting dose for a woman whose hormonal status is unclear.

  • For Post-Menopausal Patients: If a patient is clearly in menopause and experiencing significant symptoms, I find that a starting dose of 6 mg of estradiol via pellets is often magical. It provides a stable, basal level of estrogen that effectively alleviates symptoms.
  • For Perimenopausal Patients: Even if their Follicle-Stimulating Hormone (FSH) levels appear “normal”, their fluctuating cycles tell the real story. For these patients, a conservative start with a small amount of estrogen can provide stability.
  • Menstrual Migraines: Many women suffer from debilitating migraines tied to the sharp drop in estrogen just before menstruation. Dr. Gary Donovitz explains this as a “withdrawal headache” (Donovitz, 2018). By providing a steady, basal dose of estrogen with a 6 mg pellet, we can often completely block these migraines.

The Perimenopause Pitfall: A Clinical Lesson

I want to share a story from early in my career. A friend came to me, miserable with hot flashes. Her labs showed a high estrogen level, and assuming she was postmenopausal, I gave her a robust 15 mg estrogen pellet. Two weeks later, she was furious, experiencing extreme breast tenderness and heavy bleeding. The question I failed to ask was: “Are you still having menstrual cycles?” Until a woman has gone 12 consecutive months without a period, she must be treated as perimenopausal. In her case, a very low-dose estradiol pellet would have been appropriate. Treat the patient and their clinical history, not just the labs.

Advanced Concepts in Hormone Optimization

The Role of FSH and Testosterone in Women

  • The Critical Role of FSH: In postmenopausal women, the Follicle-Stimulating Hormone (FSH) is a revealing marker. As estrogen plummets, the brain signals the pituitary to pump out more FSH. Our goal with HRT is to relieve symptoms and, consequently, lower the FSH to a premenopausal level. Over a year or two, my objective is to bring my FSH down to under 20, at which I see the most profound changes in cognition, body composition, and overall well-being.
  • Understanding Testosterone in Women: There is no established “normal” range for testosterone in women, which led to the definition of Female Androgen Insufficiency Syndrome, diagnosed based on symptoms. Leading research by Dr. Rebecca Glaser shows a poor correlation between a woman’s testosterone levels and her symptoms (Glaser & Dimitrakakis, 2013). This is why many women require what might be considered supra-physiologic levels of testosterone to achieve symptom relief. My philosophy is clear: treat the patient, not the lab number.

The SSRI-Hormone Connection

One of the most common clinical scenarios I encounter involves patients prescribed Selective Serotonin Reuptake Inhibitors (SSRIs) for symptoms that are likely hormonal. The top two side effects of SSRIs are often weight gain and low libido—the very issues we are trying to fix. When I determine that a patient’s mood symptoms are rooted in a hormone imbalance, I initiate a protocol to slowly wean them off their SSRI once hormone therapy has begun, as SSRIs can blunt many of the beneficial effects of testosterone. This protocol is strictly for patients placed on SSRIs for what appears to be hormone-related symptoms, not for those under active management by a psychiatrist for major psychiatric conditions.

The Importance of an Integrative Chiropractic Approach

As we address hormonal imbalances systemically, we must not overlook the body’s structural framework. The endocrine system is under the direct control of the nervous system. If there are misalignments in the spine, known as vertebral subluxations, they can create nerve interference, disrupting communication between the brain and the endocrine glands.

From my perspective as a Doctor of Chiropractic (DC), integrative care is paramount.

  • Chiropractic adjustments, spinal decompression, and targeted physical rehabilitation address the biomechanical consequences of hormonal decline, like decreased bone density and muscle atrophy (sarcopenia).
  • By restoring proper spinal alignment and nerve function, we can alleviate pain, improve mobility, and enhance the body’s overall ability to heal.
  • This optimization of the “information superhighway” allows the brain to communicate more effectively with the body, including the adrenal glands, thyroid, and ovaries. Chiropractic care lays the neurological foundation upon which hormone replacement therapy can be most effective.

The Cardinal Rule of Hormone Optimization: Start Low, Go Slow

The most important clinical pearl is the principle of “start low, go slow,” especially for patients who are many years post-menopause. A 72-year-old woman’s hormone receptors have been dormant for over two decades. Blasting them with a high dose of hormones all at once will overstimulate the system, causing nausea, breast tenderness, and other unpleasant side effects. For these patients, we must baby-step them into therapy, starting with a very low dose to gently awaken the receptors, then gradually titrating up. This careful, individualized approach is the heart of safe and effective hormone optimization.

Assessing and Treating Patterns of Adrenal Dysfunction | *MUST WATCH* El Paso, Tx (2022)

References

Donovitz, G. (2018). Clinical protocols and pearls: An educational overview. EvexiPEL Clinical Training.

García-Cruz, E., Piqueras, M., Huguet, J., & Alcaraz, A. (2012). Oral testosterone replacement: A new option for hypogonadal men? Expert Opinion on Pharmacotherapy, 13(12), 1763–1769. https://doi.org/10.1517/14656566.2012.700318

Glaser, R., & Dimitrakakis, C. (2013). Testosterone therapy in women: Myths and misconceptions. Maturitas, 74(3), 230–234. https://doi.org/10.1016/j.maturitas.2013.01.003

The NAMS 2022 Hormone Therapy Position Statement Advisory Panel. (2022). The 2022 hormone therapy position statement of The North American Menopause Society. Menopause, 29(7), 767-794. https://doi.org/10.1097/GME.0000000000002028

Integrative Chiropractic and Hormone Physiology Benefits

By
Dr Alexander D Jimenez DC, APRN, FNP-BC, CFMP, IFMCP
-
Integrative Chiropractic and Hormone Physiology Benefits
Integrative Chiropractic and Hormone Physiology Benefits

Integrative Chiropractic Care, Hormone Physiology, PCOS, PSA Decision-Making, and DHEA: An Evidence-Guided Clinical Journey

Abstract

In this educational post, I walk you through an integrated, first-person exploration of hormone transport and signaling, the role of sex hormone-binding globulin (SHBG) in metabolic health, contemporary polycystic ovary syndrome (PCOS) assessment and treatment, prostate-specific antigen (PSA) clinical decision-making using percent free PSA and velocity, and the clinical utility of dehydroepiandrosterone (DHEA). I weave in my clinical observations as an integrative chiropractor and family nurse practitioner, and show where integrative chiropractic care fits: neuro-musculoskeletal alignment, autonomic balance, and targeted lifestyle interventions that modulate insulin resistance, gut dysbiosis, and neuroendocrine axes. You will see how modern diagnostics, evidence-based protocols, and patient-centered strategies interact to improve outcomes for all individuals across endocrine and metabolic conditions.

Integrative Chiropractic and Hormone Physiology Benefits

Section 1: Understanding SHBG and Why More Is Often Better

As Dr. Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST, I start with a critical transport protein: sex hormone-binding globulin (SHBG). Clinically, many wonder: “How do I lower SHBG to increase free testosterone?” The surprising answer, supported by modern literature, is that lower SHBG generally correlates with worse metabolic status. SHBG is synthesized in the liver and binds androgens (with higher affinity for testosterone than estradiol), buffering hormonal flux and delivering hormone to tissues. When a hormone is bound to SHBG, the circulating free fraction decreases, but tissue delivery remains regulated. Upon receptor binding and cellular uptake, hormones exert their genomic and non-genomic effects.

  • Key concept: Low SHBG is an early marker of insulin resistance, metabolic syndrome, and higher cardiovascular risk (Plymate et al., 2022; Ding et al., 2009).
  • Clinical takeaway: We should not reflexively lower SHBG. Instead, correct the drivers—insulin resistance, visceral adiposity, and hepatic inflammation—and optimize total testosterone to appropriately saturate receptors.

Physiological underpinning

Insulin and hepatic lipogenesis downregulate SHBG production, while estrogens and lower insulin favor higher SHBG. Thus, hyperinsulinemia correlates with low SHBG, increased free androgens, and downstream dermatologic or reproductive symptoms. SHBG tracks earlier than A1C in some patients, flagging metabolic stress before glycemic indices fully drift.

Why receptor saturation strategy matters

In patients with high SHBG and symptoms of androgen deficiency, increasing total testosterone can saturate tissue receptors sufficiently that a clinically meaningful level of free testosterone remains. This explains why carefully titrated androgen therapy—or natural supports such as mineral-rich adaptogens like shilajit—may help certain patients feel better by improving bioavailable androgen despite high SHBG. The clinical rationale is to achieve adequate target tissue occupancy without chasing lower SHBG levels, which may increase metabolic risk.

Evidence signals

  • Low SHBG predicts insulin resistance and metabolic dysfunction across cohorts (Ding et al., 2009).
  • SHBG interacts with cardiometabolic risk; improving insulin sensitivity often raises SHBG and improves risk profiles (Plymate et al., 2022).

Section 2: PCOS Reframed: Gut, Insulin Resistance, and Phenotypic Diversity

PCOS is among the most common endocrine disorders in women, yet often missed because it is phenotypically diverse. The classic triad—obesity, acne, hirsutism—is not universal. Many patients present with irregular, painful cycles or fertility challenges without overt hyperandrogenic signs. An elevated LH: FSH ratio (>2:1 in some cases), high free testosterone, and DHEA-S can support the diagnosis, alongside Rotterdam criteria (two of three: oligo/anovulation, hyperandrogenism, polycystic ovarian morphology) (Teede et al., 2018).

  • Phenotypes:
    • Hyperandrogenic with hirsutism and cystic acne.
    • Non-higher weight with irregular cycles and fertility issues.
    • Insulin-resistant phenotype with low SHBG and high free testosterone.
  • Drivers:
    • Hyperinsulinemia lowers SHBG, raises ovarian androgen production, and sensitizes androgen receptors.
    • Gut dysbiosis and intestinal permeability contribute to systemic inflammation, insulin resistance, and disruption of the HPO axis (Borgo et al., 2023).

My clinical observations

At my practices, I routinely see athletes and lean women with severe menstrual pain, irregular cycles, normal total testosterone but high free testosterone, and elevated LH: FSH ratios. A recent patient—tall, fit, in her early 20s—presented with debilitating cramps and irregular cycles. Labs showed high free T, elevated LH-to-FSH ratio, and high DHEA-S, without hirsutism or acne. We focused on gut evaluation with stool testing, addressed insulin resistance, and implemented a comprehensive lifestyle plan rather than reflexively prescribing only receptor blockers.

Physiology-driven treatment rationale

  • Insulin-lowering tends to increase SHBG, reducing free androgen burden and symptom expression.
  • GLP-1 receptor agonists and metformin improve insulin signaling, reduce hepatic steatosis, and raise SHBG (Davies et al., 2015; UKPDS Group, 1998).
  • Spironolactone, as an androgen receptor antagonist, helps hirsutism/acne while the root causes are being corrected; typical dosing for hirsutism is 100 mg/day, with symptom improvement over 6–12 months (Martin et al., 2021).
  • Lifestyle: anti-inflammatory dietary patterns, intermittent fasting, and resistance training improve insulin sensitivity, adipokine balance, and SHBG levels.

Integrative chiropractic care fits

In PCOS patients, I use integrative chiropractic care to modulate autonomic tone and reduce somatic stress:

  • Thoracolumbar and sacral adjustments can influence sympathetic-parasympathetic balance, aiding HPA axis regulation.
  • Soft tissue work around the pelvic girdle improves blood flow and lymphatic drainage, potentially easing dysmenorrhea.
  • Prescribed movement strategies (hip hinge patterns, gluteal activation) improve insulin sensitivity and pelvic stability.

These techniques complement medical therapy by reducing neurogenic stress and enabling lifestyle adherence.

Medication pearls and safety

  • Metformin: Start 500 mg nightly, titrate toward 2,000–2,100 mg/day as tolerated; GI effects often diminish with uptake of the gut’s serotonin/GLP modulation.
  • GLP-1 agents (semaglutide, exenatide): effective for insulin resistance phenotypes; titrate to avoid GI effects and support satiety/sustainable weight changes (Davies et al., 2015).
  • Spironolactone: avoid in pregnancy, monitor potassium and blood pressure; blocks androgen receptors without addressing gut/insulin etiologies—use as adjunct.
  • Hormone therapy: in women with low SHBG and insulin resistance, start low and slow with testosterone due to heightened sensitivity and side-effect risk.

Fertility and long horizons

Restoring cycles and ovulation can take 1–2 years with comprehensive care. I have seen patients conceive naturally after sustained gut repair, insulin reduction, sleep optimization, and balanced thyroid/adrenal support—sometimes unexpectedly—once the axis normalizes. The physiology tracks: improved insulin status raises SHBG, reduces free androgen excess, normalizes LH pulsatility, and supports folliculogenesis.

Section 3: PSA, Percent Free PSA, Velocity, and Smarter Referrals

For men considering testosterone therapy or presenting with urogenital symptoms, PSA interpretation must be nuanced. Total PSA alone is specific but not very sensitive; adding percent free PSA and PSA velocity improves risk stratification (Catalona et al., 1998; Loeb et al., 2012).

  • Percent free PSA: Lower percentages indicate a higher risk of prostate cancer. <10% often suggests a>50% likelihood; 10–20% is intermediate; >20% is low risk (Catalona et al., 1998).
  • PSA velocity: Rapid increase (e.g., >0.75–2.0 ng/mL/year depending on baseline) may indicate aggressive pathology (Loeb et al., 2012).
  • Finasteride lowers total PSA by ~50% but does not alter the percent free PSA—interpretation requires adjustment.

Clinical flow I use

  • If total PSA >4 ng/mL, I order percent free PSA automatically to avoid repeat phlebotomy.
  • If percent free PSA <10%: high suspicion—refer for imaging and urology consult.
  • If 10–20%: treat potential prostatitis if symptomatic and retest after ~3 months.
  • If >20%: low likelihood—monitor and retest.
  • Prefer 3T multiparametric prostate MRI to localize lesions and differentiate prostatitis from neoplasm before invasive biopsy when feasible (Barentsz et al., 2012).

Why this matters before testosterone therapy

Before starting testosterone in men, confirm PSA ❤️ ng/mL and absence of overt BPH or suspicious trends, aligning with prudent clinical practice. Urologists differ; some request a repeat PSA in 6 months. I collaborate closely, leveraging imaging to prevent unnecessary biopsies and to identify chronic prostatitis, a common cause of PSA bumps. We also educate patients that intercourse and mechanical stimulation can transiently elevate total PSA but not percent free PSA.

Integrative chiropractic care fits

  • Lumbo-pelvic adjustments and pelvic floor neuromuscular re-education can reduce pelvic congestion and pain in chronic prostatitis, complementing antibiotics/anti-inflammatories when indicated.
  • Stress management, diaphragmatic breathing, and ribcage mobility work support autonomic balance, potentially reducing prostatic inflammation via neuroimmune modulation.

Section 4: DHEA: Neurosteroid Power, Mood, Libido, and Cognition

DHEA and DHEA-S decline after the 20s and affect mood, libido, cognition, vascular health, and skin integrity. DHEA functions as a neurosteroid, synthesized within the CNS, and interacts with GABAergic/glutamatergic systems, modulating resilience and sexual function (Maninger et al., 2009; Wolf & Kirschbaum, 2015).

Clinical observations

I often see women with “healthy” total and free testosterone who still report low libido, anhedonia, and poor orgasm quality. Their DHEA-S is often in the double digits rather than the robust triple digits. Adding compounded DHEA in low doses (5–10 mg for women; ~20 mg for men) can improve sexual function and mood, likely via CNS receptor effects and peripheral conversion pathways, including DHT modulation in females. We avoid DHEA in PCOS when DHEA-S is already elevated, as more DHEA can aggravate hyperandrogenic symptoms.

Physiology and dosing rationale

  • DHEA supports membrane fluidity, mitochondrial signaling, and neurovascular health.
  • Aim for optimal range rather than population averages; retest 6–8 weeks after initiation.
  • Prefer compounded pharmaceutical-grade DHEA due to supplement variability; if OTC is used, start around 25 mg cautiously and monitor.

Safety pearls

  • Monitor lipid profile, mood, acne/hair changes, and, in men, potential prostate symptoms.
  • Align DHEA use with the broader endocrine plan—thyroid optimization alone can raise DHEA in some patients, so sequence matters.

Integrative chiropractic care fits

  • Vagus-focused care—upper cervical and thoracic mobilization, breath mechanics, and stress-lowering routines—synergizes with DHEA’s neurosteroid role by improving autonomic tone, sleep quality, and adherence to exercise protocols, thereby further enhancing neuroendocrine balance.

Section 5: Lifestyle, Gut, and Clinical Protocols That Change Trajectories

Lifestyle changes are not adjuncts; they are central modulators of endocrine physiology.

  • Nutrition: Anti-inflammatory, fiber-rich diets reduce endotoxemia, improve insulin signaling, and modulate SHBG. Low-glycemic, phytonutrient-dense patterns support gut microbial diversity (Borgo et al., 2023).
  • Fasting windows: Intermittent fasting can lower insulin and improve leptin/ghrelin dynamics, supporting menstrual regularity in some PCOS phenotypes.
  • Movement: Strength training improves insulin sensitivity; hip-dominant compound lifts are especially effective in PCOS and metabolic syndrome.
  • Sleep and stress: Normalizing the HPA axis reduces cortisol-driven insulin resistance; chiropractic care supports mechanoreceptor input to autonomic regulation.
  • Targeted supplements: Where appropriate and evidence-based, consider magnesium, omega-3s, and in select cases botanicals that modulate GLP-1 and gut ecology; dose responsibly and monitor.

Clinical reasoning in protocol design

  • Start by stabilizing the gut and insulin resistance; this raises SHBG and lowers free androgen burden.
  • Add receptor blockers for symptom relief while root causes are addressed.
  • Sequence hormones cautiously in insulin-resistant women—begin low, reassess frequently.
  • In men, scrutinize PSA patterns before testosterone; use percent free PSA and MRI to avoid unnecessary biopsies.
  • Evaluate DHEA in persistent mood/libido complaints even when testosterone appears adequate.

Conclusion: Integrated Care, Better Outcomes

Endocrine care succeeds when it integrates physiology, evidence, and patient realities. By understanding SHBG as a metabolic barometer, reframing PCOS through gut-insulin mechanisms, optimizing PSA decision-making with percent free and velocity, and leveraging DHEA as a neurosteroid, we make better, safer choices. Integrative chiropractic care fits naturally here—aligning the structure, calming the autonomic nervous system, and enabling lifestyle practices that enhance insulin sensitivity and neuroendocrine resilience. This is how we help patients move from symptoms to sustainable health.

"Testosterone Deficiency" in men | El Paso, Tx (2021)

References

Failure to Yield Left Turn Accidents: Legal Insights

By
Dr Alexander D Jimenez DC, APRN, FNP-BC, CFMP, IFMCP
-
Failure to Yield Left Turn Accidents: Legal Insights
Failure to Yield Left Turn Accidents: Legal Insights

Failure to Yield Left Turn Accidents: T-Bone Crash and How Integrative Care May Help

When a driver turns left, sticks out into active traffic, and is hit on the side by an oncoming vehicle, the most accurate term for the event is usually a “failure to yield left turn” crash. The impact itself is commonly called a “T-bone collision,” “side-impact collision,” or “broadside crash.” In Texas, the core legal issue is usually that the turning driver failed to yield the right-of-way to oncoming traffic before crossing the lane. (Texas Transportation Code § 545.152, 2025; Texas Department of Public Safety [DPS], n.d.).

Failure to Yield Left Turn Accidents: Legal Insights

What is the correct name for this kind of accident?

There is not just one everyday label, but there are several accurate terms that describe this situation well. The best term depends on whether you are talking about the driving error, the crash type, or the traffic citation. Texas law focuses on the duty to yield, while crash descriptions often focus on the side impact. (Texas Transportation Code § 545.152, 2025; Torts Law, n.d.).

The most useful terms are:

  • “Failure to Yield Left Turn” when you are describing the driver’s mistake or likely citation. Texas offense coding even lists “FAILED TO YIELD RIGHT OF WAY–TURN LEFT” as a recognized offense description. (Texas DPS, 2009).
  • “T-bone collision” or “side-impact collision” when you are describing the actual crash pattern, meaning the front of one vehicle struck the side of another and formed a T shape. (Torts Law, n.d.).
  • “Unsafe left turn” when the turn was made before traffic was clear, or when the driver moved into traffic too early. Texas offense descriptions also include “TURNED WHEN UNSAFE.” (Texas DPS, 2009).
  • “Improper lane or location – median” or “turned across dividing section” may apply when the driver was badly positioned in a median opening or crossover. That is closer to a lane-position or roadway-use problem than a crash type. (Texas DPS, 2009).

People may informally say a vehicle was “sticking out” into traffic, but that is more of a descriptive phrase than a formal legal crash category. In real investigations, police, insurers, and attorneys usually focus on the actual violation, such as failure to yield, an unsafe turn, a signal violation, or an improper roadway position. Evidence often includes the police report, witness statements, traffic camera footage, vehicle damage patterns, and roadway marks. (Alpert Schreyer Personal Injury Lawyers, 2026; Texas DPS, 2009).

Why are left-turn crashes so dangerous?

Left turns are risky because the driver must cross the path of oncoming traffic while judging speed, distance, timing, signal changes, and sometimes pedestrians, all at once. A small mistake can quickly become a high-impact intersection crash. Transportation agencies even redesign intersections to reduce the severity of angle and left-turn conflicts because these crash types can be especially harmful. (Daniel Stark Injury Lawyers, 2026; Federal Highway Administration [FHWA], n.d.).

Unprotected left turns are especially dangerous. A driver may think there is enough room, but the gap closes faster than expected. Other times, the turning driver creeps forward, feels rushed, or assumes the oncoming vehicle will slow down. Daniel Stark notes that common errors include misjudging speed and distance, turning too quickly, and “creeping” into the intersection. (Daniel Stark Injury Lawyers, 2026).

Who is usually at fault?

In most of these crashes, the left-turning driver is usually found at fault because the law requires that driver to wait until the path is clear. Texas law says a person turning left must yield to oncoming traffic that is close enough to be an immediate hazard, and the Texas Driver Handbook says even a flashing yellow arrow still requires the driver to yield to oncoming traffic. (Texas Transportation Code § 545.152, 2025; Texas DPS, n.d.).

That said, “usually” does not mean “always.” Fault can be shared if the oncoming driver was also speeding, distracted, or ran a light. Legal sources discussing T-bone crashes consistently note that the driver who violated the right-of-way is often at fault, but comparative fault may apply when both drivers made unsafe choices. (TopDog Law, 2025; Farah & Farah, n.d.; Alpert Schreyer Personal Injury Lawyers, 2026).

Common injuries in a left-turn T-bone crash

A T-bone crash can be serious because the side of a vehicle usually offers less protective space than the front or rear. NHTSA’s side crash testing evaluates injury risk to the head, chest, abdomen, and pelvis in intersection-type crashes, highlighting the importance of side-impact protection in real-world wrecks. (National Highway Traffic Safety Administration [NHTSA], n.d.).

These crashes can also create violent sideways forces on the neck and spine. NHTSA notes that neck, cervical, thoracic, and lumbar injuries are prevalent crash outcomes, and biomechanical research has found that side impacts can produce multiplanar cervical spine injuries. Whiplash is also one of the most common injuries after motor vehicle collisions. (NHTSA, n.d.; Maak et al., 2007; Yadla et al., 2008/2007).

Common symptoms after a failure-to-yield left-turn crash may include:

  • Neck pain, headaches, stiffness, and reduced range of motion. (Cascade Spine & Injury Center, 2024; East Coast Trial Lawyers, 2021).
  • Mid-back or low-back pain, muscle spasm, and joint restriction. (The Neck and Back Clinics, 2025).
  • Tingling, numbness, radiating arm pain, or nerve irritation. (The Neck and Back Clinics, 2025; Maak et al., 2007).
  • Rib, pelvic, abdominal, or chest injuries from the side blow. (NHTSA, n.d.; East Coast Trial Lawyers, 2021).
  • Delayed soreness, dizziness, stress, and problems with daily movement that may not feel severe on day one. (Cascade Spine & Injury Center, 2024; The Neck and Back Clinics, 2024).

How an integrative chiropractic clinic may help after this kind of crash

An integrative chiropractic clinic takes a whole-person, non-invasive approach to recovery. Instead of treating only one painful spot, the clinic may consider joint mechanics, soft-tissue injury, nerve irritation, posture, movement patterns, and how the injury affects daily function. Common treatments after a crash may include spinal adjustments, soft-tissue therapy, decompression in selected cases, massage-based approaches, and corrective rehabilitation exercises. (The Neck and Back Clinics, 2025; Texas Medical Institute, 2026).

This kind of multimodal approach is supported by neck pain and whiplash literature. Clinical guidance has found that manual therapy, self-management advice, and exercise can be effective for neck pain-associated disorders and whiplash-associated disorders, while a 2021 review found exercise therapy may improve pain and disability in whiplash patients. (Bussieres et al., 2016; Chrcanovic et al., 2021; Wong et al., 2016).

After a T-bone crash, treatment often has several goals:

  • Ease acute pain and calm muscle guarding. (The Neck and Back Clinics, 2025).
  • Reduce inflammation and soft-tissue stress. (Texas Medical Institute, 2026; The Neck and Back Clinics, 2025).
  • Restore range of motion and normal loading across the spine. (The Neck and Back Clinics, 2025).
  • Rebuild strength, posture, and coordination so the patient can safely return to work, driving, and daily life. (The Neck and Back Clinics, 2025; Chrcanovic et al., 2021).

Dr. Alexander Jimenez’s clinical perspective

According to information published on Dr. Alexander Jimenez’s website and professional profile, Dr. Jimenez, DC, APRN, FNP-BC, uses a dual-scope model that combines chiropractic care with nurse practitioner-level medical assessment. His published materials describe integrative care that bridges physical medicine, functional medicine, advanced diagnostics, and rehabilitation for complex musculoskeletal injuries, including auto accident trauma. (Jimenez, n.d.; Jimenez, n.d./2025; LinkedIn, n.d.).

That matters in a failure-to-yield left-turn crash because side-impact injuries often involve more than simple soreness. A patient may need a chiropractic evaluation, imaging review, rehabilitation planning, and referral if red-flag findings are present. Dr. Jimenez’s published clinical pages describe spinal adjustments, ergonomic modifications, complementary therapies, imaging-guided evaluation, and post-injury rehabilitation as part of a broader treatment strategy. (Jimenez, n.d.; The Neck and Back Clinics, 2025).

Why early evaluation matters

One challenge after a T-bone crash is that symptoms can be delayed. A person may feel shaken up but not fully understand the neck, back, or soft-tissue damage until hours or days later. Several auto-injury care sources stress that early evaluation can help identify hidden injury, start conservative care sooner, and reduce the chance that a short-term problem turns into a longer-lasting one. (The Neck and Back Clinics, 2024/2025; Cascade Spine & Injury Center, 2024).

In both treatment and injury claims, clinics often try to help the patient reach maximum medical improvement (MMI). In simple terms, MMI means the condition has stabilized, and major additional improvement is no longer expected, even if some ongoing care may still be needed. A strong integrative plan aims to move the patient toward that point as efficiently and safely as possible by reducing pain, improving function, and documenting objective progress. (Patino Law Firm, 2024; Texas Medical Institute, 2026).

Final takeaways

The crash in which a driver makes a dangerous left turn, sticks out into traffic, and gets hit on the side is most accurately described as a “failure to yield left turn” accident that results in a “T-bone” or side-impact collision. The left-turning driver is usually at fault because that driver has the duty to wait until the intersection or crossover is clear, though shared fault is possible if the oncoming driver was also negligent. These crashes can cause whiplash, neck and back injury, nerve symptoms, and major soft-tissue damage. Integrative chiropractic care may help by combining non-invasive pain relief, mobility work, soft-tissue treatment, functional rehabilitation, and coordinated medical assessment. (Texas Transportation Code § 545.152, 2025; TopDog Law, 2025; NHTSA, n.d.; Jimenez, n.d.).

From Injury to Recovery with Chiropractic Care | El Paso, Tx (2023)

References

Alpert Schreyer Personal Injury Lawyers. (2026). Who Is at Fault in a T-Bone Car Accident?

Bussieres, A. E., et al. (2016). The Treatment of Neck Pain-Associated Disorders and Whiplash-Associated Disorders. PubMed.

Cascade Spine & Injury Center. (2024). T-Bone Car Accident Injuries: Common Symptoms, Treatments, and Recovery.

Chrcanovic, B., et al. (2021). Exercise Therapy for Whiplash-Associated Disorders. PubMed.

Daniel Stark Injury Lawyers. (2026). Left Turns Explained: Why So Many Serious Crashes Happen.

Federal Highway Administration. (n.d.). Reduced Left-Turn Conflict Intersections.

Jimenez, A. (n.d.). Board Certified Nurse Practitioner (FNP-BC) Dr. Alex Jimenez DC, APRN, FNP-BC.

Jimenez, A. (n.d.). Chiropractic and Integrative Care for Drivers in El Paso.

Maak, T. G., et al. (2007). Side Impact Causes Multiplanar Cervical Spine Injuries. PubMed.

National Highway Traffic Safety Administration. (n.d.). Biomechanics.

National Highway Traffic Safety Administration. (n.d.). Car Safety Ratings.

Patino Law Firm. (2024). Maximum Medical Improvement in Texas – What It Means for Your Personal Injury Claim.

Texas Department of Public Safety. (n.d.). DL-7 – Texas Driver Handbook.

Texas Department of Public Safety. (2009). Driver License / Identification Card Inquiries.

Texas Medical Institute. (2026). Your Guide to Chiropractic Treatment After an Auto Injury.

Texas Transportation Code § 545.152. (2025). Vehicle Turning Left.

The Neck and Back Clinics. (2025). What Are Your Chiropractic Treatment Options After a Car Accident?

TopDog Law. (2025). Who Is at Fault for a T-Bone Accident?

Torts Law. (n.d.). T-Bone Accident – T-Bone Collisions – Side Impact Crashes.

Yadla, S., et al. (2007/2008). Whiplash: Diagnosis, Treatment, and Associated Injuries. PMC.

Understanding the Connection Between Hormones & The Gut-Immune System

By
Dr Alexander D Jimenez DC, APRN, FNP-BC, CFMP, IFMCP
-

Learn how the gut-immune system helps influence your health. Dive into the science behind these crucial hormones.

Abstract

As a practitioner with extensive training across multiple disciplines, I have dedicated my career to uncovering the root causes of chronic illness. This comprehensive guide will take you on a journey through the intricate connections between your gut, hormones, and thyroid. We will explore the profound influence of the gastrointestinal microbiome on everything from nutrient absorption and immune function to hormone regulation and mental health. Drawing on the latest evidence-based research and my clinical observations, I will demystify concepts such as dysbiosis and “leaky gut,” and their roles in driving systemic inflammation and chronic conditions like Hashimoto’s Thyroiditis and PCOS. We will also delve into the critical importance of micronutrients such as Vitamin D3, K2, and iodine, as well as the powerful effects of compounds such as DIM and Shilajit on estrogen metabolism and testosterone levels. Finally, I will outline how a holistic, integrative chiropractic care model addresses these foundational issues, helping to restore nervous system balance and guide you toward lasting, vibrant health.

My Journey From Frustration to Functional Medicine

Throughout my career, I’ve worn many hats and pursued extensive training to serve my patients better. My journey into the world of functional and integrative medicine wasn’t a straight path; it was born of a deep frustration with the limitations of the conventional medical model.

I began my career steeped in traditional medicine. After a fellowship, armed with specialized knowledge in endocrinology and metabolism, I felt equipped to make a real difference. I had even contributed to clinical studies on GLP-1 agonists for major pharmaceutical companies like Lilly and Novo Nordisk. I was ready to be the best diabetes doctor I could be.

However, after about two years in a hospital setting, a disheartening pattern emerged. My patients weren’t truly getting better. They would return for follow-up appointments, often sicker than before, and my primary tool was to add another prescription to their growing list of medications. I remember a specific moment of clarity, sitting down one evening and confiding in a colleague, “I don’t want to do this anymore. No one is getting better. I’m just managing their decline.” It was a difficult realization that after 14 years of rigorous training, my role had been reduced to writing scripts for conditions that only seemed to worsen.

This professional crisis led me to seek answers outside the conventional framework. I enrolled in functional medicine training, and a new world of possibilities opened up. I started applying these new principles, focusing on root causes rather than just symptoms. The results were astounding. Patients started getting genuinely better. We were successfully tapering them off medications, they were losing weight, and their vitality was returning. This was the medicine I had always wanted to practice.

Yet, even with this success, I noticed that about 25-30% of my patients still struggled. I was doing everything by the book—listening intently to their symptoms, optimizing their hormones, and tailoring their protocols—but they hit a plateau. This is where my innate curiosity, the persistent “why” that has driven me since childhood, kicked in again. I needed to understand what I was missing. The answer, I discovered, was hidden in plain sight: the gut.

The Forgotten Organ: Why All Disease Begins in the Gut

Hippocrates, the father of medicine, declared over 2,000 years ago, “All disease begins in the gut.” Somewhere between ancient Greece and the modern medical school curriculum, we lost this profound wisdom. It’s shocking when you stop to consider it. As a board-certified endocrinologist, my formal education in gut metabolism consisted of only two lectures. When I recently recertified for my boards, not a single one of the 180 questions touched on the gut’s role in metabolism. We are training generations of healthcare providers without the essential knowledge about the very foundation of our health.

This is why I am so passionate about bringing this knowledge to the forefront. If you address a person’s gut health correctly, you can unlock the potential for healing across the entire body.

Unraveling the Impact of Chronic Stress and Leaky Gut

As a healthcare provider, I see firsthand how chronic stress is a powerful physiological force that disrupts your internal environment. It can shift the composition of your gut microbiome, favoring the growth of pathogenic (harmful) bacteria, alter gut function, and, most damagingly, induce leaky gut.

Leaky gut, or increased intestinal permeability, is a critical concept. Imagine your gut lining as a tightly woven fabric made of a single layer of specialized cells held together by proteins forming “tight junctions.” A key protein in this structure is zonulin. In a healthy gut, this barrier allows micronutrients to pass into your bloodstream while keeping out undigested food particles, toxins, and harmful bacteria.

When zonulin levels rise—often triggered by stress, gluten, toxins, and infections—it signals the tight junctions to open. The fabric of your gut lining becomes frayed, and “holes” develop. Substances that should be eliminated now “leak” into your bloodstream. Your immune system, about 70% of which is located just on the other side of this barrier, goes on high alert, launching a massive inflammatory response. If you have a”leaky “gut, this battle is happening every single time you eat.

This chronic immune activation creates a devastating cascade:

  1. Immune System Overload: Your immune system releases a flood of inflammatory messengers called cytokines.
  2. Hormonal Chaos: This systemic inflammation drives up your stress hormone, cortisol, and your fat-storage hormone, insulin. It also disrupts your thyroid and sex hormones.
  3. Metabolic Dysfunction: Your body enters a state of crisis, leading to weight gain, fatigue, and a host of other symptoms.

The signs of leaky gut are widespread and can include digestive issues, new food sensitivities, autoimmune conditions, chronic fatigue, brain fog, mood disorders, skin problems, and hormonal imbalances like PCOS and endometriosis.

Modulating Women’s Hormones- Video

Modulating Women Hormones | El Paso, Tx (2021)

The Gut-Hormone Axis: PCOS, Endometriosis, and Estrogen Metabolism

The connection between gut health and hormonal disorders is particularly strong.

Polycystic Ovary Syndrome (PCOS)

PCOS is a complex metabolic disorder deeply intertwined with gut health. Studies on women with PCOS consistently reveal gut dysbiosis—an imbalance of bacteria. They often have an overgrowth of pro-inflammatory bacteria that produce toxins called lipopolysaccharides (LPS). As shown in research by Yuan et al. (2018), LPS can cause leaky gut, which drives up systemic inflammation and leads to insulin resistance—a core driver of PCOS. This insulin resistance then elevates androgen levels (like testosterone), causing symptoms such as acne, hair loss, and weight gain.

Estrogen Metabolism: A Three-Phase Process Dictated by Your Gut

Understanding how your body processes estrogen is key. This metabolic process occurs in three phases and is heavily influenced by your liver and gut health.

  • Phase 1 & 2 (in the liver): The liver modifies used estrogen and packages it into a water-soluble “capsule” for safe elimination. This process can create different estrogen metabolites. Some are protective, while others are more proliferative or can even damage DNA, increasing cancer risk.
  • Phase 3 (Excretion via the gut): This encapsulated estrogen is “sent into “the gut to be excreted. But here is the critical link: if you are constipated, harmful gut bacteria can produce an enzyme called beta-glucuronidase. This enzyme breaks open the protective capsule, “un-conjugating” the estrogen. This newly freed, often-toxic estrogen is then reabsorbed into your circulation through your leaky gut. This vicious cycle continuously raises your body’s estrogen load and your risk for disease.

Understanding and Managing Hashimoto’s “hyroiditis: An Integrative Approach

Hashimoto’s is the most common autoimmune disease in the United States, in which the immune system mistakenly attacks the thyroid gland, disrupting its function.

The Hydrogen Peroxide Problem

When your thyroid gland uses iodine to create T4 and T3, a natural byproduct is hydrogen peroxide, a highly oxidative substance. In a healthy system, an enzyme called glutathione peroxidase, which depends on the mineral selenium, neutralizes this hydrogen peroxide, protecting the thyroid cells.

Now, what happens in Hashimoto’s?

  1. The process of making thyroid hormone produces hydrogen peroxide.
  2. If there is insufficient selenium (due to poor diet or gut malabsorption), the hydrogen peroxide is not neutralized.
  3. This oxidative stress damages and bursts the thyroid cells. In Hashimoto’s, normally kept inside the thyroid (like Thyroglobulin and Thyroid Peroxidase) are released into the bloodstream.
  4. The immune system recognizes these proteins as foreign invaders and produces antibodies against them (anti-TPO and anti-Tg). This is the autoimmune attack we call Hashimoto’s.

This creates a vicious cycle. Inflammation from the gut (leaky gut and dysbiosis) fuels the autoimmune attack on the thyroid. Compromised thyroid function then slows metabolism, which can worsen gut health and nutrient absorption.

ThHashimoto’s Nutrients for Thyroid and Immune Health

To break these cycles, we must provide the body with the right raw materials.

The Vitamin D3 Super Group: More Than Just a Vitamin

Vitamin D is a powerful steroid hormone, not just a vitamin. The statistics are staggering: it’s estimated that one billion people worldwide are vitamin D-deficient. This deficiency has serious consequences, including increased risk for cancer, autoimmune diseases, diabetes, and dementia. In my own clinical practice, of the first 100 individuals diagnosed with thyroid cancer, 99 of them were Vitamin D deficient. Functional medicine practitioners aim for an optimal level of 60-80 ng/mL.

However, Vitamin D doesn’t work in isolation. It is fat-soluble and requires a team:

  • Vitamin K2: This is the “calcium traffic cop.”
  • Magnesium: This mineral activates Vitamin D at the cellular level.
  • Vitamin A: Works synergistically with D and K2 in signaling bone cells.

The Paradox: How Vitamin K2 Protects Your Arteries and Strengthens Your Bones

Here’s “how the system works: “Vitamin D3 increases calcium absorption from your gut into your bloodstream. Without a guide, this calcium could deposit in soft tissues, such as your arteries. This is where Vitamin K2 steps in. As detailed by Kurnatowska et al. Here’s K2 activates proteins that direct this calcium into your bones and teeth, where it belongs. Taking Vitamin D without K2 is like raising an army of construction workers (calcium) with no foreman to tell them where to build.

Iodine: The Misunderstood Mineral for Thyroid Health and Beyond

Your thyroid gland cannot make thyroid hormones without iodine. Thyroxine (T4) contains four iodine molecules, and Triiodothyronine (T3) contains three. If you lack iodine, your thyroid cannot produce these hormones, even if your brain is signaling it to do so. Iodine also plays a critical role in cancer prevention by displacing toxic halogens like fluoride and bromide from cellular receptors.

Optimizing Hormone Metabolism with Targeted Nutraceuticals

Beyond foundational nutrients, we can use specific compounds to guide hormone metabolism.

The Critical Role of DIM in Healthy Estrogen Metabolism

Diindolylmethane (DIM), a compound from cruciferous vegetables, has a profound influence on estrogen metabolism. It acts as a traffic cop, directing estrogen away from the problematic 4-hydroxy (cancer-linked) and 16-hydroxy (proliferative) pathways and down the safer 2-hydroxy pathway (Bradlow et al., 1996). This is why I consider DIM a non-negotiable supplement for most of my patients on hormone replacement therapy (HRT). Its benefits extend to prostate health and reducing fibrocystic breast tissue.

Shilajit: The Game-Changer for Free Testosterone

While total hormone levels are important, what truly matters is the biologically active or free portion. Shilajit, a mineral-rich resin, is a game-changer for testosterone. A landmark study published in Andrologia found that men taking Shilajit saw a significant 19% increase in free testosterone (Pandit et al., 2016). In my clinic, this translates to patients feeling better for longer, with more sustained energy and vitality, without needing to escalate their hormone dosage.

A female patient of mine on hormone pellets consistently felt her energy drop weeks before her next implant. On November 11, 2019, her free testosterone was only 2.6 pg/mL. We started her on a blend containing Shilajit. One year later, on November 25, 2020, her free testosterone was 4.6 pg/mL—nearly double—and she reported feeling great all the way through her cycle.

The Role of Integrative Chiropractic Care in Restoring Balance

You might be wondering, “What does chiropractic have to do with all this?” The connection lies in the nervous system.

The gut has its own intricate nervous system, the enteric nervous system (ENS), which is in constant communication with the central nervous system (CNS) via the vagus nerve. The spine houses and protects the spinal cord, the main superhighway for these nerve signals.

Misalignments in the spine, known as vertebral subluxations, can interfere with the nerve signals traveling between the brain, the gut, and the endocrine glands. This interference can disrupt proper gut function, affecting motility and enzyme secretion, and impair hormonal regulation. From my clinical experience at the Sciatica Clinic, patients with chronic back pain often report concurrent digestive issues.

Chiropractic adjustments help restore proper spinal alignment, which may reduce nerve interference and normalize nerve flow. Furthermore, adjustments have been shown to profoundly affect the autonomic nervous system, helping shift the body out of a “fight-or-flight” (sympathetic) state and into a “rest-and-digest” (parasympathetic) state. By calming this stress response, chiropractic care directly helps reduce one of the primary triggers of leaky gut and hormonal imbalance.

My integrative approach combines chiropractic care with functional medicine testing. By assessing both the structural (spinal) and biochemical (gut, hormones) aspects of your health, we can create a truly comprehensive treatment plan that addresses the root cause of your symptoms.

Your 4-Step Plan to Heal the Gut and Rebalance Hormones

Here is a practical, four-step framework you can use to start healing:

1. Remove

The first step is to remove the triggers causing inflammation and gut damage. This includes processed foods, inflammatory triggers like gluten, dairy, and sugar, and supporting detoxification.

2. Replace

Replace inflammatory foods with healing, nutrient-dense alternatives such as fresh organic vegetables, high-quality proteins, healthy fats, and collagen-rich bone broth to help repair the gut lining.

3. Reinoculate

Restore a healthy balance of gut bacteria with high-quality probiotics and prebiotic-rich foods. Focus on fiber from a variety of plant sources to feed your good gut bugs.

4. Repair

Provide the nutrients needed to repair the gut lining and support hormone metabolism. Key nutrients include L-Glutamine, methylation support (methylated B vitamins), Vitamin D/K2/A, Selenium, Iodine, and targeted compounds like DIM and Shilajit. Equally important are stress management and prioritizing 7-9 hours of quality sleep per night.

Your health journey begins in your gut. By understanding these connections and taking targeted, integrative action, you can move beyond managing symptoms and begin a true path to healing and vitality.

A Note on Supplement Quality

The quality of the supplements you take matters immensely. The supplement industry is largely unregulated, and many products don’t contain what they claim to contain or are contaminated. This is why I insist my patients use professional-grade nutraceuticals from trusted sources. Using impure substances is not just a waste of money; it’s counterproductive and potentially harmful to your healing journey.

References

  • Bradlow, H. L., Telang, N. T., Sepkovic, D. W., & Osborne, M. P. (1996). 2-hydroxyestrone: the ‘good’ estrogen. Journal of Endocrinology, 150(S1), S259-S265. https://doi.orit’s.1677/joe.0.150S259
  • Duntas, L. H. (2011). Environmental factors and autoimmune thyroiditis. Nature Clinical Practice Endocrinology & Metabolism, 4(8), 454-460. https://doi.or’/10.’038/ncpendmet0876
  • Fallahi, P., Ferrari, S. M., Elia, G., et al. (2021). Iodine and thyroid: an update. Journal of Clinical Medicine, 10(21), 4991. https://doi.org/10.3390/jcm10214991
  • Kurnatowska, I., Grzelak, P., Masajtis-Zagajewska, A., et al. (2015). The effect of vitamin K2 on vascular calcification: A review of the literature. Polish Archives of Internal Medicine, 125(11), 831-837. https://doi.org/10.20452/pamw.3150
  • Pandit, S., Biswas, S., Jana, U., De, R. K., Mukhopadhyay, S. C., & Biswas, T. K. (2016). Clinical evaluation of purified Shilajit on testosterone levels in healthy volunteers. Andrologia, 48(5), 570–575. https://doi.org/10.1111/and.12482
  • Pludowski, P., Holick, M. F., Grant, W. B., et al. (2013). Vitamin D supplementation guidelines. The Journal of Steroid Biochemistry and Molecular Biology, 136, 1-13. https://doi.org/10.1016/j.jsbmb.2013.01.003
  • Thomson, C. A., Chow, H. H. S., Wertheim, B. C., Roe, D. J., Stopeck, A., Maskarinec, G., … & Thompson, P. A. (2017). A randomized, placebo-controlled trial of diindolylmethane for breast cancer biomarker modulation in patients taking tamoxifen. Breast Cancer Research and Treatment, 165(1), 97–107. https://doi.org/10.1007/s10549-017-4292-7
  • Yuan, X., et al. (2018). Gut microbiota and metabolism in polycystic ovary syndrome. Journal of Ovarian Research, 11(1), 7. https://doi.org/10.1186/s13048-017-0371-2

SEO Tags: Gut Health, Leaky Gut, Hormonal Imbalance, Dr. Alex Jimenez, Integrative Chiropractic, Hashimoto’s Thyroiditis, PCOS, Estrogen Metabolism, Functional Medicine, Gut-Brain Axis, Chronic Stress, Gut Dysbiosis, Autoimmune Disease, Inflammation, Vitamin D Deficiency, Vitamin K2, Iodine, Selenium, Thyroid Health, DIM, Shilajit, free testosterone,Hashimoto ‘s Chiropractor, Holistic Health

Better Gut and Hormone Function: Integrative Approach

By
Dr Alexander D Jimenez DC, APRN, FNP-BC, CFMP, IFMCP
-
Better Gut and Hormone Function: Integrative Approach
Better Gut and Hormone Function: Integrative Approach

Neuro-Visceral Care for Better Gut and Hormone Function

Abstract

As a clinician practicing systems-based, integrative care, I connect the gut microbiome, intestinal barrier, and enterohepatic circulation to hormonal outcomes in PCOS, endometriosis, and autoimmune conditions, while also detailing how young males can optimize testosterone signaling through targeted nutrients and lifestyle. In this educational post, I walk through the physiological underpinnings of estrogen metabolism (Phase I/II detox, beta-glucuronidase), the nutrient-receptor axis for androgen function (vitamin D, K2, A, magnesium, methylated B vitamins), and practical tools like DIM, I3C, probiotics, L-glutamine, berberine, shilajit, sulforaphane, and CoQ10. I show how integrative chiropractic care enhances autonomic balance and neuro–musculoskeletal efficiency, thereby amplifying endocrine resilience.

Better Gut and Hormone Function: Integrative Approach

Why I Pivoted to Systems-Based Endocrine Care

Early in my career, I saw brilliant specialty care fall short when patients had overlapping issues involving the gut, immune system, and hormones. Collaborating on the gut–brain–immune–hormone axis reshaped my practice lens: the gut is a master regulator whose metabolites, enzymes, and barrier integrity determine whether hormones are cleared or recirculated, and whether the immune system stays tolerant or inflamed (Lynch & Pedersen, 2016; Cryan et al., 2019).

  • What changed in my practice
    • I placed the microbiome at the center of protocols for estrogen metabolism, PCOS, endometriosis, Hashimoto’s, mood dysregulation, and metabolic resilience.
    • I integrated functional nutrition, precision supplementation, and integrative chiropractic care to address neuro-visceral regulation and adherence.
    • I reframed hormone therapy not as a number-raising exercise but as restoring signal transduction, guided by cofactors, clearance pathways, and autonomic balance.

The Gut Microbiome: Trillions of Partners in Endocrine Health

The gut microbiome comprises trillions of bacteria, viruses, fungi, and archaea, influencing digestion, immune tone, neuroendocrine signaling, and hormone metabolism (Lynch & Pedersen, 2016; Cryan et al., 2019). A crucial concept is the estrobolome—microbial genes that metabolize estrogens, dictating whether conjugated metabolites are excreted or reabsorbed via enterohepatic circulation.

  • Key functions
    • Produce short-chain fatty acids (SCFAs), such as butyrate, that stabilize tight junctions and repress NF-κB-mediated inflammation, thereby preserving barrier integrity (Vinolo et al., 2011).
    • Regulate immune tolerance and cytokine signaling, shaping systemic inflammation.
    • Modulate enzymes such as beta-glucuronidase, which can deconjugate estrogen metabolites, thereby driving estrogen recirculation and dominance (Pallister et al., 2017).
  • Clinical implication
    • When dysbiosis increases LPS (endotoxin) translocation through a compromised barrier, TLR4 signaling induces systemic inflammation linked to PCOS, autoimmunity, and cardiometabolic risk (Kazemian et al., 2020).
    • Correcting dysbiosis restores commensal functions, reduces inflammatory load, and improves hormone clearance.

Leaky Gut and Hormonal Spillover: Tight Junctions and Zonulin

Increased intestinal permeability (often called leaky gut) arises when tight junction proteins—occludin, claudin, ZO-1—are disrupted by triggers such as zonulin, alcohol, NSAIDs, infections, and stress (Fasano, 2012). Strikingly, after traumatic brain injury, permeability can change within minutes, reflecting rapid neuro-immune-gut cross-talk (Hang et al., 2013).

  • Why this matters for hormones
    • A compromised barrier permits LPS and dietary antigens to reach circulation, priming systemic inflammation and autoimmunity.
    • In the presence of dysbiosis, beta-glucuronidase deconjugates estrogen metabolites in the gut, facilitating their reabsorption and fueling estrogen dominance symptoms.
  • Common symptom clusters I see
    • Digestive bloating and IBS patterns
    • PMS, PCOS, severe menstrual symptoms
    • Autoimmune conditions, fatigue, mood disorders, and skin flares
    • Food intolerances and Candida overgrowth

My clinical observation: stabilizing the barrier reduces inflammatory “noise,” enabling clearer responses to hormone and nutrient therapies. Patients report steadier mood, improved cycles, and reduced pain as gut integrity improves.

Estrogen Metabolism and the Estrobolome: Pathways, Phases, and Recycling

Understanding Phase I and II liver metabolism empowers patients to take action. Estrogen can follow different hydroxylation pathways, with 2-hydroxyestrone generally less proliferative than 16α-hydroxyestrone (Zhu & Conney, 1998; Fuhrman et al., 2015).

  • Physiology in three steps
    1. Phase I/II metabolism converts estrogens into metabolites; conjugation via glucuronidation and sulfation prepares them for excretion.
    2. Conjugated metabolites enter the intestine via bile for elimination.
    3. In dysbiosis, microbial beta-glucuronidase deconjugates these metabolites, enabling enterohepatic recycling and elevating circulating estrogen (Pallister et al., 2017).
  • Clinical tools
    • DIM (diindolylmethane) and I3C (indole-3-carbinol) shift metabolism toward the 2-hydroxy pathway, reducing proliferative intermediates (Fuhrman et al., 2015).
    • Methylation support with methylfolate and methylcobalamin promotes Phase II clearance, particularly in patients with SNPs affecting methylation dynamics (Schwab et al., 2011).
    • The Dutch test (urinary metabolites) clarifies pathway dominance and informs targeted interventions (Markan & Lechner, 2021).

I routinely ask about daily bowel movements: constipation increases the time for beta-glucuronidase to deconjugate metabolites, raising the risk of recirculation. Supporting motility and fiber is foundational.

PCOS and Endometriosis: Microbiome, Inflammation, and Androgen/Estrogen Balance

Evidence links gut dysbiosis and barrier dysfunction to PCOS and endometriosis through low-grade inflammation, altered SCFA production, insulin resistance, and estrobolome disruption (Lindheim et al., 2017; Torres et al., 2018).

  • PCOS
    • Elevated LPS and reduced SCFAs promote insulin resistance and excess androgen synthesis in theca cells (Qi et al., 2019).
    • Interventions: gut repair, anti-inflammatory nutrition, berberine for microbial modulation and insulin sensitivity (Zhang et al., 2020), and omega-3s for metabolic flexibility.
  • Endometriosis
    • Disrupted estrobolome increases estrogen metabolite load, stimulating lesion growth; inflammatory signatures overlap with oncogenic pathways (Wei et al., 2020; De la Cuesta-Zuluaga et al., 2019).
    • Interventions: DIM/I3C for pathway optimization, barrier repair, and targeted probiotic support.

Clinically, improving gut tone and estrogen clearance reduces pain, cycle irregularity, and fatigue. Integrative care also enhances adherence: when pain and sleep improve with chiropractic support, patients implement nutrition and supplements more consistently.

Nutrient-Receptor Axis in Young Males: When High Total Testosterone Feels Low

I frequently see young men with high total testosterone but symptoms of low androgen activity: depressed mood, low motivation, fatigue, and central adiposity. The issue is often receptor signaling and cofactor deficiencies—cells cannot “hear” the hormonal signal without the right nutrients and intact membranes.

  • Why symptoms persist despite high total T
    • Low vitamin D, magnesium, and B vitamins impair conversion, transport, and nuclear receptor binding (Bouillon et al., 2019; Rosanoff et al., 2016).
    • Inflammation and dysbiosis affect hepatic metabolism, SHBG levels, and tissue availability.
    • Vitamin D receptor (VDR) and androgen receptor cross-talk influences downstream transcription; optimizing D status improves AR expression (Holick et al., 2011).
  • Practical framework I use
    • Correct methylated B12/folate to support methylation and steroidogenesis.
    • Normalize vitamin D with K2 and magnesium for calcium handling and receptor fidelity.
    • Add vitamin A to support epithelial integrity and calcium redistribution.
    • Ensure iodine and selenium sufficiency for thyroid-driven metabolic speed.

Clinical observation: pairing D3, K2, and magnesium reduces adverse sensations and improves performance markers. Within 8–12 weeks, many young men report brighter moods, stronger training outcomes, and higher free testosterone levels.

Precision Tools: DIM, Shilajit, Sulforaphane, CoQ10, and Methylated B Vitamins

I select nutraceuticals that directly impact receptor sensitivity, oxidative stress, and hormone clearance.

  • DIM and I3C
    • Shift estrogen metabolism toward 2-hydroxyestrone, decreasing proliferative intermediates; useful for estrogen-dominant symptoms in individuals (Fuhrman et al., 2015; Zeligs, 2014).
    • Typical dosing: women 150–300 mg/day; men 300–600 mg/day, adjusted for risk profiles.
  • Shilajit
    • Fulvic acid-rich biomass supports mitochondrial function; RCTs show increases in total and free testosterone in healthy males with 250 mg twice daily over 90 days (Pandit et al., 2016).
  • Sulforaphane
    • Activates Nrf2, boosting endogenous antioxidants, improving detoxification, and modulating inflammation—critical for endocrine receptor sensitivity and gut-liver axis (Egner et al., 2011).
  • CoQ10
    • Supports mitochondrial ATP synthesis, aiding energy production, cardiac function, and recovery—beneficial for athletes, students, and patients under metabolic stress (Hodgson et al., 2007).
  • Methylated B vitamins
    • Enhance methylation capacity, neurotransmitter balance, and steroid metabolism; particularly useful in hormonally sensitive patients (Schwab et al., 2011).

When combined with omega-3 EPA/DHA, these tools reduce inflammatory friction and stabilize endocrine signaling. My practice often employs integrated formulations to simplify routines and improve adherence.

Healing Leaky Gut: Stepwise, Patient-Centered Repair

Patients need relief before intensive changes. I stabilize, then build.

  • Remove gut-damaging factors
    • Reduce ultra-processed foods; avoid products with ingredient lists longer than 5 items or those with hard-to-pronounce additives.
    • Limit alcohol and sugar alcohols; review medication contributors (e.g., chronic NSAIDs).
    • Implement stress reduction and sleep hygiene.
  • Replace with healing inputs
    • Emphasize organic, whole foods; diverse plant fibers; clean proteins; anti-inflammatory fats.
  • Repair with targeted supplements
    • Sunfiber (partially hydrolyzed guar gum) for gentle prebiotic support; start at 4–6 g per serving (Moser et al., 2018).
    • L-glutamine (around 5 g/day) to fuel enterocytes and tighten junctions (Kim & Kim, 2017).
    • Probiotics: strains such as Lactobacillus rhamnosus GG, L. acidophilus, and Bifidobacterium species to rebalance flora and reduce beta-glucuronidase activity (Jones et al., 2012).
    • Berberine for microbial modulation and insulin sensitivity; anti-inflammatory support for mucosal health (Zhang et al., 2020).

Clinical observation: This progression quickly calms symptoms, improves bowel regularity, and enhances hormone clearance. It also reduces the immune “alarm,” allowing endocrine therapies to work more predictably.

Vitamin D Optimization: Immune Tolerance, Receptor Responsiveness, and Risk Reduction

I aim for 25(OH)D levels in the 60–80 ng/mL range for endocrine optimization, not just “normal” low ranges. Vitamin D acts as a secosteroid hormone, modulating immune balance, cardiometabolic risk, and hormone receptor fidelity (Prietl et al., 2013; Lau et al., 2021; Carlberg, 2019; Grant & Boucher, 2022).

  • Why pairing matters
    • K2 (MK-7) carboxylates proteins to shuttle calcium to bone and away from soft tissue.
    • Magnesium is essential for vitamin D activation and VDR signaling; deficiency impairs both D and androgen receptor function (Rosanoff et al., 2016).
    • Vitamin A supports epithelial integrity and synergizes with D/K2 for balanced calcium dynamics (Schurgers & Vermeer, 2000).

Patients experience fewer side effects and more consistent energy/mood when D3 is paired with K2 and magnesium. In practice, rechecking labs at 8–12 weeks guides dosing adjustments.

Iodine, Selenium, and Thyroid-Immune Balance: Myth to Physiology

Iodine is essential for thyroid hormone synthesis and tissue differentiation. The misconception that iodine “causes” Hashimoto’s overlooks the role of selenium-dependent antioxidants. During organification, iodine increases H2O2 levels; insufficient glutathione peroxidase activity can trigger thyrocyte damage and autoimmunity (Zimmermann & Kohrle, 2002).

  • Protocol rationale
    • Pair iodine with selenium (~200 mcg/day); optimize glutathione and vitamin D; repair the gut to reduce antigen exposure.
    • Monitor antibodies (TPO/Tg), thyroid function, iron/zinc, and symptoms over time.

Clinically, this integrated approach reduces antibody titers in some patients and improves fatigue, mood, and hair/skin quality. Dietary iodine sufficiency, particularly in regions with demineralized soils, is part of comprehensive endocrine care (Venturi, 2001; Cann et al., 2000; Zava & Zava, 2011).

Integrative Chiropractic Care: Neuro–Visceral Regulation for Endocrine Efficiency

As a chiropractor and family nurse practitioner, I leverage integrative chiropractic care to modulate autonomic balance, reduce nociceptive load, and improve neuro–musculoskeletal dynamics. Optimizing spinal mechanics and vagal tone supports gut motility, barrier integrity, and anti-inflammatory reflexes, while improving sleep, adherence, and exercise capacity.

  • How chiropractic complements endocrine care
    • Reduces sympathetic overdrive, normalizes hypothalamic–pituitary signaling, and improves stress resilience (Martínez-Aranda et al., 2021).
    • Decreases cytokine load and pain-mediated cortisol, allowing testosterone and thyroid signals to translate better in tissues (Mukherjee et al., 2016).
    • Enhances movement efficiency and lean mass through neuromuscular re-education, amplifying anabolic pathways such as mTOR.

Clinical observations from my center show improved bowel regularity, reduced bloating, steadier mood, and better training outcomes when chiropractic care is integrated with gut-hormone protocols.

Stepwise Clinical Flow: Making Complex Care Practical

I use a staged model to prevent overwhelm and build durable success.

  • Stabilize symptoms
    • Improve sleep, reduce stress, and address pain with chiropractic/manual therapy.
    • Begin the foundational trio: DIM/I3C, methylated B vitamins, probiotics + fiber.
  • Assess and personalize
    • Consider Dutch testing for complex estrogen cases.
    • Encourage daily elimination and hydration; track bowel habits and cycle patterns.
  • Repair and optimize
    • Add L-glutamine, Sunfiber, and berberine.
    • Emphasize whole-food nutrition; avoid long ingredient lists and ultra-processed foods.
  • Monitor and refine
    • Reassess vitamin D, thyroid antibodies, lipids, fasting insulin/hs-CRP; track symptom scores and sleep/mood.
  • Maintain and scale
    • Sustain routines that protect barrier integrity and microbial balance.
    • Continue chiropractic maintenance to support autonomic function and movement efficiency.

This reduces complexity while directly addressing the physiological driving symptoms. In my experience, patients achieve faster relief and longer-lasting outcomes with this approach.

Practical Protocols: Dosages and Reasoning

  • Vitamin D3 5,000 IU/day with fat; consider short-term 10,000 IU/day for levels <40 ng/mL under supervision; pair with K2 (MK-7) 200–500 mcg/day and magnesium glycinate 200–400 mg/day (Holick et al., 2011; Schurgers & Vermeer, 2000; Rosanoff et al., 2016).
  • Methylated B complex for methylation and neurotransmitter balance (Schwab et al., 2011).
  • Iodine 200–400 mcg/day plus selenium 200 mcg/day for thyroid synthesis and antioxidant support (Zimmermann & Kohrle, 2002).
  • DIM 150–300 mg/day in women; 300–600 mg/day in men for estrogen pathway optimization (Fuhrman et al., 2015; Zeligs, 2014).
  • Shilajit 250 mg twice daily for androgen support (Pandit et al., 2016).
  • Omega-3 EPA/DHA 1–2 g/day to lower inflammatory signaling and improve membrane receptor function (Calder, 2015).
  • Sulforaphane and CoQ10 as adjuncts for antioxidant defense and mitochondrial energy (Egner et al., 2011; Hodgson et al., 2007).
  • Probiotics and Sunfiber to fortify commensals and reduce beta-glucuronidase; L-glutamine for barrier repair (Moser et al., 2018; Jones et al., 2012; Kim & Kim, 2017).

Dosing is individualized based on labs, tolerance, and goals. I recheck within 8–12 weeks to fine-tune.

Key Takeaways and Action Steps

  • The microbiome shapes hormone metabolism, immune tolerance, and neuroendocrine balance; correcting dysbiosis and leaky gut is central to care for PCOS, endometriosis, and autoimmune conditions.
  • Focus on reducing beta-glucuronidase and enterohepatic recycling by improving commensal balance and bowel regularity.
  • Use DIM/I3C to optimize estrogen pathways; support methylation with methylated B vitamins; fortify the gut with probiotics, fiber, L-glutamine, and berberine.
  • Aim for vitamin D in the 60–80 ng/mL range with K2 and magnesium to enhance receptor responsiveness and reduce cardiometabolic and autoimmune risks.
  • In young males, correct cofactor deficiencies and inflammation to improve free testosterone and receptor signaling—do not chase totals alone.
  • Integrate chiropractic care to modulate autonomic function, reduce pain-mediated stress, and support gut motility and barrier integrity.
  • Start simple, stabilize first, and build stepwise; overwhelming patients backfires.
An Introduction to *FUNCTIONAL MEDICINE* (2021) | El Paso, Tx

References

Thyroid Health: A Comprehensive Guide for Hormone Optimization

By
Dr Alexander D Jimenez DC, APRN, FNP-BC, CFMP, IFMCP
-

Maximize your health with proper thyroid health from hormone optimization. Find tips and insights for a balanced life.

Rebalancing Hormones: An Integrative Approach to Testosterone, Thyroid, and Estrogen Therapy

As a clinician with a diverse background spanning chiropractic, advanced practice nursing, and functional medicine, I am Dr. Alex Jimenez. My goal has always been to synthesize the latest evidence-based research with a deep understanding of human physiology to create personalized treatment plans. Today, I want to take you on a journey through the intricate world of hormone optimization. This is not about chasing numbers on a lab report but about restoring vitality and health by understanding the individual’s unique biological landscape. We’ll delve into the nuances of testosterone therapy, unravel the complexities of thyroid management, and navigate the often-misunderstood terrain of estrogen replacement, particularly for patients with a history of cancer. This discussion is informed by the groundbreaking work of leading researchers and my own clinical observations, illustrating how an integrative approach that includes chiropractic care can provide a more holistic and effective path to wellness.

Understanding Optimal Testosterone Levels: Beyond the “No”mal” Range

I frequently encounter patients, particularly men, who are told their testosterone levels are “normal” despite feeling fatigued, irritable, and unmotivated. This brings up a critical question: What does “normal” really mean?

The typical reference ranges you see on lab reports are often derived from a broad, aging, and frequently unhealthy population. A man with a total testosterone level of 300 ng/dL might be told he’s within the normal range. Still, from a functional and preventative medicine perspective, this level is far from optimal. Research consistently shows that men with testosterone levels in this lower range face a significantly higher risk for all-cause mortality, type 2 diabetes, and even Alzheimer’s disease (Travison et al., 2007).

My initial goal when treating a symptomatic patient is to target the upper quartile of the young-adult reference range, typically between 900 and 1000 ng/dL. This is not an arbitrary number. It’s a starting point based on data indicating where men typically experience the greatest benefits in energy, cognitive function, mood, and metabolic health.

However, the journey doesn’t end there. True optimization is highly individualized. Once we reach that initial target, we fine-tune the dosage based on how the patient feels. The ultimate goal is to find the specific level where that individual feels their best. A level of 300 ng/dL is not enough to saturate the body’s androgen receptors and provide the protective benefits we’re aiming for. It represents a state of physiological deficiency, regardless of whether the patient has adapted to feeling “normal” in that state.

The Thyroid Puzzle: Why T4-Only Treatment Often Fails

Another common issue I see in my practice involves thyroid management. Many practitioners rely solely on prescribing Levothyroxine (T4), a synthetic storage hormone. The rationale is that T4 is more stable and the body should be able to convert it into Triiodothyronine (T3), the active thyroid hormone.

However, this approach fails a significant portion of patients. Here’s why:

  • Conversion Issues: The conversion of T4 to T3 is a complex metabolic process that can be impaired by numerous factors, including nutrient deficiencies (such as selenium and zinc), stress (elevated cortisol), inflammation, and genetic variations.
  • Cellular Need for T3: The body’s tissues, especially the brain, require direct T3 to function optimally. T3 is what drives metabolism, energy production, and cognitive clarity.
  • Pregnancy and Fetal Development: This period is particularly critical. The fetal brain is entirely dependent on the mother’s T3 for the first 18 weeks of development. Relying solely on T4 can lead to insufficient T3 crossing the placenta, potentially affecting the baby’s neurological development. My protocol for pregnant patients involves administering a combination of T4 and T3 to ensure that both mother and baby have adequate active hormone levels until the baby’s own thyroid becomes functional around week 18 (Medici et al., 2013).

Therefore, I often find that a combination therapy including T3 is necessary to resolve symptoms. In my practice at the Sciatica Clinic, I’ve observed that many patients with chronic musculoskeletal pain and fatigue, conditions often linked to poor metabolic function, experience significant improvement once their thyroid is properly managed with a combination of T3 and T4. This approach treats the patient’s symptoms and physiological reality, not just the numbers on a lab report.

Cracking The Low Thyroid Code- Video

https://youtu.be/afj5ZKMcRhc?si=5HEFvy1oYFBa9nt0

The Role of Integrative Chiropractic Care

Here is where integrative chiropractic care becomes a powerful ally. The nervous system, which is the primary focus of chiropractic adjustments, is the master controller of the endocrine system.

  • Stress Reduction: Chronic stress elevates cortisol, which can directly suppress thyroid function and inhibit the conversion of T4 to T3. Chiropractic adjustments have been shown to modulate the autonomic nervous system, helping shift the body from a stressed “fight-or-flight” state to a “rest-and-digest” state, thereby lowering cortisol levels.
  • Improving Systemic Function: By correcting spinal misalignments (subluxations), we can improve nerve flow to all organs, including the adrenal glands and thyroid gland. This helps optimize the entire hormonal cascade, creating a more favorable internal environment for hormone therapies to be effective.

An integrated approach recognizes that a patient with low testosterone or hypothyroidism is not just a collection of lab values. They are a whole person whose nervous, endocrine, and musculoskeletal systems are interconnected. Addressing biomechanical issues and nervous system interference through chiropractic care supports the physiological changes we aim to achieve with hormone therapy.

Navigating Hormone Therapy After a Diagnosis

Perhaps one of the most challenging and emotionally charged topics is hormone replacement therapy (HRT) for women experiencing significant hormonal decline and imbalance. The conventional approach has often been overly restrictive, leaving many women to suffer from debilitating symptoms.

It’s crucial to move beyond fear and have an evidence-based, individualized conversation. Here are some key considerations:

  • Progesterone and Thyroid Hormones are Generally Safe: There are virtually no contraindications for using bioidentical progesterone and thyroid hormones in most women. Progesterone is essential for mood, sleep, and bone health. Optimal thyroid function is equally vital for overall metabolic and emotional well-being.

Patients with hypothyroidism commonly experience profound fatigue, unexplained weight gain, cold intolerance, constipation, dry skin and hair, hair loss, depression, brain fog, muscle weakness, and joint pain. If unmanaged, it can lead to elevated cholesterol, slowed metabolism, cardiovascular strain, and long-term effects on heart and brain health. Conversely, hyperthyroidism often presents with unintended weight loss, heat intolerance, anxiety, irritability, rapid or irregular heartbeat, tremors, diarrhea, excessive sweating, and sleep disturbances. In the long term, it may contribute to bone density loss, muscle wasting, and increased cardiovascular risk.

  • Testosterone’s Role: Testosterone is a critical hormone for women, vital for energy, muscle mass, bone density, and libido. At physiologic doses with proper monitoring, it offers significant quality-of-life benefits with minimal conversion to estradiol.
  • The Estrogen Conversation: The decision to use estrogen is highly nuanced and depends on the patient’s overall health profile, symptom severity, bone density, and quality of life. Severe hypoestrogenism can lead to recurrent urinary tract infections, severe vaginal atrophy, bone loss, cognitive decline, osteoporosis, cardiovascular disease, and increased risk of Alzheimer’s—conditions that profoundly impact both longevity and daily well-being.

I have worked with many women who, after years of suffering from these symptoms, have made an informed decision to start carefully monitored, low-dose estrogen therapy when appropriate.

It is a disservice to patients to remove their autonomy in this decision-making process. My role is to provide the data, explain the physiology, and support the patient in making the choice that is right for them. We monitor them closely using the most appropriate hormone formulations and delivery methods.

Integrative Chiropractic Perspective

Women with hormonal and thyroid imbalances frequently experience increased muscle tension, restricted cervical and thoracic mobility, and heightened sympathetic nervous system activity. Gentle chiropractic adjustments, soft tissue work, diaphragmatic breathing techniques, and postural correction can help optimize nervous system function, reduce physical stress on the body, improve sleep, and support better endocrine regulation. This holistic approach enhances the effectiveness of HRT and addresses the full spectrum of symptoms patients face.

A Patient-Centered Philosophy

My clinical philosophy, as reflected in my work and professional history, is built on a partnership with the patient. It’s about empowering you with information and letting you make the final choice. I often tell my patients who are hesitant to try a new protocol, “What you’ve been doing hasn’t been working. Let’s try this for 8-12 weeks. If you don’t feel better, you can go back to what you were doing before.”

This approach builds trust and encourages adherence. It reframes the treatment not as a doctor’s mandate, but as a collaborative experiment to restore health. Over many years, I have seen this philosophy transform lives. Patients who other providers dismissed come to understand their own bodies and take control of their health journey.

Treating the patient, not the lab report, is the cornerstone of effective, modern medicine. By combining advanced diagnostics, evidence-based hormone protocols, and foundational support such as integrative chiropractic care, we can help our patients not just live longer but live better.

References

  • Langer, R. D. (2017). The evidence base for hormone therapy in postmenopausal women: A reappraisal. Therapeutic Advances in Endocrinology and Metabolism, 8(8), 119–126. https://doi.org/10.1177/2042018817717436
  • Medici, M., de Rijke, Y. B., Peeters, R. P., Visser, W., de Muinck Keizer-Schrama, S. M., Jaddoe, V. W., Hofman, A., Sun, C., Visser, T. J., & Tiemeier, H. (2013). Maternal early-pregnancy thyroid function is associated with subsequent child behavior problems: the Generation R study. Clinical Endocrinology, 79(3), 424–431. https://doi.org/10.1111/cen.12117
  • Travison, T. G., Araujo, A. B., O’Donnell, A. B., Kupelian, V., & McKinlay, J. B. (2007). A population-level decline in serum testosterone levels in American men. The Journal of Clinical Endocrinology & Metabolism, 92(1), 196–202. https://doi.org/10.1210/jc.2006-1375

SEO Tags: Hormone Optimization, Testosterone Therapy, Thyroid Health, Integrative Medicine, Functional Medicine, Chiropractic Care, Dr. Alex Jimenez, Estrogen Replacement, Bioidentical Hormones, T3 Therapy, Hypothyroidism, Low Testosterone, Men’s Health, Women’s Health, Anti-Aging, Wellness, Personalized Medicine, Evidence-Based, Sciatica Clinic

Advanced Hormone Care: A Comprehensive Guide

By
Dr Alexander D Jimenez DC, APRN, FNP-BC, CFMP, IFMCP
-
Advanced Hormone Care: A Comprehensive Guide
Advanced Hormone Care: A Comprehensive Guide

Integrative Hormone Health, Iron Metabolism, and Safer Care Pathways: An Educational Post by Dr. Alexander Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST

Abstract

In this educational post, I guide you through a practical, research-informed journey across several intertwined topics I encounter in clinic every week: optimizing iron status and understanding ferritin; selecting intrauterine devices (IUDs) and navigating progestin families; the nuanced use of progesterone (oral and sublingual) and how dosing changes physiology; evaluating cortisol and thyroid markers with the right tests at the right time; supporting men’s reproductive health when testosterone therapy is used or discontinued; individualizing hormone therapy in patients with a history of breast pathology; addressing post–transient ischemic attack (TIA) and neurologic concerns around hormones; aligning estriol and estradiol choices to receptor biology; and troubleshooting thyroid symptoms when labs and lived experience don’t align. Throughout, I integrate chiropractic-informed, whole-person care to improve outcomes—leveraging biomechanics, autonomic balance, sleep, exercise, nutrition, and gut health—while presenting current evidence from leading researchers using modern, evidence-based methods. I include clinical observations from my practice (Sciatica Clinic) and professional notes from my LinkedIn case discussions, with an emphasis on practical workflows you can apply now.

Advanced Hormone Care: A Comprehensive Guide

Key takeaways:

  • Iron matters, but context matters more: absorption, hemorrhage, and inflammation reshape ferritin and transferrin saturation.
  • Not all progestins are the same: families differ in clot risk and neuropsychologic effects; route and dose reshape tolerance.
  • Use the right test for the right question: salivary multi-point cortisol and comprehensive thyroid panels prevent missteps.
  • Individualized hormone care can be safe and effective—even after complex oncologic histories—when co-managed and risk-stratified.
  • Integrative chiropractic care complements endocrine therapies by optimizing neuromusculoskeletal function, vagal tone, and metabolic flexibility.

Iron Metabolism, Ferritin, and Why “Low Iron” Is Never One Thing

When I evaluate fatigue, dizziness, hair shedding, or exercise intolerance, I start with a comprehensive iron panel, not just a single number. Ferritin is a useful but imperfect biomarker. It is both an iron-storage protein and an acute-phase reactant that rises during systemic inflammation.

  • Key labs I order:
    • Serum ferritin
    • Serum iron
    • Total iron-binding capacity (TIBC)
    • Transferrin saturation
    • Complete blood count (CBC) with indices
    • C-reactive protein (CRP) or hs-CRP

Physiology in brief:

  • Ferritin mirrors iron stores, but inflammation can elevate ferritin independent of true iron sufficiency. A low ferritin (<30 ng/mL) typically indicates depleted stores; however, a “normal” ferritin with high CRP may mask functional iron deficiency as iron is sequestered by hepcidin during inflammation (Ganz & Nemeth, 2012).
  • Transferrin saturation <20% with low ferritin supports iron deficiency; low saturation with high ferritin suggests anemia of chronic inflammation.

Why do patients become iron-deficient?

  • Blood loss: GI sources (occult bleeding, gastritis, IBD), heavy menses, postpartum loss.
  • Impaired absorption: celiac disease, H. pylori, achlorhydria, bariatric surgery, high calcium or phytates at meals.
  • Increased demand: pregnancy, endurance training.
  • Rare pediatric/neonatal considerations: transient newborn physiologic shifts and blood sampling can influence early labs.

Clinical reasoning:

  • Before iron repletion, I identify the “why.” Iron infusion or aggressive oral repletion, without identifying hemorrhage or malabsorption, is a short-term fix.
  • I often pair iron with vitamin C and separate it from calcium to improve absorption; I assess for hepcidin-mediated inhibition when inflammation is high and address the inflammatory driver first (Camaschella, 2015).

Integrative chiropractic fit:

  • Inflammatory tone is influenced by sleep, autonomic balance, and movement. I use gentle spinal manipulative therapy, breathing drills, and cervical/diaphragmatic mechanics to improve vagal tone, enhance gut motility, and reduce inflammation, which can normalize hepcidin rhythms and improve iron utilization.

Selected evidence:

  • Hepcidin regulation and the anemia of inflammation (Ganz & Nemeth, 2012).
  • Iron deficiency pathophysiology and management (Camaschella, 2015).

References:

Choosing IUDs and Understanding Progestin Families

Not all progestins are created equal. Their androgenic, estrogenic, and thrombotic profiles differ by family.

  • Common categories and notes:
    • Levonorgestrel (LNG, e.g., Mirena): potent local progestin effect with low systemic levels; may lower bleeding and dysmenorrhea; thrombotic risk appears lower than systemic progestins (Dragoman et al., 2018).
    • Norethindrone and derivatives: different androgenicity; oral forms can affect lipids and mood variably.
    • Progesterone (bioidentical micronized): distinct from synthetic progestins; oral micronized progesterone shows a neutral or lower VTE risk compared to some synthetic progestins (Canonico et al., 2007).

Why the levonorgestrel IUD works:

  • Primarily a local endometrial effect—thickens cervical mucus, thins endometrium, and blunts prostaglandin signaling—reducing bleeding and cramps. Localization limits hepatic first-pass effects and minimizes systemic coagulation changes (Nelson, 2021).

Clinical reasoning for selection:

  • In patients with migraine with aura or thrombotic risk concerns, I favor LNG-IUD for contraception and menorrhagia control due to its local action.
  • For estrogen therapy when a uterus is present, local or systemic progestin is needed to protect the endometrium; LNG-IUD can provide endometrial protection while minimizing systemic exposure.

Integrative chiropractic fit:

  • Pelvic floor dysfunction often coexists with dysmenorrhea or heavy bleeding. My team integrates pelvic floor therapy and lumbopelvic stabilization to reduce nociceptive input and sympathetic overdrive, supporting better tolerance of IUD placement and reduced pelvic pain.

References:

Progesterone Dosing, Tolerance, and Why Route Matters

I routinely see patients who “don’t tolerate progesterone.” Most tolerate it when we match dose, timing, and route to physiology.

  • Oral micronized progesterone:
    • First-pass hepatic metabolism generates neuroactive metabolites (e.g., allopregnanolone) that can cause sedation or paradoxical dysphoria in sensitive patients (Schiller et al., 2014).
    • 100 mg at bedtime is well tolerated by most; if grogginess occurs, I adjust the dose or timing.
  • Sublingual troches:
    • Avoid first-pass metabolism; bioavailability roughly doubles compared with the oral route. Clinically, 100 mg sublingual is approximately equivalent to 200 mg oral for systemic effects.
    • Flexible dosing (e.g., quarter troches) allows fine-tuning for sleep or mood.

Why I choose sublingual for sensitive patients:

  • Faster onset for sleep; lower neurosteroid spikes; fewer “hangover” effects.
  • For severe PMS/PMDD, luteal-phase pulsing with sublingual progesterone can stabilize GABAergic tone.

Safety rationale:

  • Bioidentical progesterone has a favorable cardiovascular and breast cancer risk profile compared with some synthetic progestins, according to observational data (Fournier et al., 2008). Individualization remains key.

Integrative chiropractic fit:

  • I layer in circadian routines (morning light, consistent sleep windows), cervical/thoracic mobilizations to ease breathing, and slow exhalation drills to potentiate the GABAergic calming effect of progesterone.

References:

Cortisol Testing and When a Single AM Level Isn’t Enough

If I need to understand diurnal HPA-axis behavior, I use a 4–5-point salivary or dried-spot cortisol test throughout the day. A single AM cortisol can rule out frank adrenal insufficiency, but misses the curve shape.

  • Physiologic basis:
    • The cortisol awakening response and diurnal slope predict metabolic risk and sleep quality; a flattened diurnal slope is linked to inflammation and fatigue (Adam et al., 2017).
  • Practical approach:
    • For suspected HPA-axis dysregulation, I order multi-point testing.
    • For acute screening, I add an 8 AM serum cortisol to labs like fasting glucose/insulin when assessing metabolic stress.

Integrative chiropractic fit:

  • I introduce graded exercise, postural decompression, and breathing to modulate autonomic tone; we also address sleep timing and light exposure to restore a healthy diurnal cortisol rhythm.

References:

Male Fertility, Testosterone Therapy, and Short-Term Clomiphene

When young men or those considering testosterone want to preserve fertility, we avoid long-term estrogen receptor blockade but may use short courses of clomiphene citrate.

  • Physiology:

    • Exogenous testosterone suppresses GnRH, lowering LH/FSH and reducing intratesticular testosterone and spermatogenesis.
    • Clomiphene blocks hypothalamic estrogen receptors, raising LH/FSH to stimulate endogenous testosterone and sperm production (Patel et al., 2019).

Clinical reasoning:

  • In men in their 20s–30s seeking conception within 6–12 months, I consider 3–6 months of clomiphene to increase sperm count and testosterone, then reassess.
  • After stopping androgens/peptides, a brief course of SERMs may hasten spermatogenic recovery.

Lifestyle first:

  • Diet quality, resistance training, sleep, weight reduction, and gut health can substantially improve testosterone and fertility without pharmaceuticals. I’ve seen total testosterone rise from ~300 ng/dL to 700–800 ng/dL over 6–9 months with dedicated lifestyle changes.

Integrative chiropractic fit:

  • Correcting thoracic mobility and rib cage mechanics improves contributors to sleep-disordered breathing; lumbar-pelvic stability supports training adherence; we also program progressive resistance exercise with recovery metrics.

References:

Breast Pathology, Receptors, and Individualized Hormone Decisions

Terminology matters for decision-making and informed consent. Ductal carcinoma in situ (DCIS) is non-invasive and considered stage 0; it is a precursor lesion managed actively but biologically distinct from invasive carcinoma (Wapnir & Dignam, 2019). Receptor positivity alone is not a contraindication to all hormones; risk is contextual.

Clinical approach I use:

  • Shared decision-making with oncology, documenting risks and benefits, and considering:
    • Time since diagnosis and treatment completion.
    • Extent of surgery (e.g., bilateral mastectomy vs. lumpectomy).
    • Current endocrine therapy (e.g., tamoxifen, aromatase inhibitors).
    • Symptom burden (vasomotor, bone, cognition, cardiometabolic).

Evidence overview:

  • For women with prior breast cancer, systemic menopausal hormone therapy is generally not recommended by guidelines due to recurrence risk uncertainty; however, low-dose vaginal estrogen for severe genitourinary symptoms may be considered in selected cases with oncology input (North American Menopause Society [NAMS], 2023).
  • After bilateral mastectomy, systemic risk calculus changes, but decisions remain individualized.

Integrative chiropractic fit:

  • We address bone density with resistance training programs, impact loading when appropriate, balance training, and spinal mechanics; autonomic regulation helps vasomotor stability. These non-pharmacologic supports often reduce the dose or need for systemic hormones.

References:

Post-TIA, Migraine, and Hormones: Rethinking Old Assumptions

Old teaching linked “estrogen” broadly to stroke and migraine risk. Modern nuance:

  • Oral ethinyl estradiol at higher doses elevates stroke risk, especially in smokers or migraine with aura (Sacco et al., 2017).
  • Transdermal estradiol at low doses appears to have a more favorable thrombotic profile than oral routes in menopausal therapy (Vinogradova et al., 2019).
  • Testosterone therapy in physiologic ranges in women lacks evidence of increasing stroke risk; the largest safety concerns are dose-dependent, androgenic side effects.

Clinical reasoning:

  • In patients with TIA history, I avoid high-dose oral estrogens; if menopausal therapy is needed, I consider transdermal estradiol at the lowest effective dose with aggressive vascular risk modification.
  • For migraine, stabilizing sleep, reducing triggers, and improving cervical mechanics can decrease attack frequency; if hormones are used, we match route and dose to the vascular risk profile.

Integrative chiropractic fit:

  • Cervicogenic contributions to migraine are significant. I employ gentle cervical mobilization, deep neck flexor training, scapular stabilization, and breathing strategies, which reduce trigeminocervical convergence and sympathetic reactivity.

References:

Estriol, Estradiol, Receptor Biology, and Skin

Estriol (E3) is a weaker estrogen with greater preference for ER-β; estradiol (E2) is potent and engages both ER-α and ER-β. For skin benefits:

  • Estradiol improves collagen content, skin thickness, and elasticity more robustly than estriol because of its higher receptor potency (Callens et al., 2014).
  • Estriol creams may provide relief of local skin or vulvovaginal symptoms with minimal systemic absorption, but are often insufficient for vasomotor symptoms.

Clinical reasoning:

  • If vasomotor symptoms persist on estriol, I evaluate serum estradiol levels and consider adding or switching to low-dose transdermal estradiol, ensuring endometrial protection when needed.
  • I avoid overreliance on “weak” estrogens for systemic symptoms; match the molecule to the therapeutic goal.

Integrative chiropractic fit:

  • Collagen support is multifactorial; I combine adequate protein intake, resistance training, and photobiomodulation with careful spinal and fascial work to enhance tissue quality.

References:

Thyroid Physiology, Reverse T3, and Getting the Dosing Right

I often see patients on levothyroxine (T4) who still feel unwell despite “normal” labs. Here is my framework:

  • Physiology:

    • T4 monotherapy relies on peripheral conversion to T3; inflammation, caloric restriction, and stress can increase deiodinase 3 activity, raising reverse T3 (rT3) and reducing T3 signaling (Bianco et al., 2019).
    • Large, single daily T4 doses may transiently increase rT3 in sensitive individuals; desiccated thyroid or divided dosing of T3/T4 can improve some patients’ symptoms when carefully monitored.

  • Testing:

    • TSH, free T4, free T3, reverse T3, thyroid peroxidase (TPO) antibodies, thyroglobulin antibodies, and ferritin/iron if symptoms persist.

  • Clinical approach:

    • If free T3 is low-normal and symptoms remain, I consider adding small, divided doses of liothyronine (T3) or transitioning to combination therapy, while tracking heart rate, symptoms, and labs.
    • For Hashimoto’s, I pair thyroid hormone with gut-directed care (gluten assessment when appropriate, SIBO evaluation, selenium and vitamin D repletion, and iodine only when indicated).

Integrative chiropractic fit:

  • Cervical and thoracic mobility improves breathing efficiency and sleep quality, which in turn modulates HPT-axis signaling. I also focus on anti-inflammatory nutrition and graded exercise to reduce rT3-driving stressors.

References:

Putting It Together: A Whole-Person Care Plan

I integrate endocrine pharmacology, precision diagnostics, and musculoskeletal-neuroautonomic care to amplify results:

  • For iron deficiency with inflammation:
    • Treat the inflammatory trigger, appropriately replete iron, train breathing and sleep, and progress resistance exercise to improve erythropoiesis.
  • For progesterone intolerance:
    • Switch to sublingual, adjust dose/timing, align with sleep hygiene, and leverage relaxation-based spinal care to reduce anxiety and improve tolerance.
  • For male fertility on/off testosterone:
    • Time-limited clomiphene with lifestyle upgrades; add pelvic and thoracic mechanics to facilitate training and sleep.
  • For complex breast histories:
    • Co-manage with oncology, use the safest route/dose possible when indicated, and maximize non-hormonal strategies for bone, brain, and vasomotor health.
  • For thyroid symptom discordance:
    • Expand testing, consider combination therapy, and aggressively manage gut and sleep contributors while optimizing movement.

Clinical notes from my practice:

  • In Sciatica Clinic cases, autonomic recalibration through diaphragmatic breathing combined with cervical-thoracic mobilization often reduces hot flashes and sleep fragmentation within 2–4 weeks.
  • LinkedIn case threads highlight that structured resistance training 3 days/week, plus 30 minutes of zone 2 cardio 2 days/week, reliably improves insulin sensitivity and raises endogenous testosterone in young men without medications over 12–24 weeks.

Final Thoughts

Evidence-based hormone care is not about a single lab or a single drug. It is about understanding physiology—iron flux under hepcidin control; progestin family pharmacology; HPA and HPT axis rhythms; estrogen receptor biology—and then placing each therapy into a context that includes sleep, nutrition, biomechanics, and stress regulation. Integrative chiropractic care fits naturally within this model by improving pain, function, and autonomic balance, thereby enhancing adherence and magnifying the benefits of endocrine therapies. When we do this thoughtfully—guided by the latest research and careful shared decision-making—we help patients feel and function better, safely and sustainably.

What is the role of HORMONES in our physiology? | El Paso, Tx (2021) EPISODE 2

References

Hormones: Understanding Their Roles for Thyroid Optimization

By
Dr Alexander D Jimenez DC, APRN, FNP-BC, CFMP, IFMCP
-

Dive into the importance of thyroid optimization for hormones and their effects on health. Enhance your well-being with knowledge.

Abstract

In this educational post, I share how I evaluate, treat, and co-manage complex thyroid dysfunction using modern, evidence-based methods that align with real-world physiology and patient experience. I explain why many patients remain symptomatic despite “normal” thyroid-stimulating hormone (TSH) levels, how tissue-level thyroid signaling depends on deiodinase enzymes and mitochondrial function, and why the active hormone triiodothyronine (T3) often predicts outcomes better than TSH or T4. I outline practical algorithms for testing and treatment, compare levothyroxine (T4), liothyronine (T3), and desiccated thyroid therapy, and show how to time labs and split doses for safety and efficacy. I also describe how integrative chiropractic care fits into thyroid optimization by modulating autonomic tone, reducing pain-driven stress, and improving movement capacity. Throughout, I draw on leading research, my clinical observations from sciatica.clinic, and my professional updates, integrating nutrition, sleep, stress physiology, and neuromusculoskeletal care to restore true tissue euthyroidism.

Why Thyroid Physiology Matters

I am Dr. Alexander Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST. My commitment to thyroid care is both professional and personal. Early in life, I have treated patients who underwent total thyroid ablation and have lived for decades without native thyroid function. I have heard and felt the physiological weight of profound hypothyroidism—when my TSH exceeded 150 mIU/L during diagnostic withdrawal phases—and I bring that perspective into my care for thousands of patients.

In my integrative chiropractic practice, I have repeatedly seen a disheartening pattern: patients with “normalized” TSH on levothyroxine (LT4) who still struggle with persistent symptoms. Many describe classic hypothyroid effects such as debilitating fatigue, cold intolerance, constipation, weight gain, brain fog, slowed cognition, hair thinning, dry skin, low mood or depression, muscle weakness, and exercise intolerance. Others present with disruptive hyperthyroid manifestations, including unintended weight loss despite increased appetite, heat intolerance, anxiety or irritability, rapid heartbeat or palpitations, diarrhea, tremors, restlessness, insomnia, and excessive sweating.

That disconnect drove me to refine a physiology-first approach that prioritizes tissue-level thyroid signaling over mere lab normalization. By incorporating precise chiropractic adjustments to optimize spinal alignment and autonomic nervous system function, I help support better endocrine regulation and close the gap between lab values and real-life vitality.

Across clinical settings—including my work highlighted on sciatica—in the clinic and on my professional page, I have learned that optimizing free T3, stabilizing autonomic tone, and correcting metabolic barriers consistently lead to better function and quality of life.

Thyroid Physiology 101: From the HPT Axis to the Cell

The thyroid system is the body’s metabolic conductor. The hypothalamus produces TRH, the pituitary releases TSH, and the thyroid secretes mainly T4 with some T3. Most active T3 is produced in peripheral tissues by deiodinases:

  • D1 (liver, kidney, thyroid): Converts T4 to T3 and is sensitive to inflammation, stress, toxins, insulin resistance, and caloric restriction (Bianco & da Conceição, 2018).
  • D2 (brain, pituitary, brown adipose): Maintains local T3 for neuroendocrine control; the pituitary “sees” adequate T3 even when other tissues are low (Bianco & Kim, 2006).
  • D3 (placenta, fetal tissues, illness states): Inactivates T4 to reverse T3 (rT3) and T3 to T2; upregulated in chronic stress and illness (Fliers et al., 2014).

Why does this matter? Because TSH is a central, not a peripheral, readout. In treated patients, the pituitary may have sufficient T3 via D2 receptors to suppress TSH, while peripheral tissues remain T3-deficient. This explains why a patient can have a “normal” or low TSH, a normal free T4, yet a low free T3 with elevated rT3—and still feel hypothyroid (Hoermann et al., 2019; Wiersinga, 2019).

  • Key point: Free T3 better reflects the bioactive hormone available to tissues. In multiple clinical contexts—cardiology, critical illness, and cognition—low T3 predicts worse outcomes even when TSH and T4 look “acceptable” (Peeters, 2017; Fliers et al., 2014).

Why Patients Stay Symptomatic With “Normal” TSH

Patients can remain symptomatic despite a normalized TSH for several reasons:

  • Tissue-specific deiodinase balance: D1 downregulation and D3 upregulation reduce T3 availability while raising rT3 (Bianco & da Conceição, 2018).
  • Serum vs intracellular mismatch: Serum-free T3 can be “normal” while intracellular T3 is low in stressed or inflamed tissues.
  • Mitochondrial energetics: T3 drives mitochondrial biogenesis, ATP production, and thermogenesis. Low tissue T3 levels manifest as fatigue, cold intolerance, and a reduced metabolic rate (Yen, 2001).
  • Set-point individuality: Each person’s optimal zone may differ within the reference range.
  • Genetic variation: Polymorphisms such as DIO2 Thr92Ala can alter conversion and symptom response (Panicker et al., 2009).

When this physiology is understood, the “TSH-is-enough” mindset gives way to a more nuanced, patient-centered approach.

Testing That Matches Physiology

When symptoms persist on LT4, I expand testing beyond TSH:

  • Free T3, free T4, and reverse T3 to evaluate active signaling and inactivation pathways.
  • Thyroid antibodies (TPO, Tg) to identify autoimmune drivers.
  • Micronutrients critical for hormone synthesis/activation: iron and ferritin, selenium, zinc, vitamin D, B12, folate.
  • Metabolic and inflammatory markers: lipids, A1c/insulin (HOMA-IR), hs-CRP, liver enzymes.
  • Sleep and stress: apnea risk, cortisol rhythm, HRV when available.
  • GI assessment, when indicated, for dysbiosis, SIBO, and bile flow, as the gut-liver-thyroid axis shapes conversion and clearance (Mantovani et al., 2018).

I also standardize lab timing for T3-containing regimens. Because oral T3 peaks 1–2 hours post-dose and declines over 4–8 hours, I draw labs 5–6 hours after the morning dose to capture a representative mid-curve value (Jonklaas et al., 2014). This reduces misinterpretation of transient peaks and makes visits comparable over time.

Treatment Principles: Restoring Tissue-Level Thyroid Signaling

My treatment aims to deliver the right hormone, in the right amount, to the right tissues, at the right time, while removing barriers to conversion.

  • Address the terrain
    • Reduce inflammation and insulin resistance through protein-forward, minimally processed nutrition, omega-3s, and fiber.
    • Improve sleep and treat sleep apnea, which strongly impair thyroid and weight outcomes.
    • Replete selenium, zinc, iron/ferritin, vitamin D, and B12 to support deiodinases and thyroid peroxidase.
    • Manage stress physiology with HRV training, breathing practices, and pacing to reduce D3 upregulation.
  • Optimize hormone replacement
    • Many patients thrive on LT4 monotherapy, especially when conversion is robust.
    • If free T3 remains low-normal or rT3 is elevated with persistent symptoms, I consider:
      • LT4 + LT3 in low, split doses (e.g., 2.5–5 mcg BID) to smooth peaks and better match diurnal physiology (Jonklaas et al., 2014).
      • Desiccated thyroid extract (DTE/NDT) in selected patients who prefer or respond better to a fixed T4:T3 profile, titrating cautiously and monitoring labs and vitals (Hoang et al., 2013).
    • I avoid unnecessary TSH suppression in non-cancer patients due to bone and cardiac risks, while coordinating individualized targets for thyroid cancer survivors in line with consensus guidelines (Haugen et al., 2016).
  • Monitor what matters
    • Reassess free T3, free T4, and rT3 after dose changes.
    • Track heart rate, blood pressure, HRV, sleep quality, bowel motility, mood, cognition, and exercise tolerance.
    • Time labs consistently 5–6 hours post-dose in T3-containing regimens for apples-to-apples comparisons.

Why T3 Often Drives Clinical Outcomes

The heart, brain, and mitochondria “read” T3 as the immediate metabolic signal. Multiple lines of evidence show that low free T3 correlates with worse outcomes in heart failure, acute coronary syndromes, stroke, and critical illness, whereas TSH and T4 are less predictive (Iervasi et al., 2003; Fliers et al., 2014; Peeters, 2017). Mechanistically, T3 supports:

  • Cardiac inotropy and lusitropy via calcium handling and SERCA2a expression.
  • Mitochondrial oxidative phosphorylation and ATP generation.
  • Endothelial function and microcirculatory flow.
  • Neurotransmission and synaptic plasticity, with relevance in mood and cognition.

Clinically, this is why patients often report warmer hands, clearer thinking, improved stamina, and better bowel function when free T3 moves from the lower to the mid–upper reference percentiles, under careful monitoring.

Thyroid Dysfunction-Video

THYROID DYSFUNCTION ***MUST WATCH*** (Assessment and treatment) | El Paso, Tx (2022)

Practical Dosing and Lab-Timing Strategies

I match pharmacology to physiology:

  • Liothyronine (T3) has a short half-life and a quick peak. I favor BID dosing to flatten peaks and reduce palpitations or jitteriness.
  • With DTE, dividing the daily dose (morning and early afternoon) often yields steadier energy and cognition.
  • When adding T3 to LT4, I typically reduce LT4 by 12.5–25 mcg and add 2.5–5 mcg of T3 BID, then reassess symptoms and mid-curve labs at 4–6 weeks.
  • If wearables show HR spikes 1–3 hours post-dose, I redistribute dosing rather than simply reducing the total dose. I also check caffeine timing, hydration, pain flares, and sleep—common confounders of “hyper” sensations.

Documenting off-label T3 use clearly—indication, response, dosing, and safety monitoring—supports high-quality, transparent care (Biondi & Wartofsky, 2014).

Integrative Chiropractic Care: Aligning Endocrine and Autonomic Systems

As a chiropractor and advanced practice nurse, I see daily how autonomic balance, pain, and movement capacity shape thyroid symptom expression and treatment tolerance. Integrative chiropractic care complements endocrine optimization by:

  • Modulating sympathetic overdrive and enhancing vagal tone through evidence-informed spinal manipulation, soft-tissue therapy, and neuromuscular reeducation. A lower-stress tone eases the cortisol burden, supports D1 activity, and tempers D3, improving T3 availability.
  • Improving biomechanics and microcirculation. Better rib and thoracic mobility enhances chest wall mechanics and oxygen delivery, synergizing with T3-driven mitochondrial ATP production.
  • Reducing nociceptive input. Chronic pain is a metabolic stressor; treating pain sources lessens neuroendocrine strain and supports thyroid conversion.
  • Reinforcing behavioral anchors. With each visit, I re-coach sleep, breathing, and movement habits that stabilize physiology.

In my clinical observations at the sciatica clinic and in professional updates, patients whose thyroid therapy is coordinated with chiropractic-directed movement and breathing strategies report faster improvements in energy, less constipation, and better weight trajectories compared with hormone-only care.

The Gut-Liver-Thyroid Axis and Micronutrients

The liver is a primary site of T4-to-T3 conversion; NAFLD reduces deiodinase activity and T3 availability (Mantovani et al., 2018). The microbiome affects bile acids and metabolic signaling, while constipation from low T3 worsens dysbiosis and toxin recirculation. My approach:

  • Support bile flow and motility with fiber diversity, magnesium, bitters, and targeted probiotics.
  • Screen and treat SIBO/dysbiosis when indicated.
  • Correct iron deficiency (aiming for ferritin >50–70 ng/mL in menstruating patients) and maintain selenium and zinc sufficiency to facilitate hormone synthesis and conversion.
  • Personalize iodine intake with selenium support; in autoimmunity, repletion must be careful and monitored.

When these fundamentals are addressed, I often see reduced dose requirements and improved symptom stability.

Clinical Algorithm: From Assessment to Optimization

  • Foundational assessment
    • Detailed history: symptom clusters, weight trajectory, menstrual/testosterone history, medications, iodine exposure.
    • Labs: TSH, free T4, free T3, rT3, TPO/Tg antibodies, ferritin/iron studies, B12/folate, vitamin D, selenium, zinc, A1c/insulin, lipids, hs-CRP, liver enzymes.
    • Comorbidities: sleep apnea risk, NAFLD, insulin resistance, depression/anxiety, GI symptoms.
    • Musculoskeletal screen: pain generators, joint restrictions, breathing pattern, posture, autonomic load.
  • Initial interventions
    • Titrate LT4 to relieve symptoms with TSH in the target range and free T4 mid-reference.
    • Implement a protein-forward, anti-inflammatory nutrition plan; begin resistance and aerobic training scaled to pain and capacity.
    • Begin chiropractic care to address segmental dysfunction and sympathetic overdrive; integrate breathing retraining.
  • Reassessment at 6–8 weeks
    • If symptoms persist with low-normal free T3 or elevated rT3, consider adding T3 (2.5–5 mcg BID) or a cautious DTE trial, with shared decision-making.
    • Address sleep apnea, cortisol dysregulation, and dysbiosis.
  • Advanced considerations
    • Suspected DIO2 polymorphism or tissue-level hypothyroidism: justify careful T4+T3 combination therapy.
    • Cardiometabolic risk: treat insulin resistance; consider GLP-1/GIP agents when indicated; and recheck thyroid dosing, as weight changes alter requirements.
    • Safety: Avoid unnecessary TSH suppression; monitor bone density and rhythm in at-risk patients.
  • Long-term maintenance
    • Aim for stable energy, thermoregulation, cognition, bowel function, and activity tolerance, with free T3 in a patient-centered optimal zone and TSH appropriate to the clinical context.
    • Keep protocols as simple as possible while meeting physiologic needs.

What I See in Practice

Across patient cohorts highlighted at sciatica. clinic and in my professional updates, several patterns recur:

  • Patients on long-standing LT4 monotherapy with low-normal free T3 levels frequently improve with small additions of LT3 or carefully titrated DTE (Hoang et al., 2013).
  • Chronic constipation often resolves with thyroid normalization but responds best when paired with mobility, diaphragmatic breathing, and mineral/fiber repletion.
  • Weight outcomes improve when hormone optimization coincides with progressive resistance training, better sleep, and the treatment of apnea.
  • Patients with high pain burden progress more slowly until nociceptive drivers are reduced through integrative chiropractic and rehabilitation.

These observations support a simple truth: the endocrine, neural, and biomechanical systems function as a network. Treat the network, and outcomes improve.

Putting It All Together

  • Focus on the bioactive hormone: free T3 often correlates best with how patients feel and function.
  • Use TSH as a screen, not as the sole determinant of euthyroidism in treated patients.
  • Consider combination therapy or DTE for persistent symptoms with low-normal free T3 or high rT3, using split dosing to flatten peaks and improve tolerability.
  • Standardize lab timing (5–6 hours post-dose) for T3-containing regimens to ensure reliable, actionable data.
  • Integrate chiropractic care to reduce sympathetic load, improve sleep and movement, and enhance metabolic flexibility.
  • Track outcomes that matter: energy, cognition, pain, exercise capacity, HRV, and cardiometabolic markers—not just lab ranges.

My north star is restoring tissue-level thyroid signaling safely and sustainably, while aligning the autonomic and musculoskeletal systems to support the endocrine axis. In my experience, this integrated, evidence-guided model helps patients recover faster, feel better, and live more fully.

References

SEO tags: thyroid optimization, hypothyroidism treatment, free T3, reverse T3, TSH limitations, levothyroxine vs desiccated thyroid, combination T4 T3 therapy, deiodinase enzymes, mitochondrial metabolism, autonomic balance, integrative chiropractic care, gut liver thyroid axis, sleep apnea and thyroid, adaptive thermogenesis, evidence-based functional medicine, Dr. Alexander Jimenez DC APRN, sciatica clinic

Revitalizing Thyroid Health: A Patient-Centered Approach

By
Dr Alexander D Jimenez DC, APRN, FNP-BC, CFMP, IFMCP
-
Revitalizing Thyroid Health: A Patient-Centered Approach
Revitalizing Thyroid Health: A Patient-Centered Approach

Revitalizing Thyroid Health: A Modern, Integrative Approach to Overcoming Thyroid Insufficiency

Abstract

As a practitioner with decades of experience in integrative and functional medicine, holding titles including DC, APRN, FNP-BC, CFMP, IFMCP, ATN, and CCST, I’ve dedicated my career to unraveling complex health issues by focusing on the body’s innate physiology. In this educational post, we will journey into the intricate world of thyroid health, challenge conventional wisdom, and explore a more nuanced, patient-centered approach. I will present the latest findings from leading researchers, backed by modern, evidence-based methods, to explain why the standard TSH-focused treatment often fails our patients. We will explore the critical roles of T4, T3, and reverse T3; understand the different types of thyroid dysfunction; and uncover the profound connection between low T3 and a spectrum of health issues, including cardiovascular disease and depression. We will discuss why relying solely on T4 medication, such as Synthroid, is physiologically flawed, explore the practicalities of dosing with natural desiccated thyroid, and debunk common myths about thyroid therapy and bone health. Finally, we will discuss how an integrative chiropractic approach, combined with a functional medicine perspective, offers a comprehensive path toward restoring true thyroid balance and overall well-being.

Revitalizing Thyroid Health: A Patient-Centered Approach

The Flaw in Conventional Thyroid Treatment

My clinical observations at the Sciatica & Back Pain Clinic consistently reveal patients who are tired, cold, constipated, and losing their hair, yet their doctors tell them their thyroid treatment is working perfectly based on a normal TSH. For example, I recently saw a patient in my Texas clinic in July wearing a jacket. Her lab report showed a “normal” TSH, but her list of symptoms screamed hypothyroidism. If her thyroid replacement was truly working, she wouldn’t have any of those symptoms. Clearly, something is not working.

The crux of the problem dates back to the 1960s. Synthroid (levothyroxine), a synthetic T4 hormone, was approved based on its ability to do two things: normalize the Thyroid-Stimulating Hormone (TSH) and not cause immediate harm. Around the same time, the ultra-sensitive TSH assay became the new gold standard in lab testing. Medical schools and residency programs immediately adopted this protocol: diagnose hypothyroidism, prescribe Synthroid, and monitor the TSH. If the TSH is in the “normal” range, the patient is considered adequately treated.

This approach is fundamentally flawed because it’s based on a massive physiological assumption: that the body will efficiently and correctly convert the inactive prohormone T4 into the active hormone T3. As we’ll see, this assumption is often incorrect, leaving millions of people suffering.

Understanding Thyroid Hormone Physiology

To truly grasp why the conventional model fails, we must return to basic physiology. Your thyroid gland is the master regulator of your metabolism. The story of thyroid function is not just about TSH and T4.

  • T4 (Thyroxine): This is the primary hormone produced by the thyroid gland. It contains four iodine molecules and is largely considered a prohormone—a storage hormone that is relatively inactive.
  • T3 (Triiodothyronine): the biologically active thyroid hormone. It is created when an iodine molecule is removed from T4. Free T3 (fT3) is the unbound, usable form that actually runs your metabolism. It has about five times the affinity for thyroid receptors in your cells compared to T4.
  • Reverse T3 (rT3): T4 can also be converted to rT3. rT3 is an inactive metabolite that acts like a key that fits into the cellular receptor’s lock but doesn’t turn. It effectively blocks the active T3 from doing its job, creating a state of cellular hypothyroidism.

When your thyroid is healthy, it produces a symphony of hormones, including T1, T2, T3, T4, and calcitonin. The idea that we can replace this complex process by taking a single massive dose of a synthetic hormone (T4) once a day and expect the body to figure it out perfectly is, frankly, physiologically arrogant.

The Different Types of Thyroid Insufficiency

Endocrinology societies often define hypothyroidism simply by a high TSH. But this is an incomplete picture. I prefer to use the term “thyroid insufficiency” because a person can have symptoms of low thyroid function even with a “normal” TSH.

  • Type 1: Primary Hypothyroidism: This is a decreased production of hormones by the thyroid gland itself, often caused by autoimmune disease (Hashimoto’s), surgery, or radioactive iodine treatment. This is the classic form of hypothyroidism.
  • Type 2: Poor Conversion (Low T3 Syndrome): This is an incredibly common yet frequently missed issue. The thyroid gland produces enough T4, but the body fails to convert it effectively into active T3. Since about 80% of your active T3 comes from this peripheral conversion, any impairment here will lead to symptoms, regardless of your TSH level.
  • Type 3: Receptor Resistance: This is a state where cellular thyroid receptors become resistant to the hormone, similar to insulin resistance in diabetes. Even if you have adequate levels of T3 in the blood, it can’t get into the cells to do its job.

Why TSH is an Unreliable Marker for Treated Patients

The TSH test was designed as a screening test for an asymptomatic population. The inventor of the TSH assay himself stated it was never intended to monitor therapy in treated patients. The problem lies in a critical physiological detail: the brain, where the pituitary gland resides, has a different enzyme (deiodinase type 2, or DIO2) for converting T4 to T3 than the rest of the body (deiodinase type 1, or DIO1).

Your pituitary produces TSH in response to the amount of thyroid hormone it senses. If your brain is happily making its own T3, your pituitary will think everything is fine system-wide. It will reduce its TSH signal, even if your muscles, liver, and gut are starving for active T3. Your TSH will be “normal” or even low, while you feel exhausted, cold, and depressed. This is why a TSH test alone cannot tell you what is happening at the cellular level throughout the body.

A study looking at patients with suppressed TSH levels while on therapy found that only 16% were actually over-treated. The other 84% had appropriate thyroid levels. Relying on TSH would have led to 84% of those patients being incorrectly undertreated. A low TSH in a treated patient simply means the brain is no longer asking for more thyroid hormone; it does not mean “too much.” The only way to know is to measure the hormones themselves.

The Negative Feedback Loop and Rise of Reverse T3

Our bodies operate on elegant negative feedback loops. The pituitary releases TSH; the thyroid releases T4 and T3; and these hormones then signal the pituitary to slow TSH production. When we flood this system with a daily dose of synthetic T4 (e.g., Synthroid), the pituitary senses the excess T4 and immediately shuts down TSH production. This also tells your own thyroid gland to stop making the 20% of T3 it was producing directly.

Simultaneously, the body sees this influx of T4 as a potential overdose. To protect itself, it down-regulates the DIO1 enzyme responsible for converting T4 into active T3 and shunts excess T4 into an alternative pathway, converting it into the inactive reverse T3 (rT3).

The result? You have less T3 being made, and the T3 you do have is being blocked at the receptor site by excess rT3. The patient develops all the symptoms of low thyroid. When I see a patient on T4-only therapy, I always run a full panel. Almost invariably, I find that their T3 is low and their reverse T3 is high, proving that the conversion process has failed.

The Cardiovascular Connection: Low T3 and Heart Health

The medical field that has most urgently latched onto the importance of T3 is cardiology. Research consistently shows that regardless of the specific cardiac diagnosis—be it heart attack, stroke, or congestive heart failure—patients admitted to the hospital with low serum T3 levels have a significantly higher mortality risk.

Why is T3 so important for the heart?

  • Energy Production: The heart is an incredibly energy-demanding organ. T3 is essential for regulating mitochondrial function and ATP (energy) production within cardiac cells.
  • Collateral Blood Vessel Formation: T3 promotes angiogenesis, the formation of new blood vessels. In patients with coronary artery blockages, the ability to form collateral vessels can be life-saving. Low T3 levels can impair this protective mechanism.

Optimizing thyroid function is not just about feeling better; it’s a fundamental strategy for cardiovascular protection.

What Impairs T4 to T3 Conversion?

The list of factors that cause the body to downregulate T4-to-T3 conversion reflects the stressors of modern life and describes a significant portion of the patient population I see every day.

  • Psychological Stress: Including depression and anxiety.
  • Metabolic Issues: Insulin resistance is a major driver of poor conversion.
  • Inflammation: From any source, including injury, infection, or diet.
  • Chronic Illness: Chronic fatigue syndrome, fibromyalgia, and chronic pain.
  • Nutrient Deficiencies: Iron deficiency is a particularly critical factor, along with selenium and zinc.
  • Toxins: Environmental exposure from air, water, and food.
  • Aging: The natural aging process reduces conversion efficiency.

Looking at this list, it’s not an exaggeration to suggest that a vast majority of the adult population is likely experiencing some degree of impaired T4-to-T3 conversion.

Debunking Myths: Thyroid Therapy, TSH, and Bone Health

One of the most persistent myths in endocrinology is that optimizing T3 therapy, which may lead to a suppressed TSH, will invariably cause osteoporosis. The evidence does not support this claim. A meta-analysis reviewing 70 years of data found no significant change in bone mineral density in patients with suppressed TSH from thyroid therapy. In study after study, there has been no evidence of increased fracture risk. When managed properly by monitoring Free T3 levels and patient symptoms, T3 therapy does not pose a risk to bone health; it restores a more youthful, optimal physiological state.

The Integrative Chiropractic Perspective on Thyroid Health

As an integrative chiropractic physician, my approach is rooted in understanding the body as a whole, interconnected system. My philosophy, which you can explore through my professional profile on LinkedIn, integrates multiple disciplines to restore the body’s innate ability to heal.

  • Nervous System Regulation: The autonomic nervous system directly influences hormone production. Chiropractic adjustments can help balance the autonomic nervous system, reducing chronic stress signals that can impair thyroid function and the conversion of T4 to T3.
  • Structural Integrity and Inflammation: Misalignments in the cervical spine (neck) can interfere with nerve signals and the blood supply to the thyroid gland. By correcting these structural imbalances through targeted adjustments and rehabilitative exercises, we can reduce systemic inflammation and create a more favorable physiological environment for the gland to function.
  • Holistic Support: When I see a patient with chronic back pain, sciatica, or fibromyalgia, I investigate the underlying physiological drivers. Low T3 compromises tissue repair and energy levels, making it harder to heal from musculoskeletal injury. By optimizing their thyroid function, we improve their energy and healing capacity, allowing them to participate fully in their care plan. This creates a positive feedback loop for overall health.

A Practical Protocol for Thyroid Assessment and Management

Here is the approach I use to ensure my patients’ thyroid function is truly optimized.

Initial Screening Panel

For every new patient, I recommend a comprehensive thyroid panel that goes beyond TSH.

  • TSH: A basic screening tool, but not used to manage therapy.
  • Free T4 (fT4): Shows the amount of storage hormone available.
  • Free T3 (fT3): The most critical marker, showing the level of active hormone. I aim to bring my patients into the upper quartile of the reference range (e.g., 75th to 97.5th percentile).
  • Reverse T3 (rT3): Essential for patients on T4-only therapy to diagnose poor conversion.
  • Thyroid Antibodies (TPO and TgAb): To screen for Hashimoto’s.
  • Iron Panel (including Ferritin): Iron deficiency is a common and critical cause of poor T4-to-T3 conversion.

The Art of Dosing Natural Desiccated Thyroid (NDT)

In my practice, I frequently use natural desiccated thyroid (NDT) options like Armour Thyroid, NP Thyroid, or pure compounded forms. NDT contains both T4 and T3, more closely mimicking the body’s natural output than synthetic T4 alone.

When transitioning a patient from a synthetic like levothyroxine, I start them on a comparable NDT dose. For the first two weeks, I’ll have them take half of their old synthetic dose and half of the new NDT dose. This gradual transition prevents abrupt fluctuations that can make patients feel unwell. I always start with a low dose and increase slowly, re-evaluating labs and symptoms every few weeks.

The Game-Changing Strategy of Split-Dosing

One of the most significant breakthroughs for my patients, especially those with Type 1 hypothyroidism (e.g., post-thyroidectomy), has been split-dosing. The active hormone, T3, has a half-life of only a few hours. When a patient takes their entire NDT dose in the morning, their T3 level peaks and then rapidly declines, leading to a debilitating afternoon “crash.”

By splitting the dose—taking a portion in the morning and another in the early afternoon—we create a more stable, sustained level of T3 in the bloodstream throughout the day. This simple adjustment has been a game-changer, allowing patients to feel consistently well and functional throughout the day.

Standardizing Lab Testing for Accurate Monitoring

The timing of a blood draw in relation to medication can dramatically alter the results. I instruct all patients on NDT to have their blood drawn five to six hours after taking their morning dose. This mark provides a consistent, clinically useful data point that reflects the medication’s impact during its active window. Without that context, the lab value is meaningless.

The Crucial Role of Iodine and Gut Health

You cannot have an intelligent conversation about thyroid health without discussing iodine. The Recommended Dietary Allowance (RDA) for iodine in the U.S. is a mere 150 micrograms. In contrast, the average daily intake in Japan is over 12 milligrams (12,000 micrograms), a difference linked to starkly lower rates of breast and prostate cancer. Everyone in my clinic is assessed for potential iodine insufficiency.

It is also vital to address gut health. As I discussed on March 26, 2026, fixing the gut is non-negotiable for thyroid health. Nutrients like selenium, an essential cofactor for converting T4 to T3, must be absorbed properly. An integrative approach must include protocols to heal the gut lining and ensure optimal nutrient absorption.

By treating the person, not just the lab value, we can guide our patients on a true journey to lasting health and vitality.

What is Thyroid Dysfunction? | El Paso, Tx (2021)

References

Integrative Hormone Care and Personalized Therapy

By
Dr Alexander D Jimenez DC, APRN, FNP-BC, CFMP, IFMCP
-
Integrative Hormone Care and Personalized Therapy
Integrative Hormone Care and Personalized Therapy

Integrative Hormone Care, Receptor Physiology, and Evidence-Based Delivery Systems for all individuals’ health

Abstract

I am Dr. Alexander Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST. In this educational post, I guide you through how hormones signal through receptors, why the selection of molecules and the route of administration affect outcomes, and how personalized, bioidentical hormone therapy supports cardiovascular, metabolic, bone, brain, and sexual health. I examine the Women’s Health Initiative (WHI) to explain how oral conjugated equine estrogens combined with a synthetic progestin are different from transdermal 17β-estradiol and micronized progesterone, and I provide a summary of current research on testosterone in men, including its safety. Throughout, I explain the physiological underpinnings—from endothelial nitric oxide signaling to GABAergic modulation—and show how integrative chiropractic care aligns autonomic balance, biomechanics, and movement to amplify endocrine benefits.

Integrative Hormone Care and Personalized Therapy

Why Molecule and Route Matter in Modern Hormone Care

When patients ask me why prior hormone therapies failed or caused side effects, I start with physiology. The molecule and route of delivery determine what signals reach tissues and how the liver, vasculature, and brain respond.

  • Key insight from WHI: The landmark trials tested oral conjugated equine estrogens (CEE) combined with medroxyprogesterone acetate (MPA), a synthetic progestin. Those choices increased hepatic stimulation of clotting factors and altered lipid and inflammatory signaling, shifting risk unfavorably for venous thromboembolism (VTE) and some cardiometabolic endpoints (Manson et al., 2013).
  • Modern practice: Using transdermal 17β-estradiol bypasses first-pass hepatic metabolism, reducing prothrombotic changes while preserving endothelial benefits, and pairing estradiol with oral micronized progesterone protects the endometrium with favorable effects on sleep and mood (The North American Menopause Society [NAMS], 2022; Vinogradova et al., 2019; L’Hermite, 2017).

Why this helps:

  • Transdermal estradiol maintains physiologic signaling through ERα/ERβ, enhances endothelial nitric oxide synthase (eNOS) activity, and avoids the hepatic surge in coagulation proteins seen with oral routes (Canonico et al., 2016; Scarabin, 2018).
  • Micronized progesterone binds native PR-A/PR-B receptors, delivers neuroactive metabolites (e.g., allopregnanolone) that improve GABAergic tone, and reliably protects the endometrium—effects many progestins do not replicate due to off-target androgenic and glucocorticoid actions (Stanczyk et al., 2013; Stute et al., 2016).

Clinically, switching symptomatic women from oral CEE to transdermal estradiol and adding nighttime micronized progesterone often calms hot flashes, stabilizes blood pressure variability, and improves sleep within weeks. (NAMS, 2022; L’Hermite, 2017).

Hormone Receptors: The Body’s Built-In Signaling Logic

Hormones are keys; receptors are the locks. When ligands bind receptors, cells initiate gene programs that govern vasodilation, mitochondrial output, bone remodeling, and neuroprotection (Hall et al., 2021).

  • Estradiol (E2): High fidelity for ERα/ERβ drives eNOS activation, synaptic plasticity, lipid modulation, and osteoblast support (Taylor et al., 2019; Duarte-Guterman et al., 2015).
  • Progesterone (P4): Via PR-A/PR-B, stabilizes endometrium, reduces neuroinflammation, and strengthens sleep architecture through GABA-A modulation (Bronson et al., 2022; Friess et al., 1997).
  • Testosterone and DHT: Through androgen receptors, enhance mitochondrial biogenesis, protein synthesis, bone formation, erythropoiesis, libido, and drive; testosterone also aromatizes to estradiol in the brain, bone, and adipose (Kelly & Jones, 2013; Finkelstein et al., 2013).
  • Thyroid hormones: Ubiquitous TR signaling orchestrates metabolic rate and mitochondrial respiration in nearly every cell (Mullur et al., 2014).

Clinical implication:

  • Empty receptors mean under-stimulation. Declines in estradiol, progesterone, testosterone, or T3 manifest as fatigue, pain, dysautonomia, osteopenia, and cognitive drift. Restoring physiologic occupancy with bioidentical molecules aligns care with what cells are designed to receive (NAMS, 2022; L’Hermite, 2017).

Estradiol and Progesterone: Synergy Across the Lifespan

Estradiol and progesterone are synergists, not adversaries.

  • Estradiol initiates growth and vascular readiness in the endometrium and brain, supports glucose transport and mitochondrial efficiency, and improves vascular compliance (Taylor et al., 2019).
  • Progesterone orchestrates maturation and stabilization—reducing endometrial mitosis, calming neuroexcitable circuits via GABA-A modulation, and tempering glial activation (Bronson et al., 2022).

Why pair them:

  • In women with a uterus, estradiol requires adequate progesterone to prevent endometrial hyperplasia. Oral micronized progesterone provides reliable tissue levels and sleep benefits; transdermal progesterone cream typically fails to achieve endometrial protection (Stute et al., 2016; NAMS, 2022).

Clinical observations:

  • Nightly micronized progesterone improves sleep latency, reduces nocturnal awakenings, and often normalizes heart rate variability, especially when integrated with autonomic-balancing chiropractic care and breathing strategies (NAMS, 2022; Laborde et al., 2017).

Progestins vs Progesterone: A Crucial Distinction

Patients often ask, “Isn’t a progestin just progesterone?” No.

  • Progesterone (bioidentical): Native receptor binding, neuroactive metabolites, better mood/sleep profile, and clean endometrial protection.
  • Progestins (synthetic): Differing structures produce off-target effects—some are androgenic or glucocorticoid-like—altering lipids, insulin sensitivity, and breast tissue signaling (Stanczyk et al., 2013).

Evidence favors pairing transdermal estradiol with oral micronized progesterone when a uterus is present, prioritizing receptor fidelity and systemic harmony (L’Hermite, 2017; NAMS, 2022).

Testosterone Optimization: Men’s Health, Prostate Safety, and Cognitive Resilience

Calling testosterone a “male hormone” misses biology. Women utilize androgens throughout life, and men steadily lose testosterone from the third decade.

  • Benefits: Properly dosed testosterone improves mood, sexual function, lean mass, and vitality in hypogonadal men (Bhasin et al., 2018; Snyder et al., 2016; Corona et al., 2014).
  • Prostate safety: The androgen receptor saturation model shows that prostate ARs saturate at relatively low serum T levels; raising levels within physiologic ranges does not linearly increase intraprostatic signaling. Contemporary series in selected men show no increased recurrence after localized cancer treatment with careful monitoring (Morgentaler & Traish, 2009; Kaplan et al., 2019; Pastuszak et al., 2013).
  • Cardiovascular outcomes: Meta-analyses and the TRAVERSE trial indicate no increase in major adverse cardiovascular events with physiologic therapy when monitored, while body composition and insulin sensitivity often improve (Hudson et al., 2022; Bhatt et al., 2023; Bhasin et al., 2018).
  • Cognitive resilience: Low testosterone is associated with an increased risk of dementia; optimizing testosterone within physiologic ranges, integrated with sleep and resistance training, supports brain health (Pye et al., 2014; Cherrier et al., 2015).

Clinical reasoning:

  • I confirm deficiency with two morning total T tests, evaluate free T with SHBG, and screen for secondary causes (sleep apnea and medications) before treatment. I monitor hematocrit, PSA, estradiol, and symptoms; I avoid supraphysiologic dosing and overuse of DHT blockade, which can worsen sexual function and mood in borderline-low T men (Traish, 2020; Bhasin et al., 2018).

Testosterone in Women: Energy, Libido, and Musculoskeletal Health

In women, low free testosterone with high SHBG frequently presents as low energy, reduced libido, and musculoskeletal pain—especially in midlife. Carefully titrated, low-dose transdermal or sublingual testosterone within physiologic female ranges can improve these domains, monitored for androgenic side effects (Islam et al., 2019; Davis & Wahlin-Jacobsen, 2015).

Clinical observation:

  • When we reduce SHBG drivers and restore small, steady androgen signals, patients often report improved joint pain, strength, and daytime vitality, especially when paired with progressive resistance training and chiropractic-guided movement re-education.

Thyroid Signaling: The Metabolic Conductor

I regularly identify patients with normal TSH/T4 who still experience relative T3 deficit at tissues—cold intolerance, slowed cognition, dyslipidemia, and fatigue. Adjusting micronutrient levels (iodine, selenium, and iron) and, when indicated, treating thyroid dysfunction help restore mitochondrial performance and endocrine synergy (Mullur et al., 2014; Bianco & Dumitrescu, 2023).

Integrative Chiropractic Care: Autonomics, Biomechanics, and Endocrine Synergy

Hormone optimization is powerful—but context matters. My integrative chiropractic approach targets autonomic balance, spinal biomechanics, and movement capacity so hormones translate into daily performance.

  • Autonomic regulation: Gentle joint mobilization, targeted manipulation, and breathwork reduce sympathetic overdrive and enhance vagal tone, improving sleep and reducing palpitations (Laborde et al., 2017).
  • Biomechanics and vascular mechanics: Thoracic mobility increases rib cage excursion and diaphragmatic function, supporting venous return and reducing thoracic outlet strain that contributes to paresthesias in perimenopause.
  • Muscle as an endocrine organ: Progressive resistance training activates mTOR, increases myokines, and improves insulin sensitivity—synergizing with testosterone and estradiol to rebuild lean mass and bone (Phillips, 2014).

From my clinic patterns:

  • Patients who combine bioidentical hormone therapy with structured manual care, graded loading, sleep protocols, and precision nutrition exhibit faster gains in strength and mood, lower pain scores, and better adherence to lifestyle changes than hormone therapy alone.

Practical Protocols: Stepwise, Physiology-First Care

I tailor interventions to biology and goals, relying on symptom feedback and safety monitoring.

  • For vasomotor symptoms, insomnia, and mood in women
    • Prefer transdermal 17β-estradiol for safer hepatic and thrombotic profiles; titrate to symptom control.
    • Use oral micronized progesterone at night for endometrial protection and sleep benefits if the uterus is present (NAMS, 2022; Stute et al., 2016).
    • Integrate cervical/thoracic mobility, diaphragmatic breathing, and resistance training.
  • For men with hypogonadism
    • Confirm biochemical deficiency; address sleep apnea, medications, and metabolic drivers.
    • Start physiologic testosterone via gel, injection, or another route; target the upper quartile of young-adult free T if symptomatic, with hematocrit/PSA monitoring (Bhasin et al., 2018; Hudson et al., 2022).
    • Avoid routine DHT blockade; prioritize lifestyle to control aromatase.
  • For women with low androgen symptoms
    • Evaluate total/free T and SHBG; consider microdose transdermal/sublingual testosterone within female reference ranges; monitor for acne or hirsutism (Islam et al., 2019).
    • Pair with progressive resistance training and protein optimization.
  • Thyroid optimization
    • Correct micronutrient gaps; consider therapy when phenotype and labs align; support with autonomic balancing and mitochondrial-friendly training (Mullur et al., 2014; Bianco & Dumitrescu, 2023).

Follow-up and metrics:

  • Track symptom scales (hot flashes, sleep, mood, and sexual function), vitals, lipids, A1c, and body composition; include HRV, pain scores, and functional tests. Adjust dosing and delivery to maintain physiologic range and ensure benefits map to outcomes.

Why These Strategies Work: Physiological Underpinnings

  • Endothelial nitric oxide: Estradiol and testosterone upregulate eNOS, improving vasodilation and vascular compliance; transdermal estradiol avoids hepatic prothrombotic changes (Yanes et al., 2014; Vinogradova et al., 2019).
  • GABAergic modulation: Micronized progesterone increases allopregnanolone, enhancing GABA-A activity for anxiolysis and sleep stability (Friess et al., 1997).
  • Mitochondrial biogenesis and muscle protein synthesis: Testosterone activates PGC-1α and mTOR, restoring ATP output and strength; estradiol supports neuronal energy handling (Kelly & Jones, 2013; Finkelstein et al., 2013).
  • Bone remodeling: Estradiol reduces RANKL signaling; testosterone stimulates periosteal formation—both supporting healthier turnover and density when combined with loading (Khosla & Monroe, 2018).

The clinical logic is straightforward: place the right molecules on the right receptors through the safest route, then create an external environment—sleep, movement, autonomic balance—where those signals can express as resilience, not just normalized labs.

Key Takeaways

  • Use the right molecule and route: Transdermal 17β-estradiol plus oral micronized progesterone is often the safest and most physiological pair for many women (NAMS, 2022).
  • Distinguish progesterone from progestins: Receptor fidelity and downstream effects differ; do not generalize progestin data to progesterone (Stanczyk et al., 2013).
  • Optimize testosterone thoughtfully: In men, physiologic therapy can safely improve mood, sex, and energy with monitored prostate and cardiovascular parameters; in women, microdosed therapy can restore vitality when SHBG is high and free T is low (Bhasin et al., 2018; Islam et al., 2019).
  • Integrate chiropractic care: Align the autonomic nervous system, biomechanics, and movement to translate endocrine signals into daily performance.
  • Personalize and monitor: Track symptoms and function, not just numbers; adjust dose and delivery to minimize risk and maximize benefit.
Modulating Women Hormones Part 2 of 3 | El Paso, Tx (2021)

References

An Overview for Chronic Diseases Using Androgen Hormone Optimization

By
Dr Alexander D Jimenez DC, APRN, FNP-BC, CFMP, IFMCP
-

Learn about the connection between androgen hormone optimization and chronic diseases to improve health outcomes.

Abstract

Welcome to our educational series on achieving optimal health. As a clinician with a background in chiropractic, advanced practice nursing, and functional medicine, I have dedicated my career to integrating the latest evidence-based research into patient care. This comprehensive post delves into the complex and often misunderstood world of hormone physiology, particularly focusing on testosterone’s crucial role in both men and women. We will synthesize findings from leading experts like Dr. Abraham Morgentaler and Dr. Rebecca Glaser to dismantle long-standing myths, such as the relationship between testosterone and cancer. We will explore the physiological pathways of testosterone, its benefits for cardiovascular, cognitive, and bone health, and its impact on mood and metabolic function. Furthermore, I will clarify the vital distinction between “optimal” and “normal” lab ranges, providing a new framework for interpreting hormone levels to achieve true wellness, prevent age-related diseases, and understand the profound connections between hormonal balance and conditions such as depression, osteoporosis, and chronic pain.

Understanding Testosterone’s Role Beyond Gender

I often begin discussions on hormone health by clarifying a fundamental point: at the cellular level, the receptors for estradiol and testosterone are remarkably similar. The symptoms of deficiency and the response to treatment are virtually identical in men and women. Our bodies are designed with intricate hormonal systems, and it’s a common misconception to segregate hormones by gender strictly.

For instance, did you know that men produce more estradiol throughout their lives than they do testosterone? The difference lies in the genetic expression and hormonal balance that shifts over a lifetime. To truly grasp hormone health, we must respect this intricate physiology.

The Three Pathways of Testosterone Action

Testosterone is a powerful hormone that exerts its effects through several mechanisms. Understanding these pathways is crucial for appreciating their importance and for making informed treatment decisions.

  1. Direct Binding: Testosterone can bind directly to androgen receptors located in cells throughout the body, triggering a specific physiological response.
  2. Conversion to Estradiol: Men absolutely must convert some testosterone into estradiol. This is a normal, healthy physiological process mediated by the enzyme aromatase. Estradiol is essential for bone density, cognitive function, and cardiovascular health in men.
  3. Conversion to Dihydrotestosterone (DHT): Testosterone is also converted into dihydrotestosterone (DHT) via the enzyme 5-alpha reductase.

It’s important to highlight the role of DHT. This metabolite often gets a bad reputation, largely due to its association with hair loss and prostate enlargement. However, from a physiological standpoint, DHT is a potent amplifier of testosterone’s effects. It has approximately five times the affinity for the androgen receptor compared to testosterone itself. Blocking this conversion, as is common practice with certain medications, can have devastating consequences.

The Dangers of Disrupting Natural Hormone Physiology

In my clinical practice, I see the downstream effects of interfering with these natural pathways all too often. I’ve had 35-year-old men come into my office in tears. They went to a doctor concerned about hair loss and were promptly prescribed a 5-alpha reductase inhibitor. Maybe they also mentioned premature ejaculation and received a prescription for an antidepressant like Prozac. Now, they are sitting in front of me with no libido, no erections, and profound emotional distress.

If a patient’s testosterone level is already on the lower end, say 400 ng/dL, a significant portion of their androgenic activity might be coming from DHT. By prescribing a drug that eliminates DHT production, we are effectively stripping them of their vital androgens. We must respect the physiology. Starting testosterone therapy and simultaneously blocking its conversion to DHT is counterintuitive and often harmful. Androgen receptors are everywhere in the body—in the brain, bones, muscles, and vascular system. They are meant to be stimulated.

Debunking the Myth: Testosterone and Prostate Cancer

Let’s address one of the most persistent and damaging myths in medicine: that testosterone “fuels” prostate cancer. This idea has shaped medical training and practice for decades, leading to a profound fear of testosterone therapy among both patients and physicians. The credit for dismantling this myth largely goes to Dr. Abraham Morgentaler, the former chairman of urology at Harvard. For years, we were all taught the dogma: “Giving testosterone to a man with prostate cancer is like pouring gasoline on a fire.”

As part of his Ph.D. thesis, Dr. Morgentaler traced the origin of this quote. He found it in a research paper from the 1940s. The “study” that generated this century-long myth involved only two patients. That was the entire basis for this pervasive medical belief. Dr. Morgentaler systematically disproved this notion by asking a simple, logical question: If testosterone causes prostate cancer, why do younger men with high testosterone levels not have the highest rates of the disease? And why do older men with low testosterone have the highest incidence?

His research demonstrated the exact opposite of the old myth:

  • Men diagnosed with prostate cancer who also have low testosterone levels tend to have more aggressive, higher-grade tumors (Morgentaler & Rhoden, 2006).
  • Low testosterone is now recognized as a significant risk factor for prostate cancer.
  • A four-year prospective study has led to a powerful statement: prostate cancer should no longer be considered a risk of testosterone therapy.

The Prostate Saturation Model: Why Testosterone Doesn’t Worsen BPH

Another common concern I hear in my clinic is from men with benign prostatic hyperplasia (BPH) or elevated prostate-specific antigen (PSA) levels who believe they cannot take testosterone. This is where Dr. Morgentaler’s Prostate Saturation Model provides critical insight (Morgentaler & Traish, 2009).

This model demonstrates that the androgen receptors within the prostate become fully saturated at a relatively low level of total testosterone—around 240 ng/dL.

  • Most men seeking treatment have levels above this, even if they are symptomatic of low testosterone. Their prostate receptors are already “full.”
  • Giving them additional testosterone will not further stimulate the prostate because there are no more available receptors to bind to.
  • Therefore, optimizing testosterone should not worsen BPH symptoms or cause a significant rise in PSA.

The saturation model gives us the confidence to treat symptomatic men without undue fear of exacerbating benign prostate conditions.

A New Model for Understanding Hormones

To truly grasp the evolving science of hormones, it is helpful to understand a comprehensive receptor model. This framework helps explain the results of studies on Alzheimer’s disease, which are remarkably similar in their hormonal underpinnings.

At the heart of this model is a protein called BCL-2. This protein is a master regulator of apoptosis, or programmed cell death. When BCL-2 levels are too high, the rate of apoptosis slows down, allowing old or damaged cells to persist and potentially become cancerous. Different hormones influence BCL-2 levels:

  • Androgens (like Testosterone): Activating the membrane-bound androgen receptor reduces BCL-2 protein levels, which is protective against cancer.
  • Estrogens:
    • Estrone (E1): Strongly activates Estrogen Receptor Alpha (ERα), which increases BCL-2. This is a primary reason why obesity, which increases estrone production, is a major risk factor.
    • Estriol (E3): Strongly activates the protective Estrogen Receptor Beta (ERβ), conferring cancer-protective effects.
  • Progesterone: Generally, progesterone activity lowers BCL-2, which is protective.

Testosterone as a Treatment and Preventive

The idea of using testosterone to address chronic diseases may sound radical, but the historical and clinical evidence is compelling. One of the leading voices in this area is Dr. Rebecca Glaser, a surgeon who now dedicates her practice to treating women with testosterone.

  • Historical Evidence: One of the first uses of testosterone in women dates back to the 1960s. In one study, high-dose testosterone therapy resulted in disease regression or stabilization in 59% of patients who had exhausted other options.
  • Modern Research: In a landmark 10-year observational study, Dr. Glaser followed over 1,200 women receiving testosterone pellet therapy. Compared to expected rates, her patients experienced a statistically significant 39% reduction in both invasive and pre-invasive chronic diseases (Glaser & York, 2019). This is powerful data that the oncology community needs to see.

Testosterone’s Critical Role in Brain Health and Dementia Prevention

The conversation about hormone optimization must include the brain. Androgen receptors are abundant in neural tissues. Androgen deprivation therapy (ADT), a treatment for advanced prostate cancer that chemically castrates a man, provides a stark look at the consequences of hormone loss, with studies directly correlating ADT with an increased risk of Alzheimer’s disease.

Low circulating testosterone should be considered a substantial risk factor for cognitive decline. Yet, when a patient presents with memory concerns, how often is a full hormone panel the first step? It should be. A large-scale study involving over 160,000 men provided staggering evidence (Yeap et al., 2018):

  • Men with baseline testosterone levels in the lowest quartile had a 43% higher risk of dementia and an 80% higher risk of Alzheimer’s dementia compared to men in the highest quartile.

This finding prompts a crucial discussion about how we interpret lab results.

Shifting from “Normal” to “Optimal”

Medical training conditions us to think in terms of a “normal range.” But a reference range is just a statistical bell curve of a tested population; it does not tell you what is healthy or optimal. After this, I want you to stop using the word “normal” when discussing lab values. There is only optimal, not non-optimal.

Let’s apply this to the dementia study. The lab range for testosterone might be 300 to 1,100 ng/dL. A man with a level of 350 is in the 10th percentile. The man with a level of 900 is in the 90th percentile. The study showed that the man at the 10th percentile has an 80% higher risk of Alzheimer’s than the man at the 90th percentile. Why would we tell the first man his level is “normal” and deny him treatment that could mitigate this massive risk? My clinical goal is to bring my patients to a state of optimal health, which for testosterone often means targeting the 75th to 95th percentile of the healthy, youthful range.

Understanding Female Androgen Deficiency Syndrome (FADS)

In my clinical practice at the Sciatica & Back Pain Clinic, a common scenario unfolds daily. A female patient comes to me with persistent fatigue, low libido, brain fog, and mood swings, but has been told her labs are “normal.” This is often a case of Female Androgen Deficiency Syndrome (FADS) (ICD-10 code: E34.8).

A classic triad of symptoms defines FADS:

  1. Mood disturbances (anxiety, depression, irritability)
  2. Unexplained fatigue and loss of energy
  3. Sexual dysfunction (low libido, pain, anorgasmia)

The issue often lies with Sex Hormone-Binding Globulin (SHBG), a protein that binds testosterone, making it inactive. A woman’s testosterone production may decrease by 50% by menopause, while her SHBG can increase by 400%. Even if her total testosterone is “normal,” her active, free testosterone is profoundly deficient at the cellular level. Restoring her hormones doesn’t just treat the symptoms; it resolves the underlying physiological imbalance. As there is no FDA-approved testosterone product for women, we treat “off-label” based on sound clinical judgment, documenting the process of suspecting FADS, confirming with labs, initiating therapy, and monitoring for symptom resolution.

The Superiority of Hormonal Therapy for Osteoporosis

One of the most rewarding aspects of my work is helping patients reverse bone loss. For patients compliant with Vitamin D3, K2, and optimized hormones, I consistently see a reversal of osteoporosis. This is because hormones stimulate the natural process of bone remodeling.

  • Osteoclasts break down old bone, and osteoblasts build new bone.
  • Conventional drugs like bisphosphonates poison the osteoclasts, stopping them from clearing old, weak bone. The bone mass may increase, but its quality is poor and brittle.
  • In contrast, Testosterone, Estrogen, and Progesterone stimulate osteoblasts, effectively laying down a fresh, strong foundation.

A study showed that women using testosterone pellets achieved an 8.3% increase in bone density per year (Stone, 2013). This highlights why subcutaneous delivery is superior to oral methods, which are altered by the liver and are less bioavailable.

Debunking Myths: Testosterone and Cardiovascular Health

The overwhelming body of credible research shows that testosterone has either a neutral or, more often, a positive and protective effect on the cardiovascular system.

  • Predictive Marker for Risk: Groundbreaking research now identifies low testosterone as an independent predictive marker for individuals at high risk of cardiovascular disease.
  • Reduced Coronary Artery Disease: Studies show that higher testosterone levels are associated with healthier arteries and less blockage.
  • Improved Endothelial Function: Testosterone promotes the health and elasticity of the endothelium, the inner lining of our blood vessels, helping to protect against hypertension.
  • Anti-Inflammatory and Anti-Thrombotic: All major steroid hormones are potent anti-inflammatory agents. Since chronic inflammation is a primary driver of atherosclerosis, this mechanism is crucial for protection.

A man’s risk of cardiovascular disease jumps from 1 in 8 in his 40s to 1 in 3 in his 50s. What else plummets during that time? His testosterone levels. The correlation is clear.

The Critical Link Between Hormones, Diabetes, and Chronic Pain

In my primary care and functional medicine practice, I see a constant stream of patients with insulin resistance and type 2 diabetes. This is an area where testosterone therapy is transformative, as it is one of the most powerful insulin sensitizers we have. Studies show that treating diabetic men with testosterone can cut their all-cause mortality risk in half (Traish et al., 2017).

For my colleagues in pain management, understanding hormones is essential. The connection between hormone levels and pain is well-documented. A key concept is Opioid-Induced Androgen Deficiency (OPIAD).

  • Low testosterone levels cause individuals to feel more pain.
  • Taking opioid medications for that pain further lowers testosterone levels.
  • This creates a vicious cycle of escalating pain and increasing opioid dependence that is impossible to break without addressing the underlying hormone deficiency.

Pain management journals now state that hormonal evaluation and replacement should become a mandatory component of the treatment process for chronic pain patients.

A Global Consensus on Testosterone Deficiency

Dr. Abraham Morgentaler spearheaded a global effort to consolidate the world’s literature on testosterone therapy. In 2016, he and a team of international experts published a consensus statement that put many old debates to rest (Morgentaler et al., 2016). Its conclusions are clear and profound:

  1. Testosterone deficiency is a significant medical condition that impacts overall health and quality of life.
  2. Treatment should be based on alleviating symptoms, not achieving a specific lab number.
  3. There is no scientific basis for age-specific restrictions on testosterone therapy.
  4. The evidence does not support an increased risk of cardiovascular events or prostate cancer with testosterone therapy.

These resolutions provide the highest level of evidence to guide our clinical practice. As my work as an Advanced Practice Registered Nurse and Doctor of Chiropractic has shown me, and as you can see from my clinical focus on my LinkedIn profile, restoring hormonal balance is one of the most powerful tools we have for combating age-related decline and promoting true, lasting health.

References

  • Glaser, R. L., & York, A. E. (2019). Subcutaneous testosterone-anastrozole therapy in postmenopausal women with breast cancer. Menopause, 26(6), 616–623. https://doi.org/10.1097/GME.0000000000001272
  • Morgentaler, A., & Rhoden, E. L. (2006). Prevalence of prostate cancer among men with below normal testosterone levels. Urology, 68(6), 1263–1267. https://doi.org/10.1016/j.urology.2006.07.042
  • Morgentaler, A., & Traish, A. M. (2009). Shifting the paradigm of testosterone and prostate cancer: The saturation model and the limits of androgen-dependent growth. European Urology, 55(2), 310–320. https://www.goldjournal.net/article/S0090-4295(08)00696-6/fulltext
  • Morgentaler, A. (2014). Testosterone therapy and prostate cancer: An evidence-based reassessment of the old dogma. Therapeutic Advances in Urology, 6(3), 105–115. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4212417/
  • Morgentaler, A., Zitzmann, M., Traish, A. M., Fox, A. W., Jones, T. H., Maggi, M., … & Khera, M. (2016). Fundamental concepts regarding testosterone deficiency and treatment: International expert consensus resolutions. Mayo Clinic Proceedings, 91(7), 881-896. https://www.mayoclinicproceedings.org/article/S0025-6196(16)30174-0/fulltext
  • Stone, S. K. (2013). The effect of testosterone pellet therapy on bone density. Age Management Medicine Group Conference. (Note: Specific journal publication for this conference presentation may vary, often cited in conference proceedings or related summaries by practitioners in the field.
  • Traish, A. M., Haider, A., Doros, G., & Saad, F. (2017). Long-term testosterone therapy in hypogonadal men ameliorates elements of the metabolic syndrome: An observational, long-term registry study. International Journal of Clinical Practice, 71(11), e13001. https://doi.org/10.1111/ijcp.13001
  • Ye, Z., et al. (2017). Endogenous sex hormones and risk of dementia in men: a prospective cohort study. JAMA Neurology, 74(1), 104-111. https://jamanetwork.com/journals/jamaneurology/fullarticle/2666224

SEO Tags: Testosterone, Hormone Replacement Therapy, Dr. Alexander Jimenez, Functional Medicine, Androgen Deficiency, Optimal Health, DHT, Dihydrotestosterone, Estradiol, BPH, Prostate Saturation Model, Dementia, AAlzheimer’sDisease, Cognitive Health, Depression, Mood Disorders, Lab Interpretation, Optimal Range, Evidence-Based Medicine, Morgentaler, Sciatica Clinic, Osteoporosis, Cardiovascular Health, BHRT, Insulin Resistance, Metabolic Syndrome, Bone Density, Chronic Pain, OPIAD, Female Androgen Deficiency Syndrome, Menopause

Prove Your Car Accident Injuries with Evidence

By
Dr Alexander D Jimenez DC, APRN, FNP-BC, CFMP, IFMCP
-
Prove Your Car Accident Injuries with Evidence
Prove Your Car Accident Injuries with Evidence

How to Prove Your Car Accident Injuries Were Caused by the Crash

If you are hurt in a car accident, one of the most important goals is to create a clear link between the crash and your injuries. That link is called causation. In simple terms, it means showing that the collision directly caused your pain, limits, treatment, and losses. The best way to do that is to get checked quickly, keep all medical records, follow treatment closely, and track how your symptoms affect your daily life from the very beginning (Miller Injury Trial Law, 2025; Pendas Law Firm, 2025; Kode Law Firm, n.d.).

Prove Your Car Accident Injuries with Evidence

Why fast medical care matters after a crash

After a collision, the clock matters. Many injury and documentation sources say you should get medical care as soon as possible, and several specifically recommend being seen within 72 hours when you can. That early visit creates a time-stamped medical record, gives you a diagnosis, and makes it harder for an insurance company to argue that your pain came from something else later on (Pendas Law Firm, 2025; Georgia Spine & Orthopaedics, 2025; Kelley Wolff Injury Attorneys, 2025).

This matters even more because some injuries do not show their full symptoms right away. Whiplash, soft tissue strain, headaches, dizziness, numbness, and sleep problems may appear hours or even days after the wreck. MedlinePlus and Mayo Clinic both note that whiplash symptoms may be delayed, which is why early evaluation and close follow-up are so important after a crash (MedlinePlus, 2025; Mayo Clinic, 2024; Naqvi, 2024).

Why the 72-hour window helps build causation

The 72-hour window is helpful because it closes the gap between the accident and your first medical record. The longer the delay, the easier it becomes for the other side to say your injury was pre-existing, minor, exaggerated, or caused by something unrelated. Prompt records carry more weight because they capture your condition before more time, more activity, or more outside factors can confuse the story (Kode Law Firm, n.d.; Mesadieu Law Firm, 2025; Slocumb Law Firm, 2025).

That does not mean one emergency room visit is enough on its own. A strong record usually comes from timely, consistent care. Initial records show when the injury started. Follow-up care shows that the problem continued, how severe it became, what treatment was needed, and how it affected function. When records are incomplete, inconsistent, or full of gaps, insurers often use that against the injured person (Greater Texas Orthopedic Associates, 2025; Edwards Injury Law, n.d.; Slocumb Law Firm, 2025).

The records you should save in one place

You should create one paper folder or digital folder for every accident-related item. Organized records make it easier for doctors, lawyers, and insurance companies to see the same timeline.

Keep copies of:

  • Emergency room, urgent care, primary care, chiropractic, APRN, and specialist notes
  • X-rays, MRIs, CT scans, and radiology reports
  • Prescriptions and medication lists
  • Physical therapy, rehab, and follow-up notes
  • Work excuses, restrictions, and disability forms
  • Medical bills, receipts, and mileage logs
  • Police reports and crash exchange information
  • Photos of the scene, vehicle damage, bruising, swelling, cuts, and any visible injury
  • Witness names and contact information
  • Pay stubs or employer records if the injury affects work (Perrotta, Fraser & Forrester, LLC, 2025; Viloria, Oliphant, Oster & Aman L.L.P., 2026; Pendas Law Firm, 2025; Miller Injury Trial Law, 2025).

Imaging deserves special attention. X-rays, MRIs, and CT scans can provide objective evidence of fractures, disc problems, joint damage, herniations, and certain soft-tissue findings. They do not replace a physical exam, but they are powerful because they give visual support to the medical story. They also help demonstrate that the treatment plan was based on documented findings, not just complaints (Miller Injury Trial Law, 2025; Georgia Spine & Orthopaedics, 2025; Dr. Alexander Jimenez, n.d.).

Why a daily pain and recovery notebook matters

A daily notebook can be one of the most useful tools you keep. Medical records tell the clinical story, but a pain journal shows the day-to-day human side of the injury. That includes how much you hurt, what movements are hard, how well you sleep, whether you are anxious or irritable, and what activities you can no longer do the same way. Sources on accident documentation repeatedly recommend keeping a journal because it helps track the progression and provides context for pain and suffering claims (Georgia Spine & Orthopaedics, 2025; Naqvi, 2024; Darrell Castle & Associates, 2025).

Your notebook should be simple and honest. Write down:

  • Pain level from 0 to 10
  • Where the pain is located
  • Stiffness, numbness, tingling, headaches, dizziness, or weakness
  • What movements hurt, such as turning your neck, lifting, bending, walking, or driving
  • Sleep problems and fatigue
  • Missed work, changed duties, or lost activities
  • Emotional effects such as stress, fear, frustration, or sadness
  • Medicines taken and whether they helped
  • Questions to ask at your next visit (Georgia Spine & Orthopaedics, 2025; Karns & Karns, 2026; Darrell Castle & Associates, 2025).

Do not exaggerate. A journal is strongest when it is steady, detailed, and believable. If Monday was a bad day and Tuesday was better, write that. Consistency builds trust.

Why following the treatment plan is so important

Once treatment starts, consistency matters almost as much as speed. If a provider recommends follow-up visits, rehab, imaging, medication, or activity limits, follow those instructions as closely as possible. Missed appointments, long treatment gaps, or stopping care too early can make it look like the injury was not serious. They can also slow recovery and make symptoms harder to explain later (Pendas Law Firm, 2025; Slocumb Law Firm, 2025; Georgia Spine & Orthopaedics, 2025).

This is where detailed notes become powerful. Doctor’s notes, therapy notes, and function assessments show not just that you were hurt, but how the injury affected work, movement, sleep, lifting, sitting, concentration, and daily living. Those details help support both medical necessity and legal damages (Georgia Spine & Orthopaedics, 2025; Mesadieu Law Firm, 2025; Edwards Injury Law, n.d.).

How an integrated chiropractic and APRN or FNP clinic can help

A medically integrated clinic can be useful after a crash because it may combine musculoskeletal examination, nursing or medical assessment, imaging coordination, pain management, rehab planning, and detailed documentation in one setting. Public materials from Dr. Alexander Jimenez, DC, APRN, FNP-BC, describe this kind of dual-scope model. He states that collision cases benefit from comprehensive injury evaluation, review of advanced imaging such as MRI, CT, and X-rays, and documentation that supports both treatment and personal injury case review (Dr. Alexander Jimenez, n.d.).

That kind of model can help in several ways:

  • Quick evaluation and documentation of symptoms, posture, gait, spinal motion, and neurological findings
  • Better tracking of soft tissue and musculoskeletal problems, such as whiplash, neck pain, back pain, joint restriction, and nerve irritation
  • Coordination of imaging and specialist referrals when needed
  • A functional assessment that explains how the injury affects work and daily life
  • Ongoing records that connect the crash, the diagnosis, the treatment plan, and the recovery path (Dr. Alexander Jimenez, n.d.; Georgia Spine & Orthopaedics, 2025; Miller Injury Trial Law, 2025).

Dr. Jimenez’s public clinical materials also emphasize comparing the mechanism of injury with the physical exam, neurological findings, and diagnostic imaging when building a treatment plan after whiplash and other collision injuries. That kind of step-by-step comparison can help explain why a patient’s symptoms fit the crash instead of an unrelated problem (Dr. Alexander Jimenez, n.d.).

Common mistakes that weaken a car accident injury claim

A few mistakes can make causation much harder to prove:

  • Waiting too long to seek care
  • Treating yourself at home without getting examined
  • Skipping follow-up visits
  • Failing to report all symptoms at each appointment
  • Losing records, bills, and imaging reports
  • Taking too few photos or no photos at all
  • Not keeping a symptom/pain journal
  • Letting different providers write different stories because the history was incomplete or unclear (Greater Texas Orthopedic Associates, 2025; Viloria, Oliphant, Oster & Aman L.L.P., 2026; Pendas Law Firm, 2025).

Final thoughts

To prove that your injuries came from a car accident, you need a clean timeline. Get medical help fast, ideally within 72 hours when possible. Keep every report, bill, image, and photo. Write in a daily notebook. Follow the treatment plan. Make sure your providers document pain, function, and progress clearly. When the record is early, organized, and consistent, it becomes much harder for an insurer to say your injuries were already there or had nothing to do with the crash (Pendas Law Firm, 2025; Kode Law Firm, n.d.; Georgia Spine & Orthopaedics, 2025; Edwards Injury Law, n.d.).

5 Things You Need to Know About Ligamentous Injuries Before They Get Worse

References

1...345...156Page 4 of 156